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Abstract 
Cells undergo reprogramming/de-differentiation through nuclear and cytoplasmic 
remodelling. Autophagy is a physiological stress response, in which cytoplasmic 
contents including mitochondria are recycled to aid cell survival in response to 
nutrient starvation. It has recently been demonstrated that a functional autophagy 
response is required for factor-based reprogramming to pluripotency, but there is 
little work explicitly linking the stimulation of autophagy with the mechanism of 
cytoplasmic clearance and metabolic remodelling. Human multipotent stromal 
cells/mesenchymal stem cells (MSCs) are cells of mesenchymal origin, which are 
cultured as adherent monolayers in vitro. MSCs can also be cultured as 3D cell 
aggregates or spheroids. Variations in spheroid size should result in variations in 
nutrient availability. I hypothesised that in 3D spheroids, controlled autophagy, 
stimulated by nutrient deprivation, and balanced in favour of its pro-survival/anti-
apoptotic effects, would be sufficient to drive cytoplasmic remodelling and de-
differentiation towards a more primitive state. When MSCs were cultured under 
optimal conditions, they had a multi-lobed irregular nuclear morphology, and 
reduced staining for the heterochromatin marker H3K9me3. 3D spheroids increased 
expression of Oct4, Nanog, Sox2 and telomerase. Under optimal conditions markers 
of increased autophagy were observed along with indicators of a shift to anaerobic 
metabolism. Mitochondria underwent remodelling to a small, rounded morphology, 
highly similar to mitochondria observed in pluripotent cells. Furthermore, oxygen 
consumption rate reduced significantly in 3D culture, and genes associated with 
oxidative metabolism were down-regulated. 3D MSCs increased expression of early 
mesendoderm markers including Brachyury (T), Goosecoid, KDR, Mixl1 and 
CXCR4. In vitro haematopoietic induction stimulated disaggregated 3D MSCs to 
form blast-like colonies, whilst 2D MSCs were unresponsive to haematopoietic 
stimulation. On implantation into nude mice, 3D MSCs formed organised 
mesodermal tissues, indicating enhanced lineage-restricted regenerative capacity, but 
did not form teratomas, so avoiding associated risks. Strikingly optimal 3D culture 
restored proliferative capacity and reversed senescence-associated hypertrophy in 
culture-aged MSCs, suggestive of cellular rejuvenation. Together these results 
suggest that a scaled autophagy response could play a fundamental role in 
reprogramming/de-differentiation and tissue regeneration in human cells. 
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Chapter 1: Introduction 
1.1 An introduction to the field of pluripotent stem cell research 
Stem cells are undifferentiated cells, which have the capacity for self-renewal and 
can give rise to a number of different cells types through differentiation. Embryonic 
stem cells (ESCs) can be isolated from early embryos, and can give rise to all cells in 
the fully developed organism, so are termed pluripotent. Adult stem cells can be 
isolated from various tissues of the body, and can give rise to some but not all tissues 
of the organism, so are termed multipotent (Wagers and Weissman, 2004). Due to 
their capacity to generate different tissues, stem cells are of significant interest to the 
fields of regenerative medicine and cell-based therapies.  
In 2006 Takahashi and Yamanaka demonstrated the generation of pluripotent cells 
similar to embryonic stem cells (ESCs) from mouse fibroblasts by forced expression 
of four transcription factors – Oct4, Sox2, Klf4 and c-Myc. The cells generated from 
these experiments were referred to as induced pluripotent stem cells (iPSCs) 
(Takahashi and Yamanaka, 2006). One year later this group generated iPSCs from 
human fibroblasts using the same four factor approach (Takahashi et al., 2007), 
whilst at the same time the Thomson laboratory demonstrated the induction of iPSCs 
from human fibroblasts using a different four factor combination - Oct4, Sox2, 
Nanog and Lin28 (Yu et al., 2007). The generation of iPSCs represented a major 
advancement in stem cell research, with the possibilities it opened up for the 
generation of patient-specific cells. It could also be said to have redefined the way 
development and differentiation are viewed, demonstrating that differentiation is not 
an irreversible procedure, and that fully differentiated cells maintain the capacity for 
pluripotency if stimulated to undergo de-differentiation/reprogramming (Figure 1.1). 
The generation of iPSCs has contributed greatly to our understanding of pluripotency 
and differentiation, although in turn, the many years of research into embryonic 
development and pluripotency regulation prior to 2006 provided the basis on which 
iPSC generation was first established. 
19 
 
  
Figure 1.1. Schematic showing the effects of differentiation and 
reprogramming/de-differentiation on cell potency 
Differentiation of ESCs results in a progressive loss of potency. Differentiated 
cells can reacquire pluripotent characteristics through forced de-differentiation 
(reprogramming to pluripotency). Adult stem cells are multipotent, maintaining 
self-renewal and the potential to differentiate into some but not all cell types. 
Adult stem cells occupy a position between pluripotent ESCs and terminally 
differentiated cells in terms of potency. 
20 
1.2 Embryonic development and cell fate specification in vivo 
During mammalian development, fertilisation is followed by early cleavage, which 
gives rise to a solid mass of cells, known as the morula. The first cell specification 
events occur at around day 3.5 after fertilisation in the mouse embryo, with the 
formation of the blastocyst, and the specification of two distinct cell populations, the 
trophectoderm and the inner cell mass (ICM). The trophectoderm, which will give 
rise to the placenta and other extra-embryonic tissue, is positioned to the outer edges 
of the blastocyst, whereas the ICM is located towards one end of the blastocyst. 
Following blastocyst formation, at around 4.5 days post-fertilisation, the ICM 
divides into two regions; the outer cells become primitive endoderm, which will 
contribute to extra-embryonic tissues, whilst the inner layer of cells will go on to 
form the epiblast, which will generate the foetus (Figure 1.2).  The blastocyst then 
implants into the uterine wall and the extra-embryonic tissues form the placenta, 
whilst the epiblast forms a cup shape, following formation of the proamniotic cavity. 
At around day 6.5 after fertilisation, gastrulation marks the beginning of 
morphological patterning within the embryo and the specification of the 3 germ 
layers (Beddington and Robertson, 1999). 
1.3 Isolation and culture of pluripotent cells in vitro 
1.3.1 Mouse embryonic stem cells 
Control of embryonic development in these early developmental stages is regulated 
by a complex transcriptional network of both maternal and zygotic factors. Prior to 
the derivation of ESCs, researchers utilised embryonal carcinoma (EC) stem cells 
which can be isolated from teratocarcinomas and differentiated via embryoid body 
formation in vitro, as a model for development and cell fate determination in the 
early embryo (Martin and Evans, 1975). Teratocarcinomas are malignant germ cell 
tumours containing both somatic tissue and undifferentiated stem cells (the EC 
cells). Teratomas are distinguishable from teratocarcinomas, as they contain only 
somatic tissue. Teratocarcinomas continue to form tumours on serial transplantation, 
whilst teratomas are benign on re-transplantation because they do not contain EC 
cells (Andrews, 2002).  
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Figure 1.2. Schematic showing the first specification events in embryonic 
development during blastocyst formation 
Following cleavage in the early embryo, the blastocyst forms from the morula. At 
this point, two distinct cell populations are specified. The trophectoderm, 
localised to the outside of the blastocyst, will form extra-embryonic tissue (the 
placenta), whilst the inner cells, localised at one end of the blastocyst form the 
inner cell mass (ICM). The ICM will generate both primitive endoderm, from its 
outer layer, which forms extra-embryonic tissue, and epiblast, from the central 
ICM, which will give rise to the foetus. 
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Mouse ESCs were first isolated in the laboratory from pre-implantation embryos 
isolated and separated in vitro. Prior to this it had not been possible to maintain 
pluripotent cells isolated from early embryos in culture. However in 1981, cells from 
the ICM of diapause (Evans and Kaufman, 1981) or normal pre-implantation 
(Martin, 1981) embryos were isolated and passaged repeatedly on inactivated 
fibroblast feeder layers, either in serum-supplemented medium (Evans and Kaufman, 
1981), or EC cell-conditioned medium (Martin, 1981). The colonies formed by these 
cultured cells resembled the domed, tightly packed colonies observed in EC cell 
cultures. It was possible to generate embryoid bodies with the cultured cells in vitro, 
and they formed teratocarcinomas on subcutaneous implantation in mice. These 
early experiments defined the characteristics of ESCs, as cells which can be 
maintained as undifferentiated pluripotent cultures in vitro, and which can 
differentiate into tissues from all 3 germ layers both in vitro and in vivo (Evans and 
Kaufman, 1981; Martin, 1981). 
In early experiments to generate mouse ESCs in the laboratory, culture on mouse 
embryonic fibroblast (MEF) feeder cells was required to maintain the 
undifferentiated state. However in the mid-1980s a factor was identified which could 
maintain pluripotency in mouse ESCs in the absence of a feeder layer. A single chain 
glycoprotein was identified in media conditioned with Buffalo rat liver cells. When 
cultured in media containing this factor, mouse ESCs maintained an undifferentiated 
morphology, and expressed the pluripotency cell surface marker SSEA1, with no 
need for a feeder layer. On removal of the factor, ESCs underwent spontaneous 
differentiation, so it was termed ‘differentiation inhibitory activity’ or DIA. The 
protein sequence of DIA was found to be identical to leukaemia inhibitory factor 
(LIF), the term by which it is now referred to when used in mouse ESC culture 
media (Smith et al., 1988) Notably it was demonstrated that established mouse ESC 
lines cultured with LIF in the absence of feeders were capable of both chimera 
contribution and germline transmission. Furthermore it was shown that in the 
presence of LIF, it was possible to establish cultures of freshly-isolated mouse ESCs 
from blastocysts, and that feeder cells were not required for this process if LIF was 
added to the media. It was possible to passage ESCs isolated in the absence of 
feeders. These cells maintained a typical pluripotent morphology and character in 
culture in LIF-supplemented media, whilst LIF withdrawal stimulated 
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differentiation. ESCs isolated in the presence of LIF (without feeders) were also 
capable of chimera contribution and germline transmission (Nichols et al., 1990). 
Taken together this demonstrated that it was possible to isolate and maintain mouse 
ESCs, in LIF-supplemented media without feeder cells, and that these cells were 
developmentally equivalent to mouse ESCs isolated and maintained in traditional 
feeder based cultures. 
1.3.2 Human and non-human primate embryonic stem cells 
Human EC cells have variable cell line-dependent capacity to form tissues from all 3 
germ layers and are usually karyotypically abnormal. This means they are less useful 
as a model of pluripotent cells from the early embryo. Non-human primate (Rhesus 
monkey) ESCs were first isolated from in vitro-separated ICM in 1995. These cells 
expressed similar cell surface markers to human ECs – SSEA3, SSEA4, Tra-1-60 
and Tra-1-81 and had alkaline phosphatase activity (Thomson et al., 1995). The 
colony morphology of primate ESCs was much flatter than observed in mouse ESC 
colonies, with individual cells clearly visible. Primate ESCs could be maintained 
undifferentiated in culture for many passages on inactivated mouse feeder cells, and 
notably this state was LIF-independent, which distinguished these pluripotent cells 
from mouse ESCs. Unlike human EC cells, isolated primate ESCs were 
karyotypically normal. Implantation into SCID mice resulted in teratomas containing 
tissues from all 3 germ layers, which confirmed the pluripotency of primate ESCs 
(Thomson et al., 1995). 
Following on from this work with non-human primates, in 1998 Thomson derived 
the first human ESCs from embryos generated by in vitro fertilisation (IVF).  Cells 
isolated from blastocyst stage embryos resembled ESCs previously isolated from 
non-human primates, characterised by high nuclear to cytoplasmic ratio and 
prominent nucleoli. Human ESCs expressed the cell surface markers SSEA3, 
SSEA4, Tra-1-60 and Tra-1-81, and had high levels of telomerase activity. Their 
colony morphology was similar to that of non-human primates, but distinct from the 
domed colonies formed by mouse ESCs. Human ESCs could proliferate for many 
passages in vitro when maintained on MEFs and this was LIF-independent, 
highlighting the differing requirements for pluripotency maintenance in primate 
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versus mouse ESCs.  The pluripotency of human ESCs was confirmed by teratoma 
assays (Thomson, 1998). Another group also demonstrated the LIF-independent 
nature of undifferentiated human ESC cultures. Flat colonies resembling human ECs 
and primate ESCs, which expressed the cell surface markers Tra-1-60 and SSEA4, 
along with the pluripotency factor Oct4, could be maintained undifferentiated  in 
culture for many passages in the absence of LIF (Reubinoff et al., 2000). 
Whilst mouse ESCs require LIF for pluripotency maintenance, human ESCs require 
signalling through the transforming growth factor β (TGFβ)/Nodal/Activin pathways 
to maintain an undifferentiated state. Signalling through these pathways results in 
phosphorylation and nuclear localisation of Smad2/3. Inhibition of Smad2/3 
phosphorylation resulted in loss of Oct4 and Nanog expression in human ESCs, with 
colony morphology changes indicative of differentiation (James et al., 2005). 
Inhibition of activin binding was also sufficient to induce loss of pluripotency 
markers such as the cell surface marker Tra-1-60 in human ESCs. However this 
effect was diminished in cells over-expressing Nodal, indicating that Nodal could 
compensate for activin inhibition. It was also noted that in Nodal over-expressing 
cells, spontaneous differentiation was uncommon (Vallier et al., 2005). Taken 
together these results suggest that TGFβ/Nodal/Activin signalling, rather than LIF, is 
required for pluripotency maintenance in human ESCs. 
Recently it has been demonstrated that specific blockade of signalling pathways that 
induce differentiation can be used to maintain ESCs in an undifferentiated state. 
Autocrine fibroblast growth factor 4 (FGF4) stimulates the mitogen-activated protein 
kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway, and 
differentiation is induced by ERK activation. Whilst LIF can maintain mouse ESCs 
in their undifferentiated state, this does not occur by inhibition of ERK activation. In 
contrast a combination of inhibitors of MAPK/ERK signalling can prevent intrinsic 
stimulation of differentiation from within the ESC population itself (Ying et al., 
2008). ESCs cultured in the presence of an FGF receptor tyrosine kinase inhibitor, in 
combination with an ERK cascade inhibitor could be maintained undifferentiated for 
many cultures, although cell death at a reasonably high frequency was observed. The 
addition of a glycogen synthase kinase 3β (GSK3β) inhibitor, which acts to stimulate 
canonical Wnt signalling, improved viability in these cultures. The use of these three 
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inhibitors (3i) allowed highly efficient expansion of ESCs over many passages. 
ESCs cultured in these conditions maintained expression of pluripotency factors, and 
there was little/no expression of genes associated with differentiation. Expansion of 
ESCs in 3i conditions was comparable to expansion in LIF-supplemented media, and 
ESC clonogenicity was actually improved in 3i versus LIF-supplemented media. 
Combinations of 3i media comprising the FGF receptor inhibitor PD184352, the 
MEK (MAPK kinase) inhibitor PD0325901 and the GSK3β inhibitor CHIR99021 
(Ying et al., 2008), or the more simplistic 2i comprising PD0325901 and 
CHIR99021 (Silva et al., 2008) are now commonly used for the long-term 
maintenance of undifferentiated ESC cultures. 
1.3.3 Epiblast stem cells 
Mouse ESCs are derived from the ICM of the pre-implantation embryo, but it is 
possible to isolate pluripotent cells from the epiblast of post-implantation mouse 
embryos. Cells isolated from post-implantation epiblasts (EpiSCs) expressed the 
pluripotency markers Oct4, Nanog and Sox2. Furthermore, like mouse ESCs, 
EpiSCs could differentiate to form tissues from all 3 germ layers in embryoid bodies 
and formed teratomas on transplantation to nude mice. However, there are a number 
of defining characteristics which distinguish EpiSCs from mouse ESCs. EpiSCs are 
pluripotent because they have the ability to form teratomas, but unlike mouse ESCs, 
they are unable to contribute to chimeras when implanted in blastocyst stage 
embryos (Brons et al., 2007; Tesar et al., 2007). Passaging mouse ESCs using 
disaggregation to single cells is common practice, but in EpiSCs this results in 
increased cell death. Rather, EpiSCs require dissociation to small cell clumps (Brons 
et al., 2007). Expression of epiblast marker genes was observed in EpiSCs (Brons et 
al., 2007; Tesar et al., 2007), whilst the ICM –specific marker Rex1 was only 
expressed in mouse ESCs and not in EpiSCs (Brons et al., 2007). In the pluripotent 
ICM and in mouse ESCs, Oct4 expression is driven by the activity of its distal 
enhancer. In contrast, the proximal enhancer drives Oct4 expression in both the 
epiblast and EpiSCs (Tesar et al., 2007). In culture, EpiSCs form large flat colonies, 
distinct from the smaller domed colonies observed in mouse ESCs. In fact the 
colonies formed by EpiSCs much more closely resemble those of human ESCs 
(Bernemann et al., 2011; Brons et al., 2007; Tesar et al., 2007). Interestingly EpiSCs 
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and human ESCs also share regulatory signalling pathways. Whilst mouse ESCs are 
dependent on LIF/BMP signalling to maintain pluripotency, human ESCs rely on 
Activin/Nodal signalling. Reliance on Activin/Nodal signalling for pluripotency 
maintenance is also a characteristic of EpiSCs (Brons et al., 2007; Tesar et al., 2007). 
Blocking Activin/Nodal signalling with an Alk inhibitor induced differentiation in 
EpiSCs and human ESCs but not in mouse ESCs, demonstrating that in morphology 
and signalling pathway dependency, EpiSCs resemble human ESCs more closely 
than mouse ESCs. Dax1 is a key pluripotency regulator in mouse ESCs, but is not 
expressed in either EpiSCs or in human ESCs. Furthermore, gene expression 
analyses revealed that different EpiSC lines cluster together and distinct from mouse 
ESCs (Tesar et al., 2007). Although cells isolated from the post-implantation epiblast 
appear to represent a distinct pluripotent cell type, it has been demonstrated that 
some EpiSCs can be reprogrammed to an ESC-like state using the stringent culture 
conditions required for maintenance of mouse ESCs. It was observed that when 
isolated epiblasts were dissociated to single cells and maintained in culture in 
standard ESC media (supplemented with LIF), there was gradual appearance at 
relatively high frequency of ESC-like cells. With continued passaging, these cells 
reactivated a GFP reporter driven by the ICM/ESC-specific distal enhancer of Oct4. 
Furthermore, these colonies had strong alkaline phosphatase activity, which is not 
associated with EpiSCs, and were capable of chimera contribution on blastocyst 
injection. The authors suggested therefore that it was possible to reprogramme some 
EpiSCs to a mouse ESC-like state, capable of chimera contribution, through 
continued culture in mouse ESC media (Bao et al., 2009). It has recently been 
confirmed by another group that such culture conditions are sufficient to drive 
reprogramming of some EpiSCs to a mouse ESC-like state. However it was noted 
that variations between EpiSC lines can affect this reprogramming process. EpiSC 
lines expressing mesendodermal markers such as Brachyury (also known as T), 
Goosecoid and Mixl1 were refractory to reprogramming using mouse ESC culture 
conditions, and displayed reduced capacity to differentiate down neural lineages in 
vitro. In contrast, a number of EpiSCs which did not express these mesendodermal 
markers were easily reprogrammed to a mouse ESC-like state by culture conditions 
alone. It was suggested that EpiSCs expressing markers of mesendoderm may 
represent a different developmental state, with a reduced capacity for reprogramming 
in vitro. However it should be noted that all the EpiSC lines in this study were 
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capable of teratoma formation, so displayed pluripotency in the in vivo environment 
(Bernemann et al., 2011). The differing characteristics of ESCs from mouse and 
human have previously been explained by species variation. The identification of 
EpiSCs from mouse has highlighted the possibility that even amongst pluripotent 
cells, there exists different subsets with subtle variations in developmental potential. 
Further analysis and comparison of such cells may give important insights into early 
events in embryonic developmental which occur after ICM specification but before 
the loss of pluripotency and germ layer commitment. 
1.4 Transcriptional, epigenetic and metabolic signature of 
pluripotency 
1.4.1 The master transcriptional regulators of pluripotency 
Pluripotency is established and maintained by a transcriptional network, regulated by 
the pluripotency factors Oct4, Nanog and Sox2 (Boyer et al., 2005). Oct4 (also 
referred to as Oct3 and POU5F1) is a homeo-domain containing transcription factor 
expressed by pluripotent, undifferentiated EC cells and ESCs; expression of Oct4 is 
lost upon differentiation (Okamoto et al., 1990; Rosner et al., 1990). In situ 
hybridisation on mouse embryos detected Oct4 in a number of cell populations prior 
to implantation, but following implantation it was only present in the epiblast 
(Rosner et al., 1990). Oct4 is essential for correct ICM development in early 
embryos. Oct4
-/-
 embryos develop to the blastocyst stage, but the cells which should 
form the pluripotent ICM form a trophoblast- restricted cell population instead, 
which cannot maintain proliferation (Nichols et al., 1998). Precise control of Oct4 
expression levels is required to maintain pluripotency and self-renewal in ESCs. A 2-
fold increase of Oct4 expression resulted in differentiation towards extra-embryonic 
endoderm and mesoderm, evidenced by expression of Gata4 and Brachyury 
respectively. In contrast, ESCs formed trophectoderm, indicating a loss of 
pluripotency through de-differentiation, when Oct4 expression was repressed (Niwa 
et al., 2000). 
Nanog is another homeo-domain transcription factor, which is only expressed in 
pluripotent cells and is required for maintenance of pluripotency. Nanog 
overexpression could sustain self-renewal in murine ESCs in the absence of LIF, 
28 
which under normal culture conditions is required to prevent differentiation. 
However in the absence of LIF, endogenous Nanog was not sufficient to maintain 
ESC self-renewal. Loss of Nanog expression resulted in differentiation to extra-
embryonic endoderm (Chambers et al., 2003; Mitsui et al., 2003).  
The transcription factor Sox2 is an SRY-related HMG box gene family member. 
Sox2 is expressed in the ICM of blastocyst stage embryos and throughout the 
epiblast. When homozygous Sox2 mutants were generated, there was loss of the 
epiblast, and instead populations of trophectoderm and extra-embryonic endoderm 
were formed. Furthermore it was not possible to isolate ESCs from homozygous 
mutant embryos, demonstrating a role for Sox2 in epiblast maintenance and in ESCs 
(Avilion et al., 2003). 
Genome-wide chromatin immunoprecipitation studies revealed that Oct4, Sox2 and 
Nanog co-occupy a high number of genes, acting as both transcriptional activators 
and repressors. They form an auto-regulatory loop to regulate their own expression, 
and also activate the expression of other pluripotency related genes, along with 
components of the Wnt and TGF-β signalling pathways, which have been linked to 
the maintenance of pluripotency and self-renewal. Many key genes associated with 
lineage specification and development are co-bound and repressed by Oct4, Sox2 
and Nanog (Boyer et al., 2005). 
1.4.2 Chromatin organisation and regulation in pluripotency  
As well as these transcriptional hallmarks, pluripotent cells also have a characteristic 
chromatin conformation, which is distinct from that of differentiated cells. Within 
the interphase nucleus, DNA is packaged as chromatin, a complex of DNA and the 
histone proteins. The nucleosome is the functional unit of chromatin, consisting of 
146bp of DNA wound approximately one and a half times around a histone octamer 
of the four core histones (H2A, H2B, H3 and H4), (Kouzarides, 2007). Histone 
modifications most strongly associated with the establishment of chromatin domains 
are methylation and acetylation. Broadly speaking, there are two different chromatin 
conformations, heterochromatin and euchromatin, which are marked by 
characteristic histone modification profiles. Heterochromatin is transcriptionally 
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repressive, and is marked by tri-methylation of a number of lysine residues on 
histones 3 and 4 (H3K9me3, H3K27me3 and H4K20me3). Euchromatin can be 
marked by both histone acetylation and tri-methylation of histone 3 (H3K4me3, 
H3K36me3 and H3K79me3), and is transcriptionally permissive (Figure 1.3), 
although not all genes marked by euchromatin marks are being actively transcribed, 
rather they have a conformation which is permissive to transcription (Kouzarides, 
2007). 
It has recently been reported that the global profile of chromatin modifications is 
altered as cells progress though differentiation. In pluripotent ESCs there is an 
enrichment of histone modifications which mark euchromatic regions of the genome, 
as well as the transcriptional elongation-associated mark H3K36me2. Levels of the 
heterochromatin marker H3K9me3 are low in ESCs, and pluripotent cells show an 
increase in global transcription compared to differentiated cells. An interesting 
observation is that ESCs express some tissue-specific genes, albeit at extremely low 
levels (Efroni et al., 2008). This suggests that ESCs express many genes which one 
would expect to be repressed (i.e. those associated with tissue-specific 
differentiation). It is hypothesised that low level transcription of lineage-specific 
genes is necessary to maintain pluripotency and upon differentiation these genes are 
either up-regulated or silenced depending on their tissue specificity (Efroni et al., 
2008). Key developmental genes such as the Hox gene cluster are marked by 
bivalent domains in pluripotent cells. Bivalent domains are genome regions which 
are modified with both activating (H3K4me3) and repressive (H3K27me3) histone 
marks, and frequently overlap the transcriptional start sites of developmental 
transcription factors which are involved in lineage specification and are expressed at 
very low levels in ESCs. This is thought to maintain them in a ‘poised’ state. As 
cells differentiate, relevant lineage-specific genes are then either fully activated or 
repressed when cell fate is specified, by the addition/removal of the appropriate 
histone modification (Azuara et al., 2006; Bernstein et al., 2006). As differentiation 
proceeds, only genes related to a specific cell fate are expressed, whilst others 
become repressed, either by repressive histone marks and/or DNA methylation.  
Recent studies have linked the master transcriptional regulators of pluripotency with 
chromatin regulatory mechanisms, demonstrating how Oct4, Nanog and Sox2 can  
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Figure 1.3. Schematic showing the organisation and characteristic 
modifications of heterochromatin and euchromatin 
Chromatin can be organised into two conformations. Heterochromatin is 
repressive to transcription, with tightly packed nucleosomes, denying access of 
the transcriptional machinery to DNA. Characteristic modifications include tri-
methylation of specific lysine residues on histones 3 and 4. Euchromatin is 
transcriptionally permissive, with more widely spaced nucleosomes allowing 
access of the transcriptional machinery to DNA. Characteristic modifications 
include tri-methylation of specific lysine residues on histone 3, and histone 
acetylation. 
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cooperate with chromatin re-modellers to achieve the precise control of gene 
expression required for maintenance of pluripotency and self-renewal.  
1.4.3 Pluripotency regulation by chromatin remodelling factors 
Brg1 is the core catalytic subunit of an ATP-dependent chromatin remodelling 
complex. Brg1 binds both active and repressed genes in ESCs, and co-occupies 
many genes with Oct4, Nanog and Sox2 (Kidder et al., 2009). Reduction of Brg1 in 
mouse ESCs resulted in colony morphology changes indicative of differentiation and 
a reduction in alkaline phosphatase activity. Furthermore, decreased expression of 
pluripotency-related genes including Oct4 and Sox2, and increased expression of 
lineage specific genes was observed. Notably Brg1 regulated the expression of the 
polycomb group (PcG) proteins, which are known to co-bind with Oct4, Nanog and 
Sox2 at many repressed genes in ESCs. Reduction of Brg1 resulted in decreased 
expression of some PcG proteins (Kidder et al., 2009). 
The PcG proteins form complexes known as the polycomb repressive complexes 
(PRC) which act to repress gene expression through histone modification and 
chromatin condensation which prevents transcription of target genes. PRC2 catalyses 
the methylation of H3K27 and this histone modification (H3K27me3) is required for 
the association of PRC1, which alters chromatin to a condensed, non-permissive 
conformation (Boyer et al., 2006; Lee et al., 2006). Eed is a PRC2 component, and 
Eed
-/- 
ESCs failed to maintain pluripotency, so were prone to spontaneous 
differentiation. In Eed
-/- 
ESCs, there was an increase in expression of genes bound by 
the PcG proteins, so clearly a functional PRC complex acts to repress the expression 
of these genes in wild type ESCs (Boyer et al., 2006). Targets of the PRCs are key 
developmental regulators including the Hox, Pax, Sox, Fox and Tbx gene families, 
and many of these genes are co-occupied and repressed by Oct4, Nanog and Sox2 in 
pluripotent cells. The master regulators of pluripotency appear to act alongside PcG 
complexes to silence genes associated with lineage specification in ESCs and indeed 
many of these genes were up-regulated upon differentiation (Boyer et al., 2006; Lee 
et al., 2006). 
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As previously discussed, other histone modifications are associated with 
transcriptional repression. Jmjd1a and Jmjd2c are histone demethylases which act to 
demethylate H3K9me2 and H3K9me3 respectively. When Jmjd1a and Jmjd2c were 
knocked down using short hairpin RNAs (shRNAs), there were widespread effects 
on ESCs indicative of a loss of pluripotency. ESC morphology was altered to a more 
fibroblast-like state, with reduced alkaline phosphatase activity. There was a 
decrease in expression of Oct4, Nanog and Sox2 along with an increase in the 
expression of lineage specific genes. Furthermore, global levels of H3K9me2 and 
H3K9me3 increased, indicative of a shift to a more differentiated state (Loh et al., 
2007). The expression of Jmjd1a and Jmjd2c is linked to the master regulators of 
pluripotency. Oct4 binds both genes and depletion of Oct4 by RNA interference 
(RNAi) resulted in down-regulation of their expression. Furthermore Jmjd2c has 
been linked to the regulation of Nanog, as it binds Nanog, and Jmjd2c depletion 
resulted in reduced expression of Nanog due to an increase in the repressive 
modification H3K9me3 in the Nanog promoter (Loh et al., 2007). 
A number of chromatin modifying proteins and complexes act in the co-binding of 
pluripotency factor target genes, and in the regulation of expression of both other 
chromatin modifiers and the pluripotency factors themselves. This clearly highlights 
the complex transcriptional networks required in pluripotent cells to precisely control 
gene expression and maintain the capacity for pluripotency and self-renewal. 
1.4.4 Metabolic hallmarks of pluripotency 
Along with a characteristic chromatin conformation, the mitochondrial network of 
pluripotent cells is distinct from that of differentiated cells. GFP-labelling of a 
component of the pyruvate dehydrogenase (PDH) complex, which localises to the 
mitochondrial matrix, revealed significant differences in mitochondrial morphology 
and positioning in pluripotent human ESCs and differentiated fibroblasts. Human 
ESCs contain small, rounded perinuclear mitochondria, which under TEM 
microscopy were shown to contain few cristae. In contrast, fibroblasts have complex 
mitochondrial networks, localised to the cytoplasm, and made up of elongated, 
tubular, cristae-rich mitochondria (Varum et al., 2011). Pluripotent and differentiated 
cells also rely on different mechanisms for energy generation. Differentiated cells 
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undergo oxidative phosphorylation under normal oxygen conditions, which can 
produce up to 38 molecules of ATP per molecule of glucose. Pluripotent ESCs have 
a glycolytic metabolism, which produces only 2 molecules of ATP per molecule of 
glucose. Glycolysis is usually adopted under hypoxic conditions, and low oxygen 
conditions have been used for ESC culture. Strikingly though, ESCs are glycolytic 
even under normoxic conditions, and rely on a high glycolytic flux to meet their 
energy requirements. When ESCs are induced to differentiate, mitochondria develop 
to more complex tubular, cristae-rich morphologies, and a cytoplasmic 
mitochondrial network is established. There is also a metabolic shift from glycolysis 
to oxidative phosphorylation (Zhang et al., 2012). The events of in vitro 
differentiation mimic those observed in embryogenesis. Immediately following 
fertilisation, embryos have an oxidative metabolism due to the inheritance of 
maternal mitochondria. However as early cleavage occurs, the metabolism in the 
morula becomes glycolytic. Prior to implantation, the embryo exists in a hypoxic 
environment, and in the ICM, there are few immature, perinuclear mitochondria. The 
mitochondria observed in ESCs very closely resemble mitochondria of the early 
embryo (Varum et al., 2011). As observed in in vitro differentiation, there is a shift 
to oxidative phosphorylation in vivo, following implantation, as differentiation to the 
three germ layers progresses (Zhang et al., 2012). 
Taken together, these studies highlight the complex characteristic profile of 
pluripotent stem cells, with both transcriptional control and metabolic capacity 
playing a role in the establishment and maintenance of the pluripotent state.   
1.5 Generation of pluripotent cells by cloning and cell fusion 
In 1962 John Gurdon demonstrated the generation of pluripotential cells from 
differentiated epithelial cells. Labelled nuclei from Xenopus laevis intestinal 
epithelia were transferred into enucleated oocytes. The experiment generated a small 
number of viable tadpoles, which had arisen from the labelled transplanted nuclei. 
This suggests that oocytes can initiate the conversion of a differentiated nucleus to a 
pluripotent nucleus, which is then capable of development into a viable organism, 
demonstrating that differentiation is not an irreversible developmental progression. 
Differentiated cells must possess the genetic capacity to regain pluripotency, and 
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oocytes must contain factors which can initiate this process (Gurdon, 1962). Decades 
later this was followed by the generation of live mammals by somatic cell nuclear 
transfer (SCNT). It was first possible to generate lambs by this method from nuclei 
from an embryo-derived cell population and from foetal fibroblasts. Most 
significantly, this study produced ‘Dolly the Sheep’, the first mammal generated 
from adult cells by SCNT. This demonstrated that fully differentiated adult 
mammalian cells (in this case mammary epithelial cells from a six year old ewe) 
could be converted to pluripotency, and could generate viable organisms on 
transplantation into enucleated oocytes (Wilmut et al., 1997). The results of this 
study supported the work of John Gurdon and provided further evidence to 
demonstrate the plasticity of differentiated nuclei when exposed to factors contained 
in enucleated oocytes.   
It is also possible to generate pluripotent cells by cell fusion of ESCs with adult 
cells. Cells resulting from the fusion of mouse ESCs with Oct4-GFP reporter 
thymocytes expressed GFP in a pattern highly similar to endogenous Oct4 
expression in ESCs. Furthermore the thymocytes used for fusion experiments were 
XX female, with an inactive X-chromosome and stable expression of the long non-
coding RNA Xist. Following fusion the hybrid cells reactivated the inactive X-
chromosome derived from the female thymocytes and expression of Xist was 
unstable, similar to undifferentiated cells. On injection into normal blastocysts, 
hybrid cells were capable of some chimera contribution, demonstrating pluripotency 
(Tada et al., 2001). Cowan and colleagues demonstrated that this technique could 
also be applied to reprogramme human cells, when cells with characteristics similar 
to ESCs were generated from fusion of ESCs with fibroblasts. Cells produced from 
these fusions had an ESC-like morphology and expressed ESC surface markers 
SSEA4, Tra-1-60 and Tra-1-81. They also reactivated expression of pluripotency-
associated genes Oct4, Nanog and Rex1. Telomerase activity was detectable in 
hybrid cells, which could be maintained in culture for many passages. Hybrid cells 
had a highly similar global gene expression pattern to ESCs. They formed embryoid 
bodies in vitro, and teratomas when transplanted into nude mice, confirming the 
pluripotential of hybrid cells (Cowan et al., 2005). These studies demonstrated that 
cell fusion with pluripotent cells is sufficient to convert differentiated cells to the 
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pluripotent state, and that ESCs possess the factors required to initiate this 
conversion. 
1.6 Induction of pluripotency by forced expression of transcription 
factors 
1.6.1 Induction of pluripotency in mouse somatic cells 
In 2006 Takahashi and Yamanaka demonstrated that the forced expression of just 
four factors could convert mouse embryonic fibroblasts (MEFs) and adult mouse 
fibroblasts to ESC-like pluripotent cells. 24 candidate genes were selected for 
screening due to their expression in ESCs and/or roles in pluripotency maintenance. 
These genes were introduced into Fbx15- reporter MEFs by retroviral transduction. 
Expression of Fbx15, which is downstream of Oct4 and is expressed specifically in 
mouse ESCs and the early mouse embryo, lead to activation of the promoter reporter 
and conferred antibiotic resistance on MEFs, indicative of successful 
reprogramming. The combination of Oct4, Sox2, Klf4 and c-Myc (OKSM) 
generated ESC-like cells which could be maintained undifferentiated in culture, 
termed induced pluripotent stem cells (iPSCs). These cells formed embryoid bodies 
in vitro and teratomas when transplanted into nude mice (Takahashi and Yamanaka, 
2006). Although morphologically similar to ESCs, expression of endogenous Oct4 
and Sox2 was variable between clones in Fbx15-selected iPSCs, due to partially 
maintained methylation in the promoter regions of these genes. Furthermore, these 
iPSCs were unable to form viable adult chimeras, and subsequently were unable to 
contribute to germline transmission when injected into blastocyst stage embryos. The 
cells generated in this study represented a pluripotent cell type, generated from 
somatic cells, which were quite distinct from mouse ESCs (Takahashi and 
Yamanaka, 2006). A schematic of iPSC generation is shown in Figure 1.4.  
Whilst Fbx15 is expressed in mouse ESCs and the early embryo, it is not essential 
for the establishment or maintenance of pluripotency. As previously discussed, Oct4 
and Nanog are key pluripotency regulators, and so the use of Oct4 (Wernig et al., 
2007) or Nanog-reporter MEFs (Okita et al., 2007; Wernig et al., 2007) provides 
more stringent evidence of reprogramming to pluripotency. Oct4-and Nanog-
selected iPSCs could be stably cultured for many passages in vitro. Unlike Fbx15- 
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  Figure 1.4. Schematic showing a typical time line for the generation of 
pluripotent iPSCs from differentiated cells using lentiviral vectors 
Differentiated cells can be reprogrammed to pluripotency by forced expression of 
transcription factors. These factors are commonly transduced into cells using 
lentiviral vectors. Following treatment with lentiviruses, differentiated cells are 
typically counted, and re-seeded onto irradiated MEF feeder cells around 5 days 
after transduction. The differentiated cells are then maintained in ESC media. 
ESC-like colonies will begin to appear, this can take less than two weeks, or up to 
a month after transduction. Oct4-GFP reporter cells are commonly used, as GFP 
fluorescence can be used to identify colonies which have reactivated endogenous 
Oct4 expression. iPSC colonies will proliferate in culture in a similar manner to 
ESCs, and should be expanded for full characterisation. 
37 
selected iPSCs, Oct4 and Nanog promoters were largely unmethylated in Oct4 and 
Nanog-selected cells. The cells formed teratomas containing tissues from all three 
germ layers, but unlike Fbx15-selected cells, were also capable of both chimera 
contribution and germline transmission (Okita et al., 2007; Wernig et al., 2007). 
There were many more colonies in Fbx15-selected cultures than in Nanog-selected 
cultures, demonstrating that activation of the Fbx-15 gene reporter was much more 
efficient than Nanog-reporter activation. However, Nanog-selected iPSCs were 
capable of sustained pluripotency factor expression in vitro, whilst this was lost with 
passaging of Fbx15-selected cells. It was also possible to propagate Nanog-selected 
iPSCs in the absence of feeder cells in LIF-supplemented media. In contrast Fbx15-
selected colonies were feeder-dependent and underwent spontaneous differentiation 
in the absence of feeder cells, even in the presence of LIF (Okita et al., 2007). 
Although Wernig and colleagues could generate iPSCs highly similar to ESCs from 
both Oct4 and Nanog-reporter MEFs, the authors noted that there was variation in 
the colonies generated, depending upon the selection genes used, even within their 
own system. Whilst Nanog-selection gave rise to more colonies overall, Oct4-
selection produced more colonies which were morphologically similar to ESCs, and 
generated a higher number of stable, homogeneous iPSC colonies. Reprogramming 
to pluripotency using Oct4-reporter MEFs was a gradual process. SSEA1 expression 
and alkaline phosphatase activity were observed some time prior to the expression of 
detectable levels of Nanog protein. Although Nanog-reporter MEFs generated more 
GFP-positive colonies, fewer of these were typical ESC colonies which could go on 
to establish stable iPSC lines, than those generated using Oct4-reporter MEFs. This 
suggested that the Nanog locus was more easily activated by exogenous pluripotency 
factor expression and highlights issues with the use of Nanog expression as a marker 
of reprogramming to pluripotency. Certainly this side by side comparison identified 
endogenous Oct4 activation as the most stringent marker of reprogramming to 
pluripotency that had been tested up to this point (Wernig et al., 2007). 
1.6.2 Reprogramming to pluripotency in the presence and absence of the 
oncogene c-Myc 
During experiments to test germline transmission of Nanog-selected iPSCs, tumours 
in which retroviral c-Myc was reactivated were observed in a number of F1 
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offspring. However in normal tissues, expression of exogenous factors including c-
Myc remained silenced. Attempts to generate iPSCs without c-Myc yielded no GFP-
positive colonies, so this raised serious concerns about the production of iPSCs using 
oncogenic factors (Okita et al., 2007). A number of later studies would demonstrate 
that exogenous c-Myc is in fact dispensable for reprogramming to pluripotency, 
however the onset of reprogramming occurs much later in the absence of c-Myc, and 
the process is less efficient (Nakagawa et al., 2008; Wernig et al., 2008). Indeed it 
was observed that some colonies generated from 3 factor reprogramming using Oct4, 
Klf4 and Sox2 (OKS) only acquired ESC-like morphology and endogenous 
pluripotency factor expression after repeated passaging (Wernig et al., 2008). Using 
the same Nanog-GFP reporter as Okita and colleagues, it was necessary to delay 
antibiotic selection until 14 days after infection with OKS, compared to the 7 days 
after infection which yielded reprogrammed colonies from OKSM-infected MEFs. 
Whilst induction of pluripotency was slower and less efficient in the absence of c-
Myc, it appeared that OKS-reprogramming resulted in a more specific induction of 
iPSC colonies. The number of non-typical GFP-negative colonies observed in the 
absence of c-Myc was much lower (Nakagawa et al., 2008). The GFP-positive 
colonies induced by three factor reprogramming were highly similar to ESCs. 
Endogenous expression of ESC marker genes was equivalent to levels in ESCs, and 
these cells contributed to adult chimeras when injected into blastocyst stage 
embryos, so pluripotency was not compromised by c-Myc omission (Nakagawa et 
al., 2008; Wernig et al., 2008). Notably, removal of c-Myc from the reprogramming 
cocktail resulted in the generation of iPSCs highly similar to ESCs using Fbx15 
selection. As previously discussed, iPSCs selected using Fbx15 selection are similar, 
but not identical to ESCs. They express lower levels of the endogenous pluripotency 
factors and cannot contribute to adult chimeras (Takahashi and Yamanaka, 2006). In 
contrast, in the absence of c-Myc, iPSCs selected for expression of Fbx15 expressed 
pluripotency factors at levels highly similar to ESCs and were capable of producing 
adult chimeras when injected into blastocyst stage embryos. Although this is again a 
very inefficient process, with few colonies produced, it demonstrates a more specific 
induction of true ESC-like cells in the absence of c-Myc. Furthermore based on 
ESC-morphology and retroviral silencing (evidenced by silencing of retroviral GFP), 
it was possible to generate OKS-reprogrammed iPSCs, which were capable of 
chimera contribution, in the absence of any form of antibiotic selection. None of the 
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chimeras generated from OKS-reprogrammed iPSCs were affected by tumours 
during early life (100 days), whilst a number of chimeras from OKSM-
reprogrammed iPSCs died from tumours during this period. This suggests that 
omission of c-Myc results in a reduction in tumorigenicity, at least in early life, 
although tumour formation in later life was not investigated (Nakagawa et al., 2008). 
1.6.3 Induction of pluripotency in human somatic cells  
In 2007 the Yamanaka group demonstrated the generation of human iPSCs from 
adult dermal fibroblasts (HDFs) using the same four factor approach they had 
applied to MEFs and mouse adult fibroblasts (Takahashi et al., 2007). At the same 
time, the laboratory of James Thompson demonstrated the generation of human 
iPSCs using a different four factor approach, comprising of Oct4, Sox2, Nanog and 
Lin28 (OSNL). These factors could induce pluripotency in foetally-derived IMR90 
fibroblasts and also in postnatal foreskin fibroblasts (Yu et al., 2007). Both groups 
demonstrated that their respective four factor combinations produced ESC-like cells 
which expressed the cell surface markers SSEA3, SSEA4, Tra-1-60 and Tra-1-81. 
iPSCs derived from both combinations expressed high telomerase activity and could 
be passaged repeatedly in culture. Both OKSM- and OSNL-derived iPSCs were 
pluripotent, evidenced by generation of tissues from all three germ layers in 
embryoid bodies and teratoma formation (Takahashi et al., 2007; Yu et al., 2007). 
As demonstrated in mice, it is also possible to generate human iPSCs in the absence 
of c-Myc at extremely low efficiency. OKSM-reprogramming produced a small 
number of ESC-like colonies, but these were difficult to isolate, as very high 
numbers of non-typical colonies were also generated in these experiments. In 
contrast a few ESC-like colonies were generated from OKS-reprogramming, but in 
the absence of c-Myc there was a notable absence of non-typical colonies, only a few 
of these cells were observed. This suggests that similar to OKS-reprogramming in 
mouse cells, omission of c-Myc results in a more specific induction of true iPSCs 
from human fibroblasts (Nakagawa et al., 2008). The iPSCs generated from 3 factor 
reprogramming could be expanded in culture and were highly similar to ESCs. 
Expression of ESC cell surface markers SSEA3, SSEA4, TRA-1-60 and Tra-1-81 
was observed, along with endogenous expression of Oct4, Nanog and Sox2 at levels 
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comparable with those in H9 ESCs. These cells could form differentiating embryoid 
bodies in vitro, which expressed markers of tissues derived from all three germ 
layers, demonstrating the pluripotency of three factor iPSCs. The authors did note 
however, that the efficiency of the process was extremely low (Nakagawa et al., 
2008). Therefore, whilst c-Myc omission appears to induce the generation of 
pluripotent cells highly similar to ESCs, with reduced concerns over tumorigenicity, 
issues regarding the generation of viable numbers of iPSCs in the absence of c-Myc 
remain.   
1.7 Methods to enhance the efficiency of reprogramming to 
pluripotency 
1.7.1 The tumour suppressor p53 as a barrier to reprogramming to 
pluripotency 
The omission of c-Myc from the reprogramming cocktail generates iPSCs at 
extremely low efficiency, and even in the presence of c-Myc the vast majority of 
cells exposed to reprogramming factors fail to undergo the full transition to 
pluripotency. Maximum reprogramming efficiencies of around 1% are typically 
observed, so whilst reprogramming technologies are reproducible, the inefficiency of 
the procedure means it is difficult to generate high numbers of iPSC clones, unless 
extremely high starting numbers of cells are transduced (Yamanaka, 2012). The p53 
pathway is stimulated in response to stress signals including over-expression of 
oncogenes and DNA damage. This stimulation results in cell cycle arrest and 
apoptosis in affected cells (Kawamura et al., 2009). Infection of cells with retroviral 
vectors in the reprogramming process results in DNA integration events and 
increased expression of the oncogenes c-Myc and Klf4. Following retroviral 
infection increased expression of p53 (Kawamura et al., 2009; Marion et al., 2009a) 
and its downstream target p21 (Hong et al., 2009) were observed, along with an 
increase in apoptosis (Marion et al., 2009a). There was a significant increase in 
reprogramming efficiency in p53-null MEFs compared to wild type cells and a 
similar result was observed in human fibroblasts treated with a short hairpin RNA 
(shRNA) to knockdown p53 (Hong et al., 2009; Kawamura et al., 2009; Marion et 
al., 2009a). Furthermore, it was possible to derive iPSCs from p53-null terminally 
differentiated T lymphocytes, whilst no colonies were observed in wild type cells 
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(Kawamura et al., 2009). Knockdown of the p53 downstream target p21, a cyclin 
dependent kinase inhibitor which halts cell cycle progression, also resulted in 
enhanced reprogramming efficiency in MEFs (Kawamura et al., 2009). Taken 
together this suggests that p53 acts as a barrier to reprogramming, probably through 
inhibition of proliferation and apoptosis induction in response to forced expression 
of reprogramming factors. Clearly p53 reduction or knockout acts to increase 
reprogramming efficiency. However such approaches should be used with caution, 
as p53 acts to detect and remove cells with genomic instabilities. In wild type cells, it 
was not possible to generate iPSCs from MEFs with critically short telomeres, 
however colonies were derived from such cells in a p53-null background (Marion et 
al., 2009a). Whilst p53 reduction can be used to increase reprogramming efficiency 
it also allows the propagation of genomic instabilities to resultant iPSCs, which 
would be a major concern for therapeutic applications. 
1.7.2 Small molecule chromatin modifiers as enhancers of reprogramming to 
pluripotency 
As previously discussed, pluripotent cells have a characteristic epigenetic profile 
distinct from lineage committed cells. Resetting of both histone modifications and 
DNA methylation to an ESC-like pattern occurs during reprogramming to 
pluripotency (Maherali et al., 2007). However even in some fully reprogrammed cell 
lines there are reports of ‘epigenetic memory’, where somatic cell DNA methylation 
patterns are observed at some sites in iPSCs (Kim et al., 2010; Lister et al., 2011). 
Frequently cells undergo partial reprogramming, adopting some but not all 
characteristics of pluripotency. Incomplete epigenetic remodelling in these cells is 
considered a significant barrier to complete reprogramming. It was observed that in a 
number of partially reprogrammed cells, pluripotency-related genes remained 
hypermethylated, and that in these cells there was little or no detectable expression 
of these endogenous pluripotency factors (Mikkelsen et al., 2008). Treatment of 
partially reprogrammed cells with the DNA methyltransferase inhibitor 5-azacytidine 
(5-AZA) resulted in transition to full pluripotency. The fully reprogrammed cells 
showed decreased DNA methylation in pluripotency related genes. Furthermore the 
cells formed teratomas on implantation in nude mice, whilst partially reprogrammed 
cells did not form teratomas under identical experimental conditions. It was noted 
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that correct timing of 5-AZA addition was required.  Treatment early in the 
reprogramming procedure had no effect on reprogramming efficiency, and actually 
resulted in significant cell death. It was suggested that in these early stages, cells are 
still susceptible to the effects of DNA hypomethylation, which in somatic cells 
induces apoptosis. However 5-AZA added later in the reprogramming process (8 
days after induction of reprogramming through addition of doxycycline) could 
increase reprogramming efficiency, suggesting that DNA de-methylation occurs at a 
later stage when cells have begun the transition towards pluripotency and are not 
therefore adversely affected by a hypomethylated state (Mikkelsen et al., 2008). 
Other small molecule epigenetic modifiers have also been demonstrated to increase 
reprogramming efficiency. Addition of the histone deacetylase (HDAC) inhibitor 
valproic acid (VPA) enhanced three factor (OKS) reprogramming of MEFs by 50-
fold compared to untreated OKS-reprogramming. The addition of VPA also 
enhanced efficiency of generation of iPSCs from human fibroblasts with OKS, 
producing colonies with morphology and marker expression similar to human ESCs 
(Huangfu et al., 2008a; Huangfu et al., 2008b). Notably the efficiency of MEFs 
reprogrammed with OKS with VPA treatment was higher than the efficiency of 
MEFs reprogrammed with OKSM, demonstrating that VPA treatment could replace 
c-Myc transduction. iPSCs generated by OKS reprogramming with VPA treatment 
were similar to ESCs in morphology and global gene expression profile. They were 
pluripotent, evidenced by embryoid body differentiation to tissues from all germ 
layers, teratoma formation and chimera contribution (Huangfu et al., 2008a). 
Furthermore, when human fibroblasts were treated with VPA during reprogramming 
it was possible to derive iPSC colonies after infection with Oct4 and Sox2 (OS) 
alone. The colonies could be repeatedly passaged in culture and maintained ESC-like 
morphology with no further need for VPA treatment. These colonies expressed ESC 
markers, and had reactivated endogenous Oct4 and Sox2. Furthermore, the Oct4 and 
Nanog promoters had undergone DNA de-methylation, resulting in DNA 
methylation profiles similar to those observed in ESCs. iPSCs derived with OS and 
VPA treatment were confirmed pluripotent in vitro and by teratoma formation in 
vivo (Huangfu et al., 2008b). In contrast to the late treatment of MEFs with 5-AZA, 
in both MEFs and human fibroblasts, VPA was applied 1 day following lentiviral 
transduction, and maintained for up to 2 weeks, for optimal reprogramming 
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enhancement (Huangfu et al., 2008a; Huangfu et al., 2008b). This suggests that the 
alteration of histone modifications early in the reprogramming process does not have 
the same detrimental effects as those observed by Mikkleson and colleagues when 
using compounds which drive DNA demethylation (Mikkelsen et al., 2008). 
Further small molecule chromatin modifiers have been demonstrated to improve 
reprogramming to pluripotency with fewer factors. Transduction of MEFs with Oct4 
and Klf4 (OK) alone yielded few non-typical colonies which were difficult to expand 
and stained weakly for alkaline phosphatase (Shi et al., 2008). However addition of a 
small molecule, the G9a histone methyltransferase inhibitor BIX01294, which acts 
to inhibit dimethylation at lysine 9 of histone 3 (H3K9me2), resulted in typical ESC-
like colonies with strong alkaline phosphatase activity. These cells were also positive 
for Oct4, Nanog and SSEA1. Furthermore, transduction with OK, along with the 
combined treatment of MEFs with both BIX01294 and another small molecule, 
BayK, increased the number of colonies observed. Cells transduced with OK and 
treated with BIX01294 and BayK produced greater numbers of colonies which 
stained strongly for alkaline phosphatase, and were positive for Oct4, Nanog, Sox2 
and SSEA1. These colonies could be maintained for many passages in vitro and had 
a highly similar gene expression pattern to ESCs. Interestingly, BayK is an L-type 
calcium channel agonist, with no known epigenetic effects, and treatment with BayK 
alone did not yield ESC-like colonies from OK-transduced cells. The mode of action 
of BayK is unclear, but it was suggested that BayK may act to impact signalling 
pathways involved in reprogramming to pluripotency (Shi et al., 2008). 
1.7.3 Inhibition of chromatin remodelling complexes in reprogramming to 
pluripotency 
A recent breakthrough has provided the strongest evidence yet that epigenetic factors 
can act as a major barrier for reprogramming to pluripotency. MBD3 is a component 
of the nucleosome remodelling and histone deacetylation (NuRD) complex. 
Depletion of MBD3 in MEFs resulted in almost 100% reprogramming efficiency, 
whilst only around one fifth of wild type cells were reprogrammed to pluripotency 
with four factor (OKSM) methods (Rais et al., 2013). Although typically in four 
factor reprogramming experiments a maximum efficiency of around 1% 
reprogramming is observed (Yamanaka, 2012). It was noted that the effects of 
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MDB3 depletion could be reversed if MEFs were infected with MBD3-expressing 
lentivirus in the first 5 days of reprogramming, but that after this point, lentiviral 
infection with MBD3 had a reduced effect on reprogramming efficiency. This 
suggested that MBD3 must act early in the reprogramming process, but could not 
significantly inhibit the final stages of conversion to pluripotency, or affect 
pluripotency maintenance in reprogrammed MEFs (Rais et al., 2013). A similar 
effect was observed when human fibroblasts with a mutation in MDB3 were 
reprogrammed to pluripotency with near 100% efficiency. Notably MDB3 inhibition 
alone was not sufficient to drive reprogramming to pluripotency in the absence of 
OKSM. However inhibition of MDB3 using short interfering RNA (siRNA) could 
induce partially reprogrammed cells to convert to full pluripotency, and activate 
endogenous Oct4 and Nanog expression. Interestingly, it was demonstrated that 
MDB3 only binds pluripotency factor target genes after induction of reprogramming, 
and that MBD3 recruitment increases at this point. OKSM co-immunoprecipitate 
with MBD3, and MBD3 co-binds many genes which are required for reprogramming 
to pluripotency. It would appear that upon the induction of reprogramming, the 
pluripotency factors co-bind with MBD3 at a number of genes, and that MBD3 is 
able to repress these genes even in the presence of pluripotency factors that would 
activate their expression. The role of MBD3 seems to be to restrain expression of 
factors required for the establishment of the pluripotent state, which would explain 
why MBD3 depletion enhances reprogramming efficiency so effectively. Clearly the 
chromatin modification and gene repression mediated by MBD3 is a major barrier to 
reprogramming, and in its absence, the pluripotency factors can freely activate genes 
which would normally be repressed by MBD3, so easily establishing pluripotency in 
the vast majority of cells exposed to reprogramming stimuli (Rais et al., 2013). 
1.7.4 Other small molecules which can enhance reprograming efficiency 
Whilst Shi and colleagues (Shi et al., 2008) noted that the small molecule BayK 
could not reprogramme MEFs to pluripotency in the absence of an epigenetic 
modifier, other groups have identified compounds with no known epigenetic effects 
which can act alone to enhance reprogramming efficiency or replace reprogramming 
factors.  
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A small molecule inhibitor of TGFβ signalling has been shown to either enhance 
reprogramming efficiency and/or replace the need for some exogenous 
reprogramming factors. E-616452, a TGFβ receptor 1 inhibitor acted to enhance the 
reprogramming efficiency of OKSM-transduced MEFs when treatment was applied 
at the same time as doxycycline (dox) in a dox-inducible system, but had no effect 
on reprogramming efficiency when administered prior to dox treatment (Maherali 
and Hochedlinger, 2009). In contrast another group used the same inhibitor, but 
found less than a 2-fold increase in colony numbers over control samples, so 
suggested that this inhibitor acted to replace exogenous factors rather than enhance 
reprogramming efficiency (Ichida et al., 2009). The inhibitor could act to 
functionally replace c-Myc in the reprogramming cocktail (Ichida et al., 2009; 
Maherali and Hochedlinger, 2009). Ichida and colleagues suggested that this 
occurred via the stimulation of endogenous L-Myc expression. L-Myc is a 
homologue of c-Myc previously shown to replace it in reprogramming to 
pluripotency (Ichida et al., 2009). Both groups also demonstrated that E-616452 
could replace Sox2 (Ichida et al., 2009; Maherali and Hochedlinger, 2009), however 
only one group found that E-616452 could replace both Sox2 and c-Myc 
simultaneously (Ichida et al., 2009). There were also striking differences in the 
optimal timing of inhibitor treatment. One group found that E-616452 was optimally 
applied with the start of dox addition, so it was concluded that the inhibitor acted 
early in the reprogramming process (Maherali and Hochedlinger, 2009). In contrast, 
the other group found that in their system, E-616452 acted on partially 
reprogrammed cells. These cells formed colonies which resembled iPSCs, and could 
be maintained for several passages, but failed to activate the endogenous Oct4-GFP 
reporter, a robust marker of full reprogramming to pluripotency. Activation of Oct4-
GFP was observed in a number of these colonies after addition of E-61642. 
Furthermore within 24-48 hours of inhibitor treatment, cells which were responsive 
to the inhibitor (i.e. those that activated Oct4-GFP following treatment) had up-
regulated endogenous Nanog expression by up to 10-fold.  Notably in this period 
endogenous Sox2 expression did not significantly increase, so it would appear that 
whilst E-616452 can replace exogenous Sox2, it does this by activating endogenous 
expression of Nanog rather than Sox2 (Ichida et al., 2009). Despite the differences 
observed with the use of E-616452 in different laboratories, inhibition of TGFβ 
signalling appears to positively benefit reprogramming to pluripotency. Indeed the 
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addition of TGFβ1 or TGFβ2 lead to a dramatic reduction in the number of colonies 
observed in OKSM-transduced MEFs compared to control samples, suggesting that 
TGFβ signalling is a barrier to reprogramming. During development, cells undergo 
an epithelial to mesenchymal transition, which is driven by TGFβ signalling, whilst 
reprogramming to pluripotency requires a mesenchymal to epithelial transition 
(Maherali and Hochedlinger, 2009). As reprogramming to pluripotency can be 
considered as the reversal of development, it would make sense that signalling which 
drives developmental progression may need to be suppressed in order to allow a 
regression to the pluripotent state. 
Lin and colleagues showed inhibition of TGFβ signalling, this time in combination 
with an inhibitor of the MAPK/ERK cascade, could improve the efficiency of 
reprogramming to pluripotency in human fibroblasts using a four factor (OKSM) 
approach. The authors observed that treatment 7 days after infection with the Alk 
inhibitor SB431542 in combination with the MEK inhibitor PD0325901 resulted in 
the generation of ESC-like colonies with increased mRNA levels of endogenous 
pluripotency factors compared to untreated control samples. Furthermore Nanog-
positive colonies were observed in treated samples, whilst there were no Nanog-
positive colonies from control experiments. This suggested that the combination of 
TGFβ and MAPK/ERK inhibition resulted in an increase in colonies which 
expressed endogenous markers of pluripotency (Lin et al., 2009) 
The MEK inhibitor PD0325901 is one part of the 2i combination of inhibitors 
commonly used in the maintenance of undifferentiated ESCs in culture. PD0325901 
combined with the GSK3β inhibitor CHIR99021 (2i) and LIF, acted to push partially 
reprogrammed neural stem cells (NSCs) to full pluripotency. In four factor (OKSM) 
transduced NSCs, early but unstable activation of Oct4-GFP was observed, which 
was not maintained on passaging, suggesting incomplete reprogramming to 
pluripotency. GFP-positive colonies first appeared at around day 5 following 
infection, so at this point NSCs were trypsinised and replated in media supplemented 
with 2i/LIF. This resulted in the growth of multiple colonies, of which around two 
thirds expressed Oct4-GFP. A similar effect was seen without the need for replating. 
Exchange of medium on days 3/5 to serum-free medium supplemented with 2i/LIF 
yielded many colonies of which over half had reactivated Oct4-GFP. These iPSCs 
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expressed endogenous pluripotency factors at levels equivalent to ESCs, and like 
ESCs were LIF-dependent in culture, differentiating on LIF withdrawal. They were 
also capable of chimera contribution on blastocyst injection, confirming the 
pluripotency of colonies treated with 2i/LIF (Silva et al., 2008). Reactivation of 
Oct4-GFP in partially reprogrammed cells following 2i/LIF treatment demonstrates 
that signalling mechanisms involved in the maintenance of the undifferentiated state 
in ESCs also play a role in reprogramming somatic cells to pluripotency. 
1.8 Metabolic restructuring during reprogramming to pluripotency 
As previously discussed, the metabolic profile of differentiated cells is quite distinct 
from that of pluripotent cells. A number of recent studies have focused on and 
highlighted the need for metabolic remodelling, along with transcriptional and 
epigenetic alterations, to achieve reprogramming to pluripotency. Folmes and 
colleagues (Folmes et al., 2011) demonstrated that during four factor (OKSM)-based 
reprogramming, MEFs undergo remodelling in which many tubular cristae-rich 
mitochondria are remodelled to a small number of perinuclear mitochondria, a 
cytotype highly similar to that seen in ESCs. iPSCs showed increased cellular levels 
and increased production of lactate compared to MEFs, along with lower oxygen 
consumption, indicative of a shift to a glycolytic metabolism. Lactate production and 
oxygen consumption rates (OCR) in iPSCs were highly similar to those observed in 
ESCs. The reprogramming factor c-Myc has previously been shown to affect 
glycolysis and mitochondrial biogenesis, so to investigate if c-Myc transduction was 
driving the observed metabolic changes, MEFs were reprogrammed to pluripotency 
using three factors (OKS). In the absence of c-Myc, iPSCs increased glycolysis, 
evidenced by accumulation of glycolytic end products, and had a limited capacity for 
oxidative metabolism. This demonstrated that the reprogramming process itself, and 
not c-Myc transduction, was driving metabolic remodelling in MEFs (Folmes et al., 
2011). The glycolysis inhibitor 2-deoxy-glucose (2DG) impaired induction of the 
pluripotency marker alkaline phosphatase (Folmes et al., 2011), and reduced the 
number of GFP-positive colonies generated (Panopoulos et al., 2012), suggesting 
that inhibition of glycolysis inhibits reprogramming to pluripotency. Conversely, 
treatment with D-fructose-6-phosphate (F6P), a glycolytic stimulator, was able to 
enhance reprogramming efficiency. Metabolomic analyses showed that iPSCs 
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clustered with ESCs and distinct from their parental cells. It was also demonstrated 
that whilst early passage (p16) iPSCs were similar to ESCs in their metabolic profile, 
late passage (>p41) iPSCs were much more similar (Panopoulos et al., 2012). This 
increased similarity to ESCs with time in culture echoes that observed with so called 
‘epigenetic memory,’ in which parental cell epigenetic characteristics are maintained 
at some points in the genome following iPSC derivation, but which are then altered 
to an ESC-like state with repeated passaging in culture. Analysis of DNA 
methylation patterns in genes related to metabolism also showed iPSCs clustering 
with ESCs, and distinct from parental cells. iPSCs up-regulated glycolytic genes and 
down-regulated expression of genes related to oxidative phosphorylation compared 
to their parental cells of origin. Notably the metabolic status of somatic cells has 
been linked to reprogramming efficiency. The authors observed that somatic cells 
have a higher oxidative:glycolytic ratio compared to pluripotent cells, which are 
highly glycolytic. Keratinocytes and human umbilical vein endothelial cells 
(HUVECs) reprogrammed with much greater efficiency than fibroblasts, and it was 
demonstrated that both these cell types had a lower oxidative:glycolytic ratio than 
fibroblasts. This meant that the starting metabolism in these cells was more similar 
to that in pluripotent cells, so it was suggested that cells with a low 
oxidative:glycolytic ratio could be reprogrammed to pluripotency with higher 
efficiency (Panopoulos et al., 2012). A schematic summary of metabolic differences 
between pluripotent and differentiated cells is given in Figure 1.5. 
1.9 Cellular remodelling during a cell stress-triggered autophagy 
response 
Autophagy is a physiological stress response which allows the recycling of 
cytoplasmic contents, as a survival mechanism under conditions of nutrient 
deprivation/starvation. Autophagy is induced by the action of nutrient sensors, which 
can act to detect fluctuations in nutrient availability. Following autophagy induction, 
there is formation of a double-membrane vesicle, which can sequester cytoplasmic 
contents, including organelles such as mitochondria. The double-membrane vesicle 
encloses cytoplasmic contents, and is then referred to as an autophagosome. The 
degradation and recycling of the autophagosome contents occurs on fusion with a 
lysosome, forming an autolysosome. This structure consists of a fusion of the  
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Figure 1.5. Schematic showing the distinct metabolic profiles of pluripotent 
and differentiated cell types  
Pluripotent ESCs have a characteristic simple cytotype, with few small, rounded, 
cristae poor perinuclear mitochondria. They rely on glycolysis (anaerobic 
metabolism) even in normoxic conditions. In contrast, differentiated cells have an 
oxidative metabolism, and a more complex cytotype, with a cytoplasmic network 
of tubular, cristae-rich mitochondria. Increased metabolic complexity develops 
during differentiation, and cells undergo a metabolic switch from glycolysis to 
oxidative metabolism. During reprogramming to pluripotency, the cytotype of 
differentiated cells must be remodelled to an ESC-like state, and iPSCs adopt the 
characteristic pluripotent cytotype and glycolytic metabolic profile. 
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lysosome and outer autophagosome membranes, whilst the autophagosome inner 
membrane is broken down, to release its contents for breakdown by lysosomal 
enzymes (Klionsky and Emr, 2000). 
Mammalian target of rapamycin (mTOR) is one such nutrient sensor, which inhibits 
autophagy in nutrient rich conditions. The compound rapamycin stimulates 
autophagy by inhibiting the action of mTOR. Rapamycin and other mTOR inhibitors 
have also been shown to promote longevity in a number of experimental organisms. 
It was demonstrated that rapamycin could act in a dose-dependent manor to increase 
the efficiency of iPSC generation from four factor (OKSM) transduced MEFs. It was 
also noted that this action of rapamycin was most effective early (1-3 days) in the 
reprogramming process (Chen et al., 2011). This result was also observed by another 
group, although they found that even earlier application (day 1) was required, and 
that rapamycin treatment started 3 days after infection could not improve 
reprogramming efficiency (Wang et al., 2013). PP242 is another mTOR inhibitor and 
longevity enhancing drug, which like rapamycin improved reprogramming 
efficiency in OKSM-transduced MEFs. The authors suggested that this could mean 
that longevity enhancing drugs positively benefitted reprogramming to pluripotency. 
They also demonstrated that a similar enhancement of reprogramming efficiency was 
observed on treatment with spermidine, a known autophagy stimulator (Chen et al., 
2011). So it is possible that rapamycin and PP242 may have been acting through 
their role in autophagy stimulation, to increase reprogramming efficiency. Recent 
work has highlighted that a functional autophagic response is required for 
reprogramming to pluripotency. Depletion of factors required for autophagosome 
formation resulted in an absence of iPSC colonies from MEFs, whilst numerous 
colonies were observed in control samples. Furthermore, in control samples, 
autophagosome formation was observed early (day 1) after initiation of 
reprogramming. This timing coincides with an early requirement for rapamycin 
treatment, and may suggest that autophagy induction is required early in the 
reprogramming process, and could act as a driver for later events. It was observed 
that ectopic expression of Sox2, actually resulted in a dramatic reduction in mTOR 
mRNA, and promoter studies revealed binding of Sox2 in a repressive region of the 
mTOR promoter. This work demonstrates how ectopic expression of reprogramming 
factors can stimulate autophagy, and highlights the requirement of a functional 
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autophagic response in reprogramming to pluripotency. Strikingly in cells depleted 
for key autophagy genes, there was a noticeable failure to reduce mitochondrial 
numbers, and an absence of iPSC colonies (Wang et al., 2013). As previously 
discussed, remodelling of the mitochondrial network and a metabolic shift to 
glycolysis are key features of successful reprogramming. Taken together these 
results suggest that a functional autophagic response is required for successful 
metabolic remodelling, and that this remodelling to immature, limited mitochondria 
may drive the metabolic shift to glycolysis.    
1.10 Enhanced expression of pluripotency factors in mesenchymal 
stem cells/multipotent stromal cells cultured as 3D spheroids 
It was previously observed in our laboratory that culturing mesenchymal stem 
cells/multipotent stromal cells (MSCs) in 3D conditions resulted in up-regulation of 
pluripotent transcription factors compared to expression in 2D MSCs (Elen Bray, 
unpublished observations). Primary human MSCs can be isolated from human bone 
marrow, and selected based on plastic-adherent growth in serum-supplemented 
media. Using appropriate induction protocols, MSCs are multipotent, and can be 
induced to differentiate down osteogeneic, adipogenic and chondrogenic lineages. 
However their potency is restricted to tissues of mesenchymal origin (Pittenger, 
1999). The laboratory in York has utilised a number of dynamic methods for 3D 
culture, including the use of spinner flasks and a rotating wall vessel bioreactor 
designed to enhance MSC stem cell properties and therapeutic potential (Frith et al., 
2010).  The laboratory also uses a static 3D methyl cellulose media-based system, in 
which MSCs are seeded into non-adherent U-bottomed 96-well plates, in media 
supplemented with methyl cellulose. Due to the viscosity of this media, MSCs are 
maintained in suspension, and adhere together to form cell aggregates, referred to 
hereafter as spheroids. Spheroid size is dependent on initial seeding cell number and 
also time in culture, as it was previously demonstrated that MSCs do not proliferate 
under these conditions, and spheroid size actually decreases with time in 3D culture. 
Along with increased expression of pluripotency markers, 3D MSCs showed a much 
greater increase in expression of cardiac markers than that observed in 2D MSCs, 
when stimulated to undergo cardiomyogenic differentiation following 3D culture in 
optimal conditions (Elen Bray, unpublished observations). In summary, it was 
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previously established that 3D MSCs can be cultured in 3D conditions and that 
during 3D culture, spheroids reduced in size. During 3D culture, 3D MSCs displayed 
characteristics of enhanced potency, including pluripotency marker expression, 
compared to 2D MSCs. However, the mechanism driving enhanced potency in 3D 
MSCs was not established. 
Recent work in iPSC research has highlighted a role for autophagy and metabolic 
remodelling in reprogramming to pluripotency, although the processes of autophagy 
and mitochondrial/cytoplasmic remodelling have not been explicitly linked.  It is 
interesting that autophagy, a physiological response to cell stress, particularly 
nutrient deprivation, has been demonstrated as a key early step in reprogramming to 
pluripotency. Given that 3D MSCs will be exposed to varying nutrient availability 
due to variations in spheroid size, and that 3D MSCs increase expression of 
pluripotency factors, as well as reducing in size during 3D culture, I hypothesised 
that controlled autophagy, stimulated by nutrient deprivation, may be the mechanism 
driving enhanced potency in 3D MSCs. In my hypothesis MSCs transferred to 3D 
culture would be exposed to varying nutrient deprivation, depending on spheroid size 
and time in 3D culture. In optimal conditions, autophagy, scaled in favour of cell 
survival, would result in cytoplasmic and metabolic remodelling, driving de-
differentiation towards a more primitive state, in 3D MSCs. 
  
53 
Project aims 
The aim of this work was to investigate whether a scaled autophagic response, 
induced by nutrient deprivation in 3D culture, was sufficient to drive de-
differentiation towards a more primitive state.  Initially this project focused on 
establishing 3D culture conditions in which enhanced pluripotency factor expression 
was observed in human MSCs. Following the establishment of such conditions the 
project then aimed to:  
 establish the extent of de-differentiation in 3D MSCs 
 examine MSCs cultured under 3D conditions for evidence of cytoplasmic 
and metabolic remodelling 
 establish if autophagy was the driving mechanism for enhanced pluripotency 
factor expression in 3D MSCs by looking for evidence of increased 
autophagy during 3D culture 
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Chapter 2: Materials and methods 
2.1 Materials 
All cell culture media, supplements and reagents were purchased from Invitrogen 
(Carlsbad, CA, USA) unless otherwise stated. Foetal bovine serum (FBS) was batch 
tested for MSC proliferation and differentiation down osteogenic and adipogenic 
lineages, and the best performing sera were purchased from Invitrogen and Biosera 
(Labtech, Uckfield, East Sussex, UK). Cell culture flasks and plates were purchased 
from Corning Life Sciences (Corning, NY, USA) and all chemicals were purchased 
from Sigma Aldrich (St. Louis, MO, USA) unless otherwise stated. 
2.2 General methods 
2.2.1 Cell culture methods 
2.2.1.1 Isolation of MSCs from femoral heads 
Bone marrow was manually isolated from femoral heads from hip replacement 
surgery following full informed consent under approval of the York Local Research 
Ethical Committee. Marrow was added to 10ml Dulbecco’s modified Eagle’s 
medium (DMEM, high glucose) supplemented with 100 units/ml penicillin and 
100µg/ml streptomycin. Bone marrow fragments were then minced with scissors, 
allowed to settle, and media was transferred to a collection tube. 10ml of medium 
was added to bone marrow fragments, and the mincing procedure was performed 
twice more. 10ml of fresh medium was then added, before vortexing. After the 
fragments had settled, the medium was transferred to the collection tube. The 
collection tube containing the cell suspension was centrifuged for 450g, 5 minutes, 
before the cell pellet was re-suspended in fresh medium, and passed through a 70µm 
cell strainer. The cell suspension was then layered over 12ml Ficoll-Paque Plus, and 
centrifuged at 350g for 30 minutes with low braking. The white mononuclear cell 
layer was isolated, and washed by centrifugation (450g, 5 minutes) in wash buffer (5 
mM EDTA, 0.2% BSA in PBS). Finally, the cell pellet was re-suspended in 2D 
MSC medium (for composition please see 2.2.1.3), and seeded into a T75 tissue 
culture flask. After 3-4 day, the medium was refreshed, removing non-adherent cells 
from the culture. 
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2.2.1.2 Isolation of MSCs from knee samples 
Bone samples from knee replacement surgery were dissected into small pieces and 
placed in cell culture 100mm dishes (BD Falcon, San Jose, CA, USA). 20ml 2D 
MSC medium (for composition please see 2.2.1.3) was added to dishes, which were 
maintained in culture (37ºC, 5% CO2) for 7 days, after which point bone pieces were 
removed and medium replenished. Samples were then cultured as described in 
2.2.1.3. 
2.2.1.3 MSC expansion conditions 
Following isolation, MSCs were cultured as adherent monolayers in 2D MSC 
medium - DMEM (high glucose) supplemented with 15% FBS and 100 units/ml 
penicillin and 100µg/ml streptomycin at 37ºC, 5% CO2. Samples were cultured to 
approximately 90% confluence, before passaging at a ratio of 1:3 or 1:4. Briefly, 
cultures were washed with PBS, before treatment with 0.25% Trypsin/EDTA. 
Following detachment, 2D MSC medium was added, and cells were re-plated into 
the appropriate number of tissue culture flasks. For the experiments performed here, 
primary MSCs from 26 donors, both male and female, with an age range from 51 – 
87 years were used. For ease of reading the donors for a particular experiment used 
were simply identified as Donors 1, 2 and 3. However this identity applies only to 
each particular experiment. 2-3 donors from the 26 were selected at random for each 
experiment, then for the purpose of this thesis identified as Donor 1, 2 or 3. 
2.2.1.4 Human dermal fibroblast (HDF) expansion conditions 
For 2D HDF culture, HDFs were maintained as described for 2D MSCs in 2.2.1.3, 
but 2D HDF medium was supplemented with 10% FBS and the passaging ratio for 
HDFs was 1:4. 
2.2.1.5 3D culture conditions 
For 3D culture, 2D MSCs were grown to approximately 90% confluence and 
trypsinised as described in 2.2.1.3. Cells were counted using a haemocytometer and 
light microscopy, and then re-suspended in 3D medium; DMEM (high glucose), 
supplemented with 15% FBS, 100 units/ml penicillin, 100µg/ml streptomycin and 
56 
0.25% methyl cellulose (2% stock solution made up in DMEM high glucose). For 
3D HDF culture, HDFs were cultured as described for MSCs above, but 3D HDF 
medium was supplemented with 10% FBS. 
2.2.1.6 ESC culture conditions 
H9 human ESCs were maintained on irradiated MEF (iMEF) feeder layers, with 
daily medium changes. ESC medium consisted of KO DMEM, supplemented with 
20% KO serum replacement, 100 units/ml penicillin, 100µg/ml streptomycin, 2mM 
L-glutamine, 100µM non-essential amino acids (NEAA), 100µM β-mercaptoethanol 
and 4ng/ml basic fibroblast growth factor (bFGF). ESCs were passaged every 3 days 
at a ratio of 1:6. 
2.2.1.7 2102Ep embryonal carcinoma cell culture conditions  
2102Ep cells were cultured as adherent monolayers in DMEM (high glucose) 
supplemented with 10% FBS and 100 units/ml penicillin and 100µg/ml 
streptomycin. Samples were cultured to approximately 80% confluence, before 
passaging at a ratio of 1:4, or harvesting by trypsinisation for further analysis. 
2.2.2 Disaggregation of spheroids for return to 2D culture 
2.2.2.1 Disaggregation and re-seeding 
At the appropriate time point, spheroids were collected, washed in PBS and then re-
suspended in Liberase TL working solution (32 µl Liberase TL (Roche, Basel, 
Switzerland) mixed with 318µl sterile PBS). Spheroids were incubated on an orbital 
shaker for 20 minutes at 37°C and then disaggregated to a single cell suspension by 
pipetting. Disaggregated 3D (d-3D) MSCs were then either collected in suspension 
for further analysis or re-seeded onto tissue culture plastic in 2D MSC medium. 
Following this process, d-3D MSCs were cultured as 2D MSCs (described in 
2.2.1.3) and were treated as 2D MSCs for RNA and protein extraction.  
57 
2.2.2.2 Crystal violet staining 
To observe the morphology of 3D MSCs following disaggregation (d-3D MSCs), 
samples were fixed in 95% ethanol for 5 minutes, followed by incubation in 0.5% 
Crystal Violet (in 95% ethanol) for 30 minutes. Samples were then washed in tap 
water and air dried. Imaging was performed using a Leica IRB inverted microscope.  
2.2.3 3D MSC snap freezing and sectioning  
3D MSCs were transferred to the caps of 500µl Eppendorf tubes, and then washed 
with PBS (2/3 spheroids per cap). Samples were then embedded in OCT Tissue Tek 
and snap-frozen by submersing in liquid nitrogen. Samples were stored at -80ºC, and 
when required were cryosectioned at 5-7μm, before mounting on Superfrost Plus 
microscope slides (Thermo Scientific, Waltham, MA, USA). Slides were either 
freshly stained or stored at -20ºC. 
2.2.4 Transmission electron microscopy 
2.2.4.1 Sample preparation and fixation 
2D MSCs were cultured on Thermanox cover slips (Thermo Scientific), to enable 
sectioning. 3D MSCs were collected in Eppendorf tubes. Samples were fixed in 8% 
formaldehyde, 5% glutaraldehyde in 100mM phosphate buffer mixed 50/50 with 3D 
MSC medium for 10 minutes followed by fixing with 4% formaldehyde, 2.5% 
glutaraldehyde in 100mM phosphate buffer, pH7.2 for 30 minutes at room 
temperature. Samples were then washed in 100mM phosphate buffer, 2 x 20 
minutes. 
2.2.4.2 Preparation for imaging 
Following fixation, samples were treated as described in Table 2.2.1  
Table 2.2.1 TEM sample preparation 
Procedure/Reagent Time 
1% OsO4 in 100mM buffer on ice 60 minutes 
Wash in 100mM phosphate buffer  2 x 10 minutes 
25% Ethanol 20 minutes 
50% Ethanol 20 minutes 
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70% Ethanol 20 minutes 
90% Ethanol 20 minutes 
100% Ethanol 2 x 20 minutes 
Epoxy propane  15 minutes 
25% epon araldite, 75% epoxy propane  30 minutes 
50% epon araldite, 50% epoxy propane 30 minutes 
75% epon araldite, 25% epoxy propane  30 minutes 
100% epon araldite  
2.2.4.3 Preparation for imaging (enhanced contrast) 
Following fixation, for enhanced contrast TEM used in Chapter 5, samples were 
prepared as described in Table 2.2.2  
Table 2.2.2 TEM sample preparation (enhanced contrast) 
Procedure Time 
1% tannic acid in 100mM phosphate   10 minutes 
100mM phosphate buffer 2 x 20 minutes 
0.5% OsO4 on ice 60 minutes 
Water   2 x 20 minutes 
1% uranyl acetate in water (in dark) 60 minutes 
Water  20 minutes 
Water (at 4ºC) overnight 
25% acetone  20 minutes 
50% acetone  20 minutes 
70% acetone  20 minutes 
90% acetone  20 minutes 
100% acetone  2 x 25 minutes 
25% Spurr (R) : 75% acetone  30 minutes 
50% Spurr (R) : 50% acetone  30 minutes 
75% Spurr (R) : 25% acetone  30 minutes 
100% Spurr (R)  2 hours 
100% Spurr (R) 2 x 30 minutes 
 
2.2.4.4 Sectioning and imaging 
Polymerised sample blocks and 2D samples were then sectioned at 70nm using a 
Leica RM2165 rotary microtome and imaged on a FEI Tecnai G transmission 
electron microscope. 
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2.2.5 RNA techniques 
2.2.5.1 Cell lysis 
2D MSCs/HDFs were trypsinised, centrifuged at 400g for 5 minutes, and then re-
suspended in 350 µl RA1 lysis buffer (Nucleospin RNA II kit) with 3.5µl β-
mercaptoethanol. 3D MSC/HDF spheroids were collected in Eppendorf tubes, 
washed with PBS, re-suspended in lysis buffer as above, before homogenisation with 
a hand-held tissue micro-homogeniser for 5 seconds. H9 ESC colonies were 
trypsinised using recombinant trypsin (TrypLE) and resuspended in lysis buffer as 
above. 
2.2.5.2 RNA extraction 
Following cell lysis, RNA was extracted using Nucleospin RNA II columns 
(Macherey Nagel, Duren, Germany) following manufacturer’s instructions. Briefly, 
lysates were cleared by passing through the filter column, before being mixed with 
350µl 70% ethanol. Samples were then bound to the extraction column by 
centrifugation. Membrane desalting buffer (MBD) was added to desalt the silica 
membrane. Buffer was removed by centrifuging and samples were treated with 95µl 
DNase reaction mixture for 15 minutes at room temperature. Columns were washed 
by centrifugation with RA2 buffer, followed by 2 washes with RA3 buffer. To 
ensure columns were free of buffer, they were centrifuged at 11,000g for 30 seconds 
in a dry collection tube. RNA was then eluted in 30-40µl RNase-free H2O. For 
maximal RNA recovery, the total volume of RNase-free H2O was centrifuged 
through the column twice. Samples were kept on ice throughout and all 
centrifugation steps were performed at 4ºC, 11,000g for 1 minute unless otherwise 
stated. RNA samples were then quantified using the Nanodrop spectrophotometer 
(Thermo Scientific). 
2.2.5.3 cDNA synthesis 
cDNA was synthesised from 1µg mRNA, all reagents were from Invitrogen unless 
otherwise stated. Briefly, mRNA was mixed with 1µl Oligo dT primer, 1µl 10mM 
dNTPs and RNase-free H2O, to a total volume of 12µl. Samples were then incubated 
at 65ºC for 5 minutes. After 2 minutes cooling on ice, a master mix (consisting of 
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4µl First Strand Buffer, 2µl 0.1mM DTT and 1µl RNase-free H2O), was added to 
samples, before incubation at 42ºC for 2 minutes. Samples were then mixed with 1µl 
Superscript II reverse transcriptase (or 1µl RNase-free H2O for No RT controls). 
cDNA synthesis consisted of incubation at 42ºC for 1 hour, followed by 15 minutes 
at 70ºC (to inactivate the reverse transcriptase). All samples were then diluted to a 
total volume of 100µl. 
2.2.5.4 qPCR 
Samples were prepared for qPCR by mixing with Power SYBR Green PCR Master 
Mix (Applied Biosystems, Carlsbad, CA, USA). Briefly, 5 µl of cDNA was added to 
a master mix consisting of 12.5µl Power SYBR Green, 5.5µl RNase-free H2O, and 
1µl each of 20µM forward and reverse primer, in triplicate wells for all genes of 
interest. QPCR was performed using the Applied Biosystems 7300 Real Time PCR 
System, (50°C for 2 minutes, 95°C for 10 minutes followed by 40 cycles of 95°C for 
15 seconds, 60°C for 1 minute). Primer sequences are listed in each chapter. Fold 
changes were calculated as follows: Delta (D) Ct values were calculated by 
normalising Ct values for target genes to average Ct values for GAPDH, which was 
selected as an appropriate housekeeping gene from three others (actin, B2M, 
RPS27a, GAPDH primer sequences are given in Table 2.2.3). DDCt values were then 
calculated between control conditions and experimental conditions. Fold changes 
were calculated as 2
(-DDCt)
. Statistical analyses were performed using Sigmaplot 
software. Data were analyzed using Kruskal Wallis One Way Analysis of variance 
on ranks (with Tukey test for pairwise multiple comparison procedures). 
Table 2.2.3 Primer sequence for GAPDH (housekeeping gene for all qPCR) 
Gene Forward primer sequence (5’-
3’) 
Reverse primer sequence (5’-3’) 
GAPDH TGCACCACCAACTGCTTAGC 
 
GGCATGGACTGTGGTCATGAG 
 
 
2.2.6 Immunocytochemistry 
For 2D samples, MSCs were seeded on coverslips in 24-well plates at a density of 
10,000 cells per cm
2
 in MSC expansion medium and allowed to adhere overnight. 
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3D MSCs were snap-frozen and sectioned as described in 2.2.3.1. Sections and 
coverslips were fixed in 4% paraformaldehyde for 10 minutes at room temperature, 
followed by washing in PBS. Samples were blocked in 10% serum from the animal 
in which the secondary antibody was raised. For intracellular proteins, blocking sera 
contained 0.3% Triton X-100. Primary antibody incubations were overnight at 4ºC 
(in PBS, also containing 0.3% Triton X-100 for intracellular proteins). Samples were 
then washed 3 times for 5 minutes in 1 x PBS, before incubation with fluorescently-
conjugated secondary antibodies for 1 hour at room temperature in the dark. 
Washing was repeated, before nuclear counterstaining with 4',6-diamidino-2-
phenylindole (DAPI). Samples were mounted in Vectashield Mounting Medium for 
Fluorescence (Vector Labs, Peterborough, UK). Slides were imaged using the 
LSM510 confocal imaging system (Zeiss). Antibody details are given in each 
chapter. 
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Chapter 3: Culture of human MSCs as 3D spheroids 
3.1  Introduction 
Human MSCs adopt an adherent fibroblastic morphology when seeded as 2D 
monolayers onto tissue culture plastic, and this morphology is maintained through 
repeated passage in culture (Pittenger, 1999). As previously discussed, the laboratory 
at York has developed a number of methods of 3D MSC culture, in which MSCs 
form spheroids. Up-regulation of transcription factors expressed exclusively by 
pluripotent cells was observed when 3D MSCs were cultured using the static methyl 
cellulose-based method (Elen Bray, unpublished observations). 
Pluripotency marker expression characterises pluripotent ESCs, which are 
morphologically and transcriptionally distinct from MSCs. In contrast to the 
fibroblastic form of MSCs, human ESCs grow as colonies of rounded cells, with a 
high nuclear:cytoplasmic ratio (Thomson, 1998). This distinct pluripotent 
morphology is also re-adopted by somatic cells when they undergo factor-based 
reprogramming to pluripotency (Yu et al., 2007). High nuclear physical plasticity is 
observed in pluripotent ESCs, and it is thought that this may reflect the requirement 
for migration of undifferentiated cells through established tissue blocks during 
embryogenesis in vivo. Certainly, nuclear plasticity is associated with the pluripotent 
state, and nuclear rigidity increases during differentiation. It is thought that the high 
nuclear envelope flexibility in ESCs can be attributed to its unique composition in 
pluripotent cells (Pajerowski et al., 2007). Pluripotent cells do not express the 
nuclear lamina component Lamin A/C. In cultured human ESCs Lamin A/C was first 
detected after down-regulation of the cell surface markers Tra-1-60, Tra-1-81 and 
SSEA-4, but before down-regulation of the transcription factor Oct4. However this 
differed in a mouse in vivo model, where Oct4 was down-regulated before detectable 
expression of Lamin A/C was observed (Constantinescu et al., 2006). Despite 
differences in the precise timing of Lamin A/C up-regulation, its expression can act 
as a differentiation marker, and may be required for the differentiation process. 
Indeed a recent study has demonstrated that Lamin A/C haploinsufficiency or 
knockdown in mouse ESCs affects differentiation. Whilst there was no observed 
defects in undifferentiated Lamin A/C
+/- 
ESCs or those expressing a short hairpin 
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RNA (shRNA) to Lamin A/C, upon differentiation there were defects in the 
formation of a number of tissues, linking the expression of Lamin A/C to lineage 
specification during development (Sehgal et al., 2013). In contrast, the nuclear 
lamina components Lamin B1 and Lamin B2 are expressed in both pluripotent and 
differentiated cells. It is though that increased nuclear rigidity during differentiation 
may reflect the establishment of a defined cell fate, without the need for cellular or 
chromatin plasticity, as nuclear lamina-chromatin interactions are known to regulate 
gene expression. The absence of Lamin A/C is considered a key requirement for high 
flexibility in the pluripotent nuclear envelope (Pajerowski et al., 2007).  
As described in Chapter 1, ESCs and other pluripotent cells also have a characteristic 
chromatin organisation, with reduced abundance of heterochromatin markers, and 
the presence of bivalent domains. It is considered that the nuclear lamina plays a role 
in the organisation of chromatin, and the determination of chromosome positioning, 
and through these roles can influence gene expression. In particular, heterochromatin 
can be linked to the nuclear lamina, and this interaction assists transcriptional 
repression. Loss of heterochromatin marks is observed in cells with Lamin A/C 
deficiencies, or those cells which produce mutant truncated forms of the Lamin A/C 
protein (Dechat et al., 2008).  
During the reprogramming to pluripotency of human somatic cells, one of the first 
observed events is the emergence of ESC-like colonies, which are morphologically 
distinct from the originating parental population (Yu et al., 2007).  The work 
presented in this chapter will investigate how 3D spheroid size can be regulated by 
initial cell seeding number and time in culture. It will also examine nuclear 
morphology, envelope composition and chromatin organisation, to observe any 
changes, which could act as markers of de-differentiation/reprogramming in 3D 
MSCs.   
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3.2 Aims 
The general aims of the work presented in this chapter are to investigate how 3D 
culture affects MSC cellular and nuclear morphology, viability and chromatin 
organisation, and to observe changes which could indicate de-differentiation towards 
the pluripotent state. 
Specific objectives are to: 
 Observe changes in size of 3D MSC with time in culture. 
 Assess cellular and nuclear morphology changes of MSCs cultured as 
3D spheroids. 
 Identify the effects of 3D culture on MSC viability after spheroid 
disaggregation. 
 Determine how nuclear morphology changes may affect chromatin 
organisation in 3D MSCs. 
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3.3 Methods 
3.3.1 Analysis of 3D spheroid size 
3D MSCs were seeded with initiating cell numbers of 30-, 60-, and 120,000 MSCs 
and cultured as described in section 2.2.1.5. On days 1, 3, 5 and 7 of culture, 6 
replicate spheroids for each initial seeding density were imaged using light 
microscopy and analysed using Image J software to measure spheroid diameters. 
Briefly, image files were uploaded to Image J, and the diameter of each spheroid was 
measured. Unit values in Image J were equated to µm (77.364 units = 100µm), 
which allowed the calculation of spheroid diameters in µm.  
3.3.2 Observation of nuclear morphology by TEM 
3D spheroids were seeded with initiating cell numbers of 60,000 MSCs and cultured 
as described in 2.2.1.5 for up to 5 days. On days 1 and 5 of culture, 3D spheroids 
were fixed and prepared as described in 2.2.4.1 and 2.2.4.2, before imaging using 
TEM as described in 2.2.4.4. 
3.3.3 Quantitative real time polymerase chain reaction 
2D MSCs were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 30-, 60-, and 120,000 MSCs and cultured for up to 6 days 
as described in 2.2.1.5. Samples were isolated on days 1,3,4,5 and 6 of 3D culture. 
RNA was isolated from 2D and 3D samples before cDNA was generated and 
analysed by qPCR as described in 2.2.5. Primer sequences are shown in Table 3.3.1. 
 
Table 3.3.1 Nuclear lamina genes primer sequences 
Gene Forward primer sequence (5’-3’) Reverse primer sequence (5’-3’) 
Lamin A/C GATCAAGCGCCAGAATGGA CCCAGCCTTCAGGGTGAAC 
Lamin B AAGGCGAAGAAGAGAGGTTGAAG GCGGRRTGAGAGATGCTAACACT 
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3.3.4 Immunocytochemistry 
2D monolayers were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 60,000 MSCs, cultured for 5 days, then snap-frozen and 
sectioned as described in 2.2.1.5 and 2.2.3.2. 2D and 3D samples were then fixed 
and stained as described in 2.2.6. Antibody details are given in Table 3.3.2. Samples 
were imaged using a Zeiss LSM 510 upright confocal microscope. 
Table 3.3.2 Nuclear antibodies 
Antibody Host Dilution Supplier Cat. no. 
Anti-Lamin B1 Goat 1:400 Santa 
Cruz  
sc-6217 
Anti-H3K4me3 Rabbit 1:200 Cell 
Signalling 
#9751 
Anti-H3K9me3 Rabbit 1:800 Abcam ab8898 
Anti-Goat IgG (Cy3 congugate) Rabbit 1:400 Sigma c-2821 
Anti-Rabbit IgG (Cy3 congugate) Sheep 1:400 Sigma c-2306 
 
3.3.5 Assay of MSC plastic-adherent growth following 3D culture 
2D MSCs were cultured to 90% confluence as described in 2.2.1.3 in 35mm dishes. 
3D spheroids were seeded with initiating cell numbers of 60,000 MSCs as described 
in 2.2.1.5. On day 5 of 3D culture 3D spheroids were disaggregated to single cells 
and then d-3D MSCs were seeded in 35mm culture dishes and cultured as described 
in 2.2.2.1. At 5, 24 and 48 hours post-disaggregation, d-3D MSC samples were fixed 
and stained with Crystal Violet as described in 2.2.2.2. All samples were then 
imaged using light microscopy. 
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3.4  Results 
3.4.1 3D MSC spheroid size is dependent on cell number and decreases with 
time in culture 
MSCs are traditionally cultured as adherent 2D monolayers on tissue culture plastic. 
However this method of culture means that nutrients are readily available to all cells 
in the population, and that cells are not susceptible to mechanical cell stress. In order 
to test the hypothesis that culturing MSCs as 3D spheroids would induce a 
physiological stress response and stimulate cytoplasmic clearance to a rejuvenated 
state, it was first necessary to examine the behaviour of MSCs cultured as 3D 
spheroids. MSCs were removed from 2D culture, seeded as spheroids containing 
different initiating numbers of cells (30-, 60-, or 120,000 cells per spheroid), and 
maintained in culture for 7 days. On days 1, 3, 5 and 7 of 3D culture, spheroids were 
imaged by light microscopy. Initial spheroid size was dependent on cell number, the 
higher the cell number, the larger the spheroid. 3D spheroids reduced in size with 
time in culture, with the greatest reduction in size seen between days 1 and 3 of 
culture (Figure 3.4.1. A). On average, spheroids seeded from 30,000 MSCs reduced 
in size from 741µm - 438µm diameter over 7 days in culture, and on day 7 the 
average spheroid diameter was 41% smaller than the average diameter on day 1. 
Spheroids seeded from 60,000 MSCs reduced in size from 1017µm - 609µm 
diameter over 7 days in culture, and on day 7 the average spheroid diameter was 
40% smaller than the average diameter on day 1. Spheroids seeded from 120,000 
MSCs reduced in size from 1474µm - 793µm diameter over 7 days in culture, and on 
day 7 the average spheroid diameter was 46% smaller than the average diameter on 
day 1 (Figure 3.4.1. B). Nutrient availability/deprivation in 3D MSCs will be 
dependent on spheroid size, and this static 3D culture method generates a wide 
repertoire of spheroid sizes by varying initial seeding number and culture time. This 
method should therefore have also resulted in varying levels of nutrient deprivation 
in the different sized spheroids. 
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  Figure 3.4.1. Analysis of changes in MSC spheroid size over time in 3D 
culture 
MSCs were cultured as 3D spheroids with initiating cell numbers of 30-, 60-, or 
120,000 cells for up to 7 days in culture. On days 1, 3, 5 and 7, 3D spheroids were 
imaged using light microscopy. Images were then subject to analysis using Image 
J to measure spheroid diameters. A) Example images of 3D MSC spheroids over 
time in culture. B) Changes in spheroid size with time in 3D culture (mean 
diameters are shown ± SEM, n = 1, 6 replicates, scale bar = 250µm). 
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3.4.2 Nuclear morphology and envelope composition changes in MSCs 
cultured as 3D spheroids 
3.4.2.1 Nuclei of MSCs cultured in 3D have a multi-lobed, distorted morphology  
In order to examine changes in 3D MSC nuclear morphology, TEM was used to 
examine sections from 3D MSCs isolated at different times during 3D culture. 2D 
MSC nuclei had a rounded regular shape, reflecting the fibroblastic morphology of 
MSCs when cultured as adherent monolayers on tissue culture plastic (Figure 3.4.2, 
left panel). In contrast, in spheroids initiated from 60,000 cells, 3D MSCs had multi-
lobed nuclei, with irregular morphologies, throughout 3D culture (Figure 3.4.2, 
centre and right panels), possibly suggestive of increased nuclear envelope flexibility 
in 3D MSCs (Only spheroids initiated from 60,000 MSCs were examined in this 
way, as this was established as the optimal 3D culture condition for markers of de-
differentiation, please see 4.4.1).  
3.4.2.2 Reduced expression of the nuclear lamina component Lamin A/C early in 
3D culture 
The observed changes in nuclear morphology in 3D MSCs may have reflected 
changes in the composition of the nuclear lamina. Lamin A/C is a nuclear lamina 
component expressed in most cell types. Only pluripotent cells do not express Lamin 
A/C, so Lamin A/C expression acts as a marker of non-pluripotent cells. In order to 
examine the expression of Lamin A/C in 3D MSCs, spheroids initiated from 30-, 60- 
or 120,000 cells were cultured for up to 6 days. In the two primary MSC donors 
examined expression of Lamin A/C was initially reduced in 3D culture. mRNA 
expression of Lamin A/C in all spheroid sizes fell below levels in 2D MSCs on day 
1, with expression levels similar across all spheroid sizes. By day 3, mRNA 
expression of Lamin A/C had started to recover in donor 1, in 30,000 and 60,000 
MSCs spheroids, although this recovery occurred slightly later (day 4) in Donor 2. 
Recovery of Lamin A/C levels towards those observed in 2D MSCs continued with 
time in 3D culture for both these spheroid sizes; by days 5 and 6 of culture, 3D 
levels were similar to those in 2D MSCs. In contrast Lamin A/C levels in 120,000 
MSC spheroids remained much lower than 2D MSC levels throughout 3D culture 
(Figure 3.4.3) 
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Figure 3.4.2. Analysis of nuclear morphology changes in MSCs cultured as 3D 
spheroids 
MSCs were cultured as 2D monolayers or 3D spheroids with initiating cell 
numbers of 60,000 cells for up to 5 days in culture. 2D MSCs were cultured on 
Thermanox coverslips (to allow monolayer sectioning). 3D spheroids were 
removed from culture at days 1 and 5, and sectioned. Samples were examined by 
transmission electron microscopy (TEM). Example images of nuclei are shown 
(scale bars = 2µm) 
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  Figure 3.4.3. qPCR analysis of expression of the nuclear lamina component 
Lamin A in MSCs over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with 
initiating cell numbers of 30-, 60-, or 120,000 cells for up to 6 days in culture. 
cDNA samples were generated and then analysed by qPCR. A) Expression of 
Lamin A for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in the donor matched 2D sample. 
Fold changes were calculated as 2
-ddCt
. B) Data from both donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 2).  
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3.4.2.3 Sustained loss of the nuclear lamina component Lamin B in 3D MSCs 
Lamin B is a nuclear lamina component expressed in all cell types. To analyse 
expression of Lamin B in 3D MSCs, spheroids initiated from 30-, 60-, or 120,000 
cells were cultured for up to 6 days. In the two primary MSC donors examined, 
expression of Lamin B mRNA remained below levels in 2D MSCs throughout 3D 
culture. In donor 1, expression of Lamin B was variable and low in 60,000 and 
120,000 MSC spheroids. This pattern was also observed for donor 2 in spheroids 
initiated from 120,000 cells, although in this donor, the expression of Lamin B in 
60,000 MSC spheroids increased slightly with time in 3D culture, as did expression 
in 30,000 MSC spheroids. In contrast, an increase in Lamin B expression with time 
in 3D culture was only observed in donor 1 in spheroids initiated from 30,000 
MSCs. Notably, whilst there was a small increase in expression of Lamin B in some 
samples, the recovery of expression was not comparable to that observed for Lamin 
A/C, and expression remained well below 2D MSC levels in all 3D samples (Figure 
3.4.4). 
To examine if reduced Lamin B transcript resulted in a reduction in Lamin B protein, 
3D MSC spheroids were initiated from 60,000 cells, as this was established as the 
optimal 3D culture model for markers of enhanced potency (please see 4.4.1). 3D 
MSCs were maintained in culture for 5 days, then snap-frozen, sectioned and stained 
for Lamin B. Immunocytochemistry revealed clear strong Lamin B staining at the 
nuclear periphery in 2D MSCs. In contrast, there was no detectable Lamin B protein 
expression in 3D MSCs. Although no Lamin B protein was observed by 
immunocytochemistry, DAPI counter-staining highlighted the multi-lobed irregular 
nuclear morphology of 3D MSCs, previously shown by TEM microscopy (Figure 
3.4.5). 
There was a substantial loss of Lamin B transcript expression within one day of the 
initiation of spheroid culture. In order to examine how soon MSCs down-regulated 
expression of Lamin B, spheroids initiated from 60,000 MSCs were cultured for up 
to 24 hours. At 4 hours and 24 hours after spheroid seeding, samples were isolated 
and analysed by qPCR for expression of Lamin B. In the two primary MSC donors 
examined, there was already a prominent reduction in Lamin B expression within 4  
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  Figure 3.4.4. qPCR analysis of expression of the nuclear lamina component 
Lamin B in MSCs over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with 
initiating cell numbers of 30-, 60-, or 120,000 cells for up to 6 days in culture. 
cDNA samples were generated and then analysed by qPCR. A) Expression of 
Lamin B for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in the donor matched 2D sample. 
Fold changes were calculated as 2
-ddCt
. B) Data from both donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 2).  
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Figure 3.4.5. Staining of 2D MSCs and 3D MSC spheroid sections for the 
nuclear lamina component Lamin B 
2D MSCs were cultured as monolayers on coverslips. 3D spheroids were initiated 
from 60,000 MSCs and cultured for 5 days. Spheroids were then snap-frozen and 
sectioned. All samples were fixed and stained for Lamin B (red) and DAPI (cyan), 
2º antibody only controls were also performed; these showed no positive red 
staining. Imaging was performed using confocal microscopy under identical 
conditions (example images from 2 donors shown, scale bars = 10µm). 
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hours of spheroid initiation, which continued to decrease up to 24 hours in culture 
(Figure 3.4.6). Four hours after spheroid initiation, the spheroid structure has only 
just started to aggregate together, with individual rounded cells remaining visible by 
light microscopy.  
3.4.3 MSCs can be returned to plastic-adherent culture following 
disaggregation of spheroids 
Nuclear lamina composition was altered and nuclei underwent major morphological 
changes in MSCs cultured as 3D spheroids. To examine if these nuclear structural 
alterations affected the capacity of 3D MSCs to return to 2D culture conditions, 
MSCs were cultured as 3D spheroids (initiating cell number = 60,000 MSCs) for 5 
days. On day 5 of 3D culture, spheroids were disaggregated to a single cells 
suspension using enzymatic digestion (d-3D MSCs). The resulting cell suspension 
was re-seeded onto plastic, and cultured as 2D MSCs. At 5, 24 and 48 hours after re-
seeding d-3D MSCs were fixed and stained with crystal violet solution. A sample of 
the originating 2D MSC population was also stained. 2D MSCs had a typically flat, 
fibroblastic morphology. At 5 hours after re-seeding, d-3D MSCs were small and 
rounded, but had adhered to plastic, so remained viable immediately after spheroid 
disaggregation. 24 hours after seeding, there appeared to be slightly fewer cells 
remaining, although there was a clear change in morphology, with d-3D MSCs 
adopting a more fibroblastic morphology. This morphology change continued to 48 
hours after re-seeding, where d-3D MSCs had continued to spread into a flatter more 
typical MSC morphology. At this point there also appeared to be a small increase in 
cell numbers, suggesting that d-3D MSCs retain proliferative capacity after spheroid 
disaggregation (Figure 3.4.7).  
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Figure 3.4.6. qPCR analysis of expression of the nuclear lamina component 
Lamin B in MSCs following 3D spheroid seeding 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with 
initiating cell numbers of 60, 000 cells for up to 24 hours in 3D culture. cDNA 
samples were generated and then analysed by qPCR. A) Expression of Lamin B 
for each donor was normalised to expression of the housekeeping gene GAPDH 
and made relative to expression levels in the donor matched 2D sample. Fold 
changes were calculated as 2
-ddCt
. B) Data from both donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 2).  
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Figure 3.4.7. Analysis of MSC behaviour 
following disaggregation of 3D spheroids 
and return to 2D culture  
MSCs were cultured as 2D monolayers and 
3D spheroids with initiating cell numbers 
of 60,000 cells for 5 days in culture. On 
day 5 of 3D culture, 3D spheroids were 
disaggregated to a single cell suspension 
(d-3D MSCs) using enzymatic digestion 
and re-seeded onto tissue culture plastic. 
Samples were isolated at 5, 24 and 48 
hours following spheroid disaggregation. 
2D MSC and d-3D MSC samples were 
fixed and stained with crystal violet 
staining solution, and then imaged using 
light microscopy. (Example images shown, 
scale bar = 100µm).  
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3.4.4 Reduced staining for the heterochromatin marker H3K9me3 in 3D 
MSCs 
3D MSCs underwent major nuclear morphology changes during 3D culture, but 
remained viable after spheroid disaggregation. Linking of chromatin to the nuclear 
lamina can regulate gene expression, so changes in nuclear lamina composition and 
morphology may lead to changes in chromatin organisation. To examine this, MSC 
spheroids initiated from 60,000 cells were cultured for 5 days. On day 5, spheroids 
were snap-frozen, sectioned and stained for histone markers. Euchromatin is 
permissive to transcription and is marked by the presence of the histone modification 
H3K4me3 (histone 3 trimethylated at lysine 4). Comparative staining of 2D MSCs 
and 3D MSC sections showed little difference in H3K4me3 staining, with relatively 
bright staining seen throughout nuclei of MSCs cultured in both conditions (Figure 
3.4.8). A more notable difference was observed when MSCs were stained for 
H3K9me3 (histone 3 trimethylated at lysine 9). H3K9me3 is a marker of 
heterochromatin, which has a conformation that is repressive to transcription. 
Reduction in H3K9me3 has been reported in pluripotent cells. Whilst 2D MSCs 
stained strongly for H3K9me3, with a typical punctate staining pattern, the staining 
of 3D MSC sections was much fainter at identical imaging conditions (Figure 3.4.9). 
This may suggest a reduction in detectable H3K9me3 when MSCs are cultured as 
3D spheroids. 
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Figure 3.4.8. Staining of 2D MSCs and 3D MSC spheroid sections for the 
euchromatin marker H3K4me3 
2D MSCs were cultured as monolayers on coverslips. 3D spheroids were initiated 
from 60,000 MSCs and cultured for 5 days. Spheroids were then snap-frozen and 
sectioned. All samples were fixed and stained for H3K4me3 (red) and DAPI 
(cyan), 2º antibody only controls were also performed; these showed no positive 
red staining. Imaging was performed using confocal microscopy under identical 
conditions (example images from 2 donors shown, scale bars = 10µm). 
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  Figure 3.4.9. Staining of 2D MSCs and 3D MSC spheroid sections for the 
heterochromatin marker H3K9me3 
2D MSCs were cultured as monolayers on coverslips. 3D spheroids were initiated 
from 60,000 MSCs and cultured for 5 days. Spheroids were then snap-frozen and 
sectioned. All samples were fixed and stained for H3K9me3 (red) and DAPI 
(cyan), 2º antibody only controls were also performed; these showed no positive 
red staining. Imaging was performed using confocal microscopy under identical 
conditions (example images from 2 donors shown, scale bars = 10µm). 
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3.5 Discussion 
MSCs are traditionally cultured as monolayers on tissue culture plastic. In these 
conditions nutrients and oxygen are readily available, and sufficient space for cell 
growth is maintained through repeated passaging in culture.  In contrast, when MSCs 
are cultured as 3D spheroids, they are subject to mechanical forces and enhanced 
cell-cell contacts by growing as a cell aggregate. As well as this, there will be a 
gradient of nutrient availability across the spheroid structure. Previous work in this 
laboratory demonstrated that 3D MSCs do not express the proliferation marker Ki67 
whilst in 3D culture, so appeared to have adopted a quiescent state, and MSC 
spheroids did not increase in size with time in culture (Elen Bray, unpublished 
results). It was demonstrated here that MSC spheroid size is understandably 
dependent on initial cell seeding density, with more cells resulting in a bigger 
spheroid. Furthermore, MSC spheroids reduced in size over time in 3D culture, with 
between 40 – 46% reductions in spheroid diameter over 7 days. This change in size 
with time in culture meant that not only would MSCs in 3D be exposed to nutrient 
gradients, but that these gradients would vary, as spheroid size changed with time in 
culture.  Consequently, this screen, varying both initial cell number and time in 
culture, generated a large repertoire of spheroid sizes, which I hypothesised would 
induce varying degrees of cell stress due to nutrient deprivation. Although MSCs in 
3D culture would be experiencing varying nutrient availability across the spheroid 
structure, there was no evidence to suggest that spheroids had a necrotic core caused 
by nutrient deprivation. Spheroids generated from 60,000 MSCs cultured for 5 days 
were not cystic, samples for both TEM and immunocytochemistry consisted of 
complete sections with no obvious internal cyst, which would have suggested a 
necrotic core. Lack of cell death in the centre of spheroids suggested that the 
magnitude of stress imposed on MSCs by 3D culture was sub-lethal.  
Using TEM microscopy, it was revealed that nuclei in 3D MSCs had undergone 
major morphological changes. Whilst the nuclei of 2D MSCs were regular and 
rounded, nuclei observed in 3D MSCs were multi-lobed and irregular in shape. This 
distorted nuclear morphology was observed throughout 3D culture in 60,000 MSC 
spheroids. 3D MSCs showed a prominent reduction of Lamin A/C transcript early in 
3D culture, however in both 30-, and 60,000 MSC spheroids, levels of Lamin A/C 
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transcript increased with time in 3D culture. By day 5/6, levels had returned to those 
observed in 2D MSCs. Very low level/absence of Lamin A/C expression can act as a 
marker of pluripotency (Constantinescu et al., 2006). However, Lamin A/C down-
regulation was transient in 3D MSCs, so did not indicate a sustained shift to a 
pluripotent state. Given that reprogramming somatic cells to a reprogrammed state 
occurs over a period of days to weeks, rather than hours, it is also unlikely that very 
low levels of Lamin A/C early in 3D culture represented a transient passage through 
a pluripotent state. Early loss of Lamin A/C is more likely to reflect the major 
structural alterations MSCs undergo on entry to 3D culture, and reduced Lamin A/C 
in our model may allow for increased nuclear envelope flexibility early in 3D 
culture. Absence of Lamin A/C is considered an important factor in the high level of 
flexibility of the pluripotent nuclear envelope (Pajerowski et al., 2007).  
In contrast there was sustained down-regulation of the expression of Lamin B, 
another nuclear lamina component, during 3D culture. Lamin B transcript was 
significantly down-regulated, and Lamin B protein was undetectable by 
immunocytochemistry in 3D MSCs. Recently, loss of Lamin B has been identified as  
a both a biomarker (Dreesen et al., 2013; Freund et al., 2012; Shimi et al., 2011) and 
a trigger (Shimi et al., 2011) of cellular senescence. However these findings have 
proved contradictory, as another study demonstrated that in mutant mice with skin 
keratinocyte knockouts for both Lamin B1 and Lamin B2, the cells proliferated 
normally, and the skin and hair development in knockout mice was equivalent to 
wild type (Yang et al., 2011). So the absence of Lamin B does not affect cellular 
proliferation or trigger senescence in some cell types. Indeed it was demonstrated in 
mouse ESCs that both Lamins B1 and B2 are dispensable for self-renewal and 
pluripotency. ESCs maintained normal marker expression, colony morphology, and 
karyotype even in the absence of any Lamin B proteins. The nuclear envelopes of 
Lmnb1
-/-
 Lmnb2
-/-
 ESCs were also normal and indistinguishable from wild type 
ESCs (Kim et al., 2011). As previously mentioned, ESCs do not express Lamin A/C, 
so pluripotent cells can maintain self-renewal and pluripotency in the absence of any 
Lamins. It was demonstrated here that within 4 hours of spheroid seeding, Lamin B 
transcript levels had fallen substantially. It is unlikely that transfer to 3D culture had 
triggered such an immediate onset of senescence. Furthermore it was possible to 
disaggregate MSC spheroids to a single cell suspension (d-3D MSCs) which could 
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be re-seeded on tissue culture plastic. Five hours after re-seeding, d-3D MSCs 
appeared as small rounded cells, which maintained plastic adherence. After 24 hours 
there was a small reduction in adherent MSCs, indicating that some cells were 
unable to survive the disaggregation process. However the remaining cells had begun 
to adopt a more typical MSC fibroblast-like morphology. This morphology change 
continued to 48 hours, and by this point there appeared to be a small increase in cell 
numbers, indicating that d-3D MSCs retained proliferative capacity. Taken together 
these results indicate that down-regulation of Lamin B in our 3D model does not 
mark or trigger the onset of cellar senescence. Rather 3D MSCs are quiescent, and 
retain their ability to proliferate when re-seeded onto plastic. In 3D MSCs, down-
regulation of both nuclear lamina components early in 3D culture may provide 
increased nuclear envelope flexibility and permit the major structural changes which 
are initiated by removal from plastic and seeding in 3D culture. 
Whilst nuclear envelope morphology and composition in MSCs had been changed 
by 3D culture, there was no evidence from these changes to suggest that 3D MSCs 
had undergone de-differentiation or reprogramming towards pluripotency. However, 
as previously discussed, pluripotent cells have a distinct chromatin state, 
characterised by an increase in histone modifications which mark euchromatin, and a 
decrease in histone markers of repressive heterochromatin, which can also be used to 
track reprogramming to pluripotency. Immunocytochemistry was used to analyse the 
expression of two different histone modifications, H3K4me3 (a euchromatin marker) 
and H3K9me3 (a heterochromatin marker which is expressed at low levels in 
pluripotent cells). There was little detectable difference in H3K4me3 staining 
between 2D and 3D MSCs. Relatively strong staining was observed throughout 
nuclei of both 2D and 3D MSCs, indicative of transcriptionally permissive genome 
regions in both conditions. There was a greater difference observed when staining 
for H3K9me3. Whilst 2D MSCs showed relatively strong nuclear staining, this was 
much fainter in 3D MSCs, which could indicate changes in abundance or 
organisation of the H3K9me3 modification. 2D MSCs showed a staining pattern 
typical of a more differentiated cell type, with H3K9me3 foci (observed by strong 
punctate staining) marking repressed genomic regions. Low levels of global 
H3K9me3 are observed in pluripotent ESCs, and they lack the distinct H3K9me3 
foci observed in more differentiated cells. Rather, H3K9me3 staining appears in a 
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more diffuse pattern, which is suggested to indicate a less organised, more dynamic 
chromatin organisation. It is proposed that as differentiation progresses and genes 
become modified by repressive histone marks, chromatin becomes organised into 
distinct genomic regions, marked by the presence of H3K9me3 foci (Meshorer et al., 
2006). Although immunocytochemistry suggested a reduction in H3K9me3 levels in 
3D MSCs, the staining pattern was dissimilar to that generally observed in 
pluripotent cells. The data presented here is therefore not sufficient to confirm wide 
scale chromatin alterations in 3D MSCs. Further quantitative analysis, and gene 
targeted approaches may provide evidence for significant chromatin remodelling 
which has been driven by transfer to 3D culture. 
In conclusion, the work presented in this chapter demonstrates that MSCs can be 
cultured in a self-assembling 3D structure, known as a spheroid. 3D spheroid size is 
dependent on initiating seeding number of cells, and reduces with time in culture, 
indicating that MSCs do not proliferate in 3D. 3D MSCs undergo nuclear structural 
changes, including alterations to the composition of the nuclear lamina, and may also 
have reduced abundance/altered distribution of H3K9me3, a histone modification 
associated with heterochromatin. It is possible that altered distribution may be due to 
the nuclear morphology and lamina composition changes already described, as the 
nuclear lamina is known to interact with and regulate heterochromatin organisation 
within the nucleus (Dechat et al., 2008). Loss of Lamin B can be a marker of 
senescence onset, although in our 3D system, MSCs down-regulate Lamin B 
expression, whilst maintaining viability and proliferative capacity. It was noted in 
one study that Lamin B1 depletion in fibroblasts resulted in reduced proliferation, 
but not in increased cellular senescence. Strikingly in Lamin B1-depleted fibroblasts, 
senescence associated biomarkers were only observed when cells were exposed to 
cell stress by culture at low seeding density (Dreesen et al., 2013). When considered 
in the light of these findings, the results presented here could highlight Lamin B 
reduction as a marker of the onset of cell stress, which if not countered by pro-
survival mechanisms, would lead to senescence and apoptotic cell death. However if 
cell stress remained at a sub-lethal rather than lethal level, cells may be able to 
overcome the onset of stress-induced cell death by triggering survival mechanisms. 
This could also explain why Lamin B expression appeared to stabilise or rise slightly 
with time in 3D culture. During 3D culture, MSC spheroids reduce in size, possibly 
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by recycling of cytoplasmic contents via a pro-survival response stimulated by cell 
stress. Taken together, the work presented in this chapter demonstrates that 3D 
MSCs undergo some changes to nuclear morphology, envelope composition and 
chromatin organisation, but none of these changes provide conclusive evidence of 
de-differentiation or reprogramming towards pluripotency. Work presented in the 
later chapters of this thesis will analyse 3D MSCs further, to investigate markers of 
de-differentiation, and look for evidence of autophagy as the mechanism driving this 
process. 
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Chapter 4: Assessment of the potency of MSCs cultured as 
3D spheroids 
4.1 Introduction 
As previously described, a complex network of transcription factors and chromatin 
remodelling complexes, work together to maintain ESCs in an undifferentiated, self-
renewing state (Boyer et al., 2005). Factors involved in pluripotency regulation are 
also amongst those capable of inducing reprogramming of fibroblasts to the 
pluripotent state (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 
2007). Reprogramming cocktails, including the oncogene c-Myc, can result in the 
occurrence of tumours, at relatively high frequency, in offspring produced by 
blastocyst injection of iPSCs (Okita et al., 2007). However, whilst c-Myc is 
dispensable for reprogramming of both mouse and human fibroblasts, the efficiency 
of iPSC generation is much lower in the absence of c-Myc (Nakagawa et al., 2008; 
Wernig et al., 2008). Whilst some groups have explored the use of small molecules 
which regulate chromatin organisation and cell signalling, others have attempted to 
identify optimal cell types for reprogramming to pluripotency. Although the 
expression of reprogramming factors in fibroblasts is undetectable/extremely low, 
neural stem cells (NSCs) already express c-Myc, Klf4 and Sox2 at levels equivalent 
to those in pluripotent stem cells, making them ideal candidates for reprogramming 
to pluripotency (Kim et al., 2008). Endogenous expression of these genes means that 
it is possible to reprogramme NSCs using fewer exogenous factors.  It was possible 
to generate iPSCs from mouse NSCs using just two factors, Oct4 in combination 
with either c-Myc (OM) or Klf4 (OK). Sox2 was dispensable for reprogramming of 
NSCs, most likely because endogenous expression of Sox2 was around 2-fold higher 
than expression in mouse ESCs. Both OM- and OK-derived iPSCs had similar 
endogenous expression of ESC markers to mouse ESCs. Furthermore, the 
pluripotency of both was confirmed by teratoma formation. As previously described, 
c-Myc can enhance tumourigenesis in offspring, so OK-derived iPSCs were selected 
for further analysis. They were capable of chimera contribution, and similar to three 
factor-derived iPSCs (without c-Myc), showed no tumour formation in early stage 
F1 progeny (Kim et al., 2008). One year later, the same group demonstrated the 
generation of iPSCs from mouse NSCs with a single factor, Oct4. One factor-derived 
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iPSCs had highly similar gene expression profiles to ESCs, and were pluripotent, 
evidenced by in vitro differentiation studies, teratoma formation and chimera 
contribution (Kim et al., 2009b). Following on from the work in mice, this group 
next demonstrated that human fetal NSCs can also be reprogrammed to pluripotency 
by both two-factor (OK) reprogramming and by Oct4 (O) alone. Global gene 
expression profiling revealed that both OK- and O-derived iPSCs clustered closely 
with human ESC lines, and separate from parental NSCs. Pluripotency of OK- and 
O-derived iPSCs was confirmed in vitro and in vivo (Kim et al., 2009a). The work of 
Kim and colleagues highlighted the possibilities of using fewer factors for 
reprogramming to pluripotency, by utilising cell types which already express some 
of the factors required for this process. Whilst this represented a major technological 
advance, the accessibility of human NSCs means that they are not the most viable 
option for use in cell-based therapies. Dermal papilla cells are cells of mesenchymal 
origin located in the hair follicle, which can be isolated with relative ease. Similar to 
NSCs, these cells also express endogenous Klf4, c-Myc and Sox2. It was possible to 
reprogramme mouse dermal papilla cells to pluripotency using two factor OK and 
single factor O reprogramming. iPSCs derived from both OK and O reprogramming 
of dermal papilla cells are pluripotent, evidenced by teratoma formation and 
germline contribution (Tsai et al., 2011; Tsai et al., 2010). Notably, Oct4 alone was 
also sufficient to reprogramme human adult keratinocytes to pluripotency, when 
used in combination with a small molecule cocktail. Keratinocytes are also 
accessible cells isolated from the skin or hair follicle, and endogenously express Klf4 
and c-Myc. When infected with exogenous Oct4, and exposed to a cocktail of small 
molecules regulating cell signalling pathways, chromatin organisation and 
metabolism, iPSCs colonies were generated. These cells expressed endogenous 
pluripotency factors, and had an ESC-like DNA methylation profile. Furthermore, 
they were capable of embryoid body and teratoma formation, evidence of their 
pluripotential (Zhu et al., 2010). These studies demonstrate that it is possible to 
apply the principles of fewer-factor reprogramming to a more accessible cell type, 
which may improve the clinical relevance of iPSC technology. It has also recently 
been demonstrated that the same type of factor-based approach can be used for direct 
differentiation – the differentiation of one somatic cell type to another, by exogenous 
expression of relevant transcription factors, so the principles of factor-based 
reprogramming can also be applied when a transition to full pluripotency is not 
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desired or required (Huang et al., 2011; Ieda et al., 2010; Szabo et al., 2010; 
Vierbuchen et al., 2010). 
The work presented in this chapter will investigate optimal 3D culture conditions for 
the induction of de-differentiation towards pluripotency in human MSCs, through 
assays and marker analysis commonly used to confirm pluripotency in human cells. 
It will also examine the suitability of MSCs ‘primed’ by optimal 3D culture, for 
traditional factor-based reprogramming techniques. Finally it will seek to examine 
the extent of de-differentiation driven by optimal 3D culture conditions, and identify 
markers to confirm the developmental position of MSCs cultured in 3D. 
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4.2 Aims 
The aims of the work presented in this chapter are to assess the extent to which 3D 
culture is driving de-differentiation of MSCs, to examine the effects of 3D culture on 
the efficiency of factor-based reprogramming in human MSCs, and to use marker 
expression to establish the developmental position of 3D MSCs. 
More specifically, the objectives are to: 
 Determine the effects of 3D culture on the expression of pluripotency-
related factors in MSCs  
 Assess 3D MSC pluripotency by in vivo teratoma assays  
 Identify expression of reprogramming factors in MSCs and other cell 
types used in factor-based reprogramming to pluripotency 
 Derive iPSCs by factor-based methods from both 2D and 3D MSCs to 
allow comparison of the efficiency of iPSC derivation 
 Establish suspension culture methods for 3D MSCs, aimed at 
maintaining pluripotency factor expression and stimulating 
proliferation 
 Assess the expression of known early mesoderm markers during 3D 
culture 
 Examine mesodermal potency of MSCs in vitro and in vivo 
 Investigate the effects of 3D culture on culture-aged senescent MSCs 
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4.3  Methods 
4.3.1 Quantitative real time polymerase chain reaction (qPCR) 
2D MSCs were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 30-, 60-, and 120,000 MSCs and cultured for up to 6 days 
as described in 2.2.1.5. Samples were isolated for RNA extraction on days 1,3,4,5 
and 6 of 3D culture. For qPCR using disaggregated 3D MSCs (d-3D MSCs, re-
plated on plastic), 3D spheroids were initiated from 60,000 MSCs, and maintained in 
culture for 5 days as described in 2.2.1.5. On day 5, 3D MSCs were disaggregated to 
single cells and re-seeded onto tissue culture plastic as described in 2.2.2.1. d-3D 
MSCs were maintained as described for 2D MSCs in 2.2.1.3, and samples were 
isolated at 5, 24 and 48 hours after re-seeding. HDF monolayers were cultured as 
described in 2.2.1.4, and samples were analysed at 90% confluence. H9 human ESCs 
were cultured as described in 2.2.1.6. For early mesoderm markers 3D spheroids 
were seeded with 60,000 MSCs and cultured for up to 5 days as described in 2.2.1.5. 
Samples were isolated for RNA extraction on days 1, 3, and 5 of 3D culture.  RNA 
was extracted from all 2D, 3D and d-3D samples before cDNA was generated and 
analysed by qPCR as described in 2.2.5. Primer sequences are shown in Table 4.3.1. 
For comparison of expression levels in MSCs versus ESCs (Figure 4.4.10), 
following calculation of 2
(-DDCt)
, fold changes were then converted to positive and 
negative numbers using the formula: IF(X>=1,(X),(-1/X)), where X = 2
(-DDCt)
, in 
order to more easily visualise expression differences in the different samples. 
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Table 4.3.1 Pluripotency and reprogramming factor primer sequences 
Gene Forward primer sequence (5’-
3’) 
Reverse primer sequence (5’-3’) 
Oct4 CCCACACTGCAGCAGATCAG CACACTCGGACCACATCCTTCT 
Nanog CCTCCATGGATCTGCTTATTCAG TGCGACACTATTCTCTGCAGAAG 
Sox2 GAGAACCCCAAGATGCACAAC CGCTTAGCCTCGTCGATGA 
Telomerase CATTTTTCCTGCGCGTCAT GCGTTCTTGGCTTTCAGGAT 
Klf4 CGCCACCCACACTTGTGAT GTGCCTTGAGATGGGAACTCTT 
c-Myc CGTCTCCACACATCAGCACAA TCTTGGCAGCAGGATAGTCCTT 
Brachyury  GGGTCCACAGCGCATGAT 
 
TGATAAGCAGTCACCGCTATGAA 
Goosecoid GATGCTGCCCTACATGAACGT 
 
GACAGTGCAGCTGGTTGAGAAG 
KDR TGATGCCAGCAAATGGGAAT 
 
CCACGCGCCAAGAGGCTTA 
MIXL1 AAGCCCCAGCTGCCTGTT 
 
CCCTCCAACCCCGTTTG 
CXCR4 CGCCTGTTGGCTGCCTTA 
 
ACCCTTGCTTGATGATTTCCA 
 
 
4.3.2 Immunocytochemistry 
3D spheroids were seeded with initiating cell numbers of 60,000 MSCs, cultured for 
5 days, then snap-frozen and sectioned as described in 2.2.1.5 and 2.2.3. 3D samples 
were then fixed and stained as described in 2.2.6. Antibody details are given in Table 
4.3.2. Samples were imaged using a Zen 510 upright confocal microscope. 
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Table 4.3.2 Antibodies used in immunocytochemistry 
Antibody Host Dilution Supplier Cat. no. 
Anti-Oct4A Rabbit 1:100 Cell 
Signalling  
#2840 
Anti-Nanog Rabbit 1:40 Cell 
Signalling 
#3580 
Anti-Brachyury Goat 1:15 R and D 
Systems  
AF2085 
Anti-KDR Mouse 1:25 R and D 
Systems 
MAB3571 
Anti-CXCR4 Rabbit 1:100 Chemicon 
(Millipore) 
AB1846 
Anti-Rabbit IgG (Alexa 594 
conjugate) 
Rabbit 1:500 Life 
Technologies 
A-11012 
Anti-Goat IgG (Cy3 congugate) Rabbit 1:400 Sigma c-2821 
Anti-Rabbit IgG (Cy3 congugate) Sheep 1:400 Sigma c-2306 
Anti-Mouse IgG (Alexa488 
congugate) 
Goat 1:500 Life 
Technologies 
A-11001 
 
4.3.3 Flow cytometry 
2D MSCs were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 60,000 MSCs and cultured for 5 days as described in 
2.2.1.5. 2102Ep embryonal carcinoma cells were cultured as described in 2.2.1.7. 2D 
MSCs and 2102Ep cells were harvested by trypsinisation as described in 2.2.1.3. 3D 
MSCs were disaggregated to single cells (d-3D MSCs) as described in 2.2.2.1, and 
pipetted through a 25 gauge needle to remove any residual cell clumps. To enable 
intracellular staining, all samples were fixed in 4% PFA for 10 minutes at room 
temperature. Samples were chilled for 1 minute, and then permeabilised by 
incubation in 90% methanol for 30 minutes on ice. Samples were then washed twice 
in incubation buffer (0.5% BSA in PBS), before 10 minutes blocking in incubation 
buffer at room temperature. Samples were incubated on ice with primary antibodies 
for 45 minutes. See Table 4.3.3 for antibody details. Samples were then washed in 
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incubation buffer followed by centrifugation, before incubation on ice in the dark 
with secondary antibodies for 45 minutes. Finally, samples were washed with 
incubation buffer, and re-suspended in 500µl incubation buffer before being 
analysed on a Beckman Coulter CyAn ADP analyser. Secondary antibody only 
controls were also performed for all samples. 
Table 4.3.3 Antibodies for flow cytometry 
Antibody Host Dilution Supplier Cat. no. 
Anti-Oct4A Rabbit 1:100 Cell 
Signalling  
#2840 
Anti-Nanog Rabbit 1:100 Cell 
Signalling 
#3580 
Anti-Sox2 Rabbit 1:100 Cell 
Signalling 
#3579 
Anti-Rabbit IgG (Alexa 488 
conjugate) 
Rabbit 1:200 Life 
Technologies 
A-11034 
 
4.3.4 Teratoma assay 
For the teratoma assay, 2D MSCs were cultured as described in 2.2.1.3. 3D 
spheroids were seeded with initiating cell numbers of 60,000 MSCs and cultured for 
5 days as described in 2.2.1.5. The assay was performed by Reinnervate Ltd, who 
cultured and prepared mouse ESC controls prior to implantation. All work was 
carried out in accordance with ethical guidelines under the Home Office project 
licence of Reinnervate Ltd. 2D MSCs and mouse ESCs were trypsinised, and 
counted before 5x10
5 
cells were injected. 50 MSC spheroids were injected for 3D 
samples. Injections were performed subcutaneously on adult male nude mice. After 
12 weeks, mice were sacrificed, and samples were immediately dissected and fixed, 
before sectioning on a Leica RM2165 rotary microtome at 5µm. Sections were oven 
dried at 40ºC prior to histological staining with haematoxylin and eosin and Massons 
Trichrome.  
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4.3.4.1 Haematoxylin and eosin staining 
After sectioning samples were stained as described in Table 4.3.4. Samples were 
then mounted in DPX mounting media. 
Table 4.3.4 Haematoxylin and eosin staining of tissue sections 
Procedure/Reagent  Time  
Histoclear 5 minutes 
Absolute alcohol 2 minutes 
95% alcohol 1 minutes 
70% alcohol 1 minutes 
Distilled Water 1 minutes 
Mayers Haematoxylin 5 minutes 
Distilled water 30 seconds 
Alkaline Alcohol 30 seconds 
70% Alcohol 30 seconds 
95% Alcohol 30 seconds 
Eosin 30 seconds 
95% Alcohol 10 seconds 
95% Alcohol 10 seconds 
Absolute Alcohol 15 seconds 
Absolute Alcohol 30 Seconds 
Histoclear 3 minutes 
Histoclear 3 minutes 
 
4.3.4.2 Massons Trichrome staining 
After sectioning samples were stained as described in Table 4.3.5. Samples were 
then mounted in DPX mounting media. 
Table 4.3.5 Massons Trichrome staining of tissue sections 
Procedure/Reagent Time  
Histoclear 5 minutes 
Rehydrate: 100% ethanol 2 minutes 
                      95% ethanol 1 minutes 
                     70% ethanol 1 minutes 
Distilled water  1 minutes 
Weigerts Iron Haematoxylin 25 minutes 
Rinse in running tap water 10 minutes 
Rinse in distilled water  
Biebrich Scarlet 10 minutes 
Rinse in distilled water  
Phosphomolybdic/phosphotungstic acid 15 minutes 
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Aniline Blue 7 minutes 
Rinse distilled water  
1% acetic acid 3 minutes 
Rinse distilled water  
Dehydrate 95% ethanol 10 seconds 
                 100% ethanol 10 seconds 
Histoclear 3 minutes 
 
4.3.5 Generation of iPSCs 
2D MSCs were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 60,000 MSCs and cultured for 5 days as described in 
2.2.1.5. 2D MSCs were trypsinised and re-seeded in 6-well plates, 10,500 cells per 
cm
2
. 3D MSCs were disaggregated to single cells as described in 2.2.2.1, before 
counting and seeding as above for 2D MSCs. Duplicate wells were seeded for each 
sample. 2 wells for each sample were also seeded for GFP transduction controls. 5 
hours after seeding, medium was removed and replaced with transduction media 
(DMEM high glucose supplemented with 10% FBS, 100 units/ml penicillin and 
100µg/ml streptomycin and 6ug/ml polybrene) containing lentiviral vectors for 
OKSM (Stemgent Lentivirus set:hOKSM ST00044) or GFP (Life Technologies, 
A1357701). Samples were incubated with lentivirus for 22 hours, and medium was 
refreshed every other day. For GFP-transduced cells, wells were washed with PBS, 
then imaged using both brightfield and fluorescence microscopy. 10 images per 
sample were taken, before GFP images were inverted. Samples were counted for 
total cells, and GFP+ cells, and these values were used to calculate transduction 
efficiencies as detailed below: 
Transduction efficiency = (No. of GFP+ cells/Total cell no.) x 100 
For OKSM-transduced cells, 5 days after transduction, infected cells were removed 
from plastic with TrypLE, counted and 10,500 cells per cm
2
 re-seeded in 6-well 
plates onto irradiated MEF feeder cells in ESC media (see 2.2.1.6). Duplicate wells 
were seeded for each sample. Media changes were performed daily until day 18 
(Donor 1) and day 27 (Donor 2) after transduction, when samples were fixed and 
stained as described in 2.2.6. Antibody details are given in Table 4.3.2. Samples 
were imaged using a Zeiss LSM 710 inverted microscope. This involved a tile 
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scanning method, which then generated a composite image of the whole well. For 
each sample, Oct4A+ colonies were manually counted. This number was then used 
to calculate a reprogramming efficiency, using previously calculated transduction 
efficiencies as detailed below: 
No. of transduced cells per sample =  
(transduction efficiency (in %)/100) x total cells (which is 20,000 for all samples) 
Reprogramming efficiency = (No. of Oct4A+ colonies/No. of transduced cells) x 100 
OKSM-transduced wells were also imaged conventionally using the Zeiss LSM 710 
inverted microscope for higher magnification images of individual colonies. 
4.3.6 Semi-solid culture of MSCs 
For semi-solid expansion studies, MSCs were cultured as 60,000 cell spheroids for 5 
days as described in 2.2.1.5, before disaggregation to very small cell clumps/single 
cells as described in 2.2.2.1, although here incubation time was reduced to 15 
minutes to ensure maximum cell viability. d-3D MSCs were then re-suspended in 
100µl DMEM high glucose before mixing with semi-solid media (either DMEM 
high glucose supplemented with 5% FBS and 1% methyl cellulose or ESC media 
supplemented with 1% methyl cellulose.) d-3D MSCs were cultured in non-adherent 
50mm dishes (Sterilin) at 37°C, 5% CO2 for 7 days, with no media change or 
refreshment. Samples were imaged by light microscopy. For RNA extraction, d-3D 
MSCs were isolated by washing with PBS, then pelleted by centrifugation, before 
RNA extraction was performed using Trizol. Briefly, 500µl Trizol was added to each 
sample, before samples were frozen overnight at -80ºC. Samples were then brought 
to room temperature and 100µl chloroform was added, before samples were 
vortexed, then incubated for 5 minutes at room temperature. Samples were next 
centrifuged at 12000g for 20 minutes at 4ºC, before the upper aqueous phase was 
transferred to a new tube, and mixed with 500µl 100% isopropanol by vortexing. 
Following 30 minutes incubation at 4ºC, samples were centrifuged at 12000g, 4ºC 
for 15 minutes. After isopropanol removal, 1ml of 75% ethanol was added and 
samples were centrifuged for 5 minutes at 12000g. Ethanol was removed, and 
97 
samples were air dried briefly before re-suspension in 12µl RNase-free H2O. cDNA 
samples were generated and analysed by qPCR as described in 2.2.5.3 and 2.2.5.4.  
Primers are listed in Table 4.3.1. 
4.3.7 Analysis of Brachyury+ cell percentage and position using Volocity 
A fluorescent image of a single section stained with DAPI and Brachyury as 
described above was analysed using Volocity software. Due to the nuclear location 
of Brachyury staining, it was possible to establish thresholds by which the software 
identified individual nuclei. The number of Brachyury+ cells was calculated as a 
percentage of the total cells (DAPI+). The software was then used to identify and 
highlight the highest- and lowest-intensity Brachyury+ cells, to track their 
distribution throughout the spheroid structure. 
4.3.8 Haematopoietic induction of MSCs 
2D MSCs were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 60,000 MSCs and cultured for 5 days as described in 
2.2.1.5. On day 5 2D MSCs were trypsinised to a single cell suspension, and 3D 
MSCs were disaggregated to a single cell suspension (d-3D MSCs) as described in 
2.2.2.1. 2D and d-3D MSCs were counted and seeded in MethoCult Enriched (Stem 
Cell Technologies, H4435), according to manufacturer’s instructions. Briefly cells 
were seeded at 2100 cells per cm
2
 in 50mm dishes (Sterilin) in complete MethoCult 
Enriched medium. Samples were maintained at 37ºC, 5% CO2, for 16 days. At this 
point samples were imaged using bright field microscopy, to assess the formation of 
haematopoietic-like colonies. Dishes were performed in duplicate for each sample 
from 2 different primary MSC donors.  
4.3.9 Assessment of the effect of 3D culture on mitotically inactive MSCs 
2D MSCs were cultured as described in 2.2.1.3, with repeated passaging, until they 
ceased to actively proliferate. Cells were counted at each passage until a stable, non-
proliferative point was reached, but before cells began to undergo apoptosis. 3D 
spheroids were seeded with initiating cell numbers of 60,000 MSCs and cultured for 
5 days as described in 2.2.1.5. 3D MSCs were disaggregated to a single cell 
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suspension and re-seeded onto plastic as described in 2.2.2.1. Samples of cells 
immediately before 3D culture and 48 hours following disaggregation and re-seeding 
were fixed and stained with stained with Crystal Violet as described in 2.2.2.2. 
Samples were then imaged using light microscopy. Example grayscale images of 
crystal violet stained cells are shown. Following re-seeding onto plastic, d-3D MSCs 
were counted at each passage for a further 14 days. 
  
 
  
99 
4.4 Results 
4.4.1 Enhanced expression of pluripotency-related transcription factors in 
MSCs cultured as 3D spheroids 
Pluripotency is established and maintained by the expression of a network of 
transcription factors which activate the expression of factors required for self –
renewal and repress expression of factors required for differentiation (Boyer et al., 
2005). The transcription factors Oct4, Nanog and Sox2 act together to maintain 
pluripotency. To test the hypothesis that culturing MSCs as 3D spheroids would 
induce a cellular stress response and stimulate cytoplasmic clearance to a 
rejuvenated state, MSCs were removed from 2D culture and seeded as spheroids, 
containing different initiating numbers of cells. As spheroids shrink with time in 
culture, this method established spheroids with a range of sizes, in which cell stress 
from nutrient/oxygen availability and mechanical forces would vary.  
3D MSC spheroids initiated from 30-, 60-, or 120,000 cells were cultured for up to 6 
days. RNA samples were isolated and analysed for expression of Oct4, Nanog and 
Sox2. Across the three different primary MSC donors tested there was an increase in 
expression of all three pluripotency factors across different sized spheroids from day 
3 of culture onwards.  
The expression of Oct4 was up-regulated to a maximum of around 5-fold compared 
to the donor-matched 2D sample in Donor 3 when 30,000 MSCs were cultured in 3D 
for 6 days. Donor 1 also showed the highest up-regulation of Oct4 under these 
conditions, whilst in Donor 2, culturing 60,000 MSCs in 3D for 5 days achieved the 
highest up-regulation of Oct4 expression compared to the donor matched 2D sample. 
In both Donors 1 and 3 a considerable up-regulation of Oct4 was also seen when 
60,000 MSCs were cultured in 3D for 5 days (Figure 4.4.1. A). 
An approximate 15 fold up-regulation of Nanog expression was observed in Donor 1 
when 120,000 MSCs were cultured in 3D for 5 days.  However for both Donors 2 
and 3, maximal Nanog up-regulation was observed when 60,000 MSCs were 
cultured in 3D for 5 days, and in these donors, expression in 120,000 MSC spheroids 
remained close to monolayer levels at day 5. In Donor 1, expression of Nanog at day  
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Figure 4.4.1. qPCR analysis of expression of the pluripotency factor Oct4 in 
MSCs over time in 3D culture 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with 
initiating cell numbers of 30-, 60-, or 120,000 cells for up to 6 days in culture. 
cDNA samples were generated and then analysed by qPCR. A) Expression of 
Oct4 for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in the donor matched 2D sample. 
Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 3).  
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5 in 60,000 MSC spheroids was enhanced around 10 fold compared to 2D MSCs, 
and other than 120,000 day 5, no other conditions in this donor resulted in a greater 
increase in Nanog expression (Figure 4.4.2. A). 
Notably in both Donors 2 and 3 maximal up-regulation of expression of Sox2 was 
again observed when 60,000 MSCs were cultured as a spheroid for 5 days, whilst in 
Donor 1 120,000 MSCs cultured for 5 days again saw the highest expression of Sox2 
relative to the donor matched 2D sample, with a prominent increase in expression 
also observed in 60,000 MSCs at day 5 of 3D culture (Figure 4.4.3. A). 
Across the three primary donors used in this experiment, there was a notable 
similarity in the expression pattern of pluripotent transcription factors in 3D culture. 
Whilst there was some variation in observed fold changes between donors, the 
pattern of up-regulation of expression was highly similar, across donors and genes. 
The variability of MSCs from different primary donors means that normally pooling 
of data from different donors may be inappropriate. However in this case, given the 
similarity of response across donors, sample data was pooled, in order to identify 
patterns in expression, and to help in the choice of optimal conditions to use in 
further study. When pooled, the highest up-regulation of Oct4 expression was in 
120,000 MSC spheroids at day 6, whilst the second highest level of up-regulation 
was observed in day 5 60,000 MSCs spheroids (Figure 4.4.1. B). Pooled data for 
both Nanog (Figure 4.4.2. B) and Sox2 (Figure 4.4.3. B) showed that across donors, 
up-regulation of expression of both genes was substantially higher in 60,000 MSC 
spheroids at day 5 than under any other conditions tested. For this reason further 
study was focused on MSC spheroids initiated from 60,000 cells and cultured for 5 
days was selected as the optimal culture condition. 
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Figure 4.4.2. qPCR analysis of expression of the pluripotency factor Nanog 
in MSCs over time in 3D culture 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with 
initiating cell numbers of 30-, 60-, or 120,000 cells for up to 6 days in culture. 
cDNA samples were generated and then analysed by qPCR. A) Expression of 
Nanog for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in the donor matched 2D sample. 
Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 3).  
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Figure 4.4.3. qPCR analysis of expression of the pluripotency factor Sox2 in 
MSCs over time in 3D culture 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with 
initiating cell numbers of 30-, 60-, or 120,000 cells for up to 6 days in culture. 
cDNA samples were generated and then analysed by qPCR. A) Expression of 
Sox2 for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in the donor matched 2D sample. 
Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 3).  
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Telomerase is expressed by pluripotent cells and is required for their self-renewal 
capacity. Telomerase activity is repressed in normal replicating somatic cells, 
resulting in telomere shortening and eventually leading to replicative senescence. 
MSCs from 3 primary donors were cultured as 2D monolayers, induced to form 
spheroids initiated from 60,000 cells, then maintained in culture for up to 6 days. 
RNA samples were isolated and analysed for expression of telomerase. 3D culture 
also resulted in an increase of telomerase transcript, with maximal expression on 
either day 3, 4 or 5, depending on donor. The highest up-regulation of telomerase 
expression was seen in Donor 3, with an approximately 17-fold increase at Day 3, 
compared to the donor matched 2D sample (Figure 4.4.4. A). The changes in 
telomerase expression were more varied between donors than those seen for the 
pluripotent transcription factors, but were still highly similar, considering the 
variability of MSCs from different primary donors. Pooling sample data revealed 
that the highest up-regulation of telomerase was observed at day 3 of 3D culture, 
although high variation across donors at this time point meant that statistically the 
only time point at which expression was significantly different to monolayer levels 
was day 5 (Figure 4.4.4. B). This supports the results from pluripotency factor 
qPCR, and highlights day 5 in 60,000 MSC spheroids as an optimal point for 
expression of factors associated with pluripotent cells. It should be noted here that 
telomerase is an enzyme, and that these qPCR results only report an increase in 
telomerase transcript. Functional testing would be required to see if this was 
accompanied by an increase in telomerase activity in the optimised 3D spheroid 
model.  
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Figure 4.4.4. qPCR analysis of expression of Telomerase in MSCs over time 
in 3D culture 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60, 000 cells for up to 6 days in culture. cDNA samples 
were generated and then analysed by qPCR. A) Expression of Telomerase for 
each donor was normalised to expression of the housekeeping gene GAPDH and 
made relative to expression levels in the donor matched 2D sample. Fold 
changes were calculated as 2
-ddCt
. B) Data from all 3 donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 3).  
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4.4.2 Oct4, Nanog and Sox2 proteins are not expressed at detectable levels in 
2D or 3D MSCs 
To examine if increases in transcript levels of pluripotency factors resulted in 
increased protein expression, MSCs were cultured as 60,000 MSC spheroids for 5 
days. Spheroids were then snap-frozen, sectioned and stained for Oct4A and Nanog. 
There was no specific Oct4A or Nanog staining in 3D MSC sections (Figure 4.4.5), 
suggesting that protein levels of these factors were not detectable by 
immunocytochemistry. It was possible that a small population of cells within the 
spheroid had significantly up-regulated expression of pluripotency factors, and that 
this population would also be expressing protein at detectable levels. To ensure all 
cells within the spheroid were examined, 3D MSC spheroids were disaggregated to a 
single cell suspension, incubated with antibodies to Oct4A, Nanog and Sox2, and 
then analysed by flow cytometry. Donor matched 2D MSCs and 2102Eps (positive 
control) were also analysed using this method. 2102Eps are an embryonal carcinoma 
cell line, known to express pluripotency factors, and are a useful positive control for 
in vitro pluripotency assays. Oct4A, Nanog and Sox2 were all highly expressed in 
2102Eps, confirming that the proteins of interest were detectable by flow cytometry 
(Figure 4.4.6). 3 primary MSC donors were examined using flow cytometry, and 
there was no detectable protein expression in any donor in either 2D or 3D samples 
(Figures 4.4.7 – 4.4.9). Although in all MSC donors there was a small but noticeable 
shift in the peak for Nanog. However, the magnitude of this shift was similar to that 
observed when the Nanog peak was compared to peaks for Oct4A and Sox2 in 
2102Eps. As 2D MSCs have not previously been reported to express Nanog, it is 
possible that the Nanog antibody used in this study may bind with higher affinity 
than the other antibodies used. Further antibody titrations and use of an IgG control 
would demonstrate if the concentration of Nanog antibody used may have been 
resulting in a degree of non-specific binding in the samples shown. Overall, the 
results from flow cytometry and immunocytochemistry suggest that MSCs do not 
express pluripotency-associated proteins at levels comparable to 2102Eps and that 
protein expression is not up-regulated in 3D MSCs, despite a significant up-
regulation of transcript levels of Oct4, Nanog and Sox2 under these conditions. 
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Figure 4.4.5. Staining of 3D MSC spheroid sections for the pluripotency 
markers Oct4a and Nanog 
MSCs were cultured as 3D spheroids with an initiating cell number of 60,000 
cells for 5 days in culture. Spheroids were then snap-frozen, sectioned and 
stained for markers of pluripotency. Samples were imaged using confocal 
microscopy. Oct4a (red) with DAPI (cyan) staining of 3D MSC sections (left 
panel). Nanog (red) with DAPI (cyan) staining of 3D MSC sections (right 
panel). Example images from one donor shown, scale bar   = 10µm. 
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Figure 4.4.6 Flow cytometry analysis of expression of pluripotency markers 
in 2102Ep embryonal carcinoma cells 
2102Ep cells were incubated with antibodies for Oct4a, Nanog and Sox2 in 
solution and analysed by flow cytometry. The histograms show marker 
expression of A) Oct4a, B) Nanog, C) Sox2 and D) 2º antibody only control. 
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Figure 4.4.7 Flow cytometry analysis of expression of pluripotency markers 
in 2D and 3D MSCs (Donor 1) 
2D and 3D MSCs (disaggregated to a single cell suspension) cells were 
incubated with antibodies for Oct4a, Nanog and Sox2 in solution and analysed 
by flow cytometry. The histograms show marker expression of A) Oct4a, B) 
Nanog, C) Sox2 and D) 2º antibody only control in 2D MSCs (left panel) and 3D 
MSCs (right panel). 
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Figure 4.4.8 Flow cytometry analysis of expression of pluripotency markers 
in 2D and 3D MSCs (Donor 2) 
2D and 3D MSCs (disaggregated to a single cell suspension) cells were 
incubated with antibodies for Oct4a, Nanog and Sox2 in solution and analysed 
by flow cytometry. The histograms show marker expression of A) Oct4a, B) 
Nanog, C) Sox2 and D) 2º antibody only control in 2D MSCs (left panel) and 3D 
MSCs (right panel). 
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Figure 4.4.9 Flow cytometry analysis of expression of pluripotency markers 
in 2D and 3D MSCs (Donor 3) 
2D and 3D MSCs (disaggregated to a single cell suspension) cells were 
incubated with antibodies for Oct4a, Nanog and Sox2 in solution and analysed 
by flow cytometry. The histograms show marker expression of A) Oct4a, B) 
Nanog, C) Sox2 and D) 2º antibody only control in 2D MSCs (left panel) and 3D 
MSCs (right panel). 
112 
4.4.3 Transcript levels of pluripotency factors are lower in the 3D MSC 
optimised model than in human ESCs 
Despite enhanced expression of pluripotency factors at the transcript level in 3D 
MSCs, protein expression in these cells was not detected. Using RNA isolated from 
three different primary MSCs donors, cultured as both 2D monolayers and as 60,000 
cell 3D spheroids for 5 days, transcript levels of Oct4, Nanog and Sox2 were 
compared directly to transcript levels in H9 human ESCs, cultured on feeders, by 
QPCR. As previously demonstrated, expression levels of Oct4, Nanog and Sox2 
were higher in 3D MSCs than in the donor matched 2D samples. However levels in 
3D MSCs remained lower than those in H9 ESCs for all genes examined. Oct4 
expression was between 30 – 60 fold lower in 3D MSCs than ESCs, whilst Nanog 
expression was 104 – 181 fold lower, and Sox2 expression was 15 – 30 fold lower. 
Notably, although the expression levels of pluripotent transcription factors varied 
across donors, the expression of all factors in all 3D MSC samples was higher than 
the expression observed in all 2D samples. Oct4 expression was between 82 – 98 
fold lower in 2D MSCs than ESCs, whilst Nanog expression was 665 – 3080 fold 
lower, and Sox2 expression was 275 – 1700 fold lower (Figure 4.4.10). So whilst the 
optimised 3D model results in a substantial increase in transcript levels of these 
factors compared to those seen in 2D MSCs, it cannot enhance expression of 
pluripotency factors to ESC levels. The observed increase in transcript levels in 3D 
MSCs does not appear sufficient to increase protein expression, which is required for 
the establishment and maintenance of pluripotency.  
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Figure 4.4.10. qPCR analysis of expression levels of pluripotent 
transcription factors in 2D and 3D MSCs compared to expression in human 
ESCs  
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60, 000 cells for 5 days in culture. cDNA samples were 
generated and then analysed by qPCR. Expression of Oct4 (A), Nanog (B) and 
Sox2  (C) for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in pluripotent human H9 ESCs. 
Fold changes were calculated as 2
-ddCt
. 
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4.4.3 3D MSC spheroids form small organised tissue masses but not teratomas 
in vivo 
Lack of detectable protein expression, and lower mRNA expression than ESCs 
suggested that although 60,000 MSCs cultured in 3D for 5 days resulted in enhanced 
pluripotent transcript expression, MSCs cultured in these conditions were not 
pluripotent. To test this, MSC spheroids initiated from 60,000 cells were cultured for 
5 days, before implantation into nude mice. Donor-matched 2D MSCs were also 
implanted to test their in vivo potency, and mouse ESCs were implanted to act as a 
positive control for teratoma generation. After 12 weeks, tissue masses generated 
from the implanted cells were isolated, fixed, sectioned and examined by histological 
analyses. Sections of tissue masses generated from both mouse ESCs and 3D MSCs 
were examined by stereo microscopy. At the same magnification it was clear that 
mouse ESCs formed very large tissue masses, typical of teratomas, whilst the tissue 
masses isolated from 3D MSCs were much smaller (Figure 4.4.11. A). 2D MSCs 
failed to form any tissue structures. When H & E stained sections of the large tissue 
masses generated from mouse ESCs were examined under higher magnification, 
tissues from all three germ layers were clearly visible, confirming that the masses 
were indeed teratomas, generated from pluripotent cells (Figure 4.4.11 B). By 
comparison, there was no evidence of tissue from endoderm or ectoderm in the tissue 
masses generated by 3D MSCs, although distinct, segregated mesodermal structures 
including connective tissue, muscle and adipose tissue were observed, and these 
tissues appeared highly organised, in contrast to the typically disorganised 
arrangement of teratoma tissue (Figure 4.4.11. C).  
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Figure 4.4.11. Histological analysis of in vivo tissue generation capacity 
following implantation into nude mice  
3D MSC spheroids (initial cell number = 60’ 000 cells) were cultured in 3D 
conditions for 5 days before subcutaneous injection into nude mice. Mouse ESCs 
were also implanted as a positive control for teratoma formation. After 12 weeks 
tissue samples were recovered, fixed and stained with hematoxylin and eosin (H 
+ E). A) Stereo – microscopy images of tissue masses generated by positive 
control mouse ESCs (left panel) and 3D MSCs (centre panel and right panel, 
scale bar = 500µm). B) Light microscopy images of teratomas generated by 
positive control mouse ESCs tissues (arrows indicate the presence of tissues 
from all 3 germ layers - Mes = mesoderm, Ect = ectoderm, End = endoderm; 
scale bar = 100µm). C) Light microscopy images of organised tissue masses 
generated by 3D MSCs (labels indicate tissues of mesodermal origin – Mu = 
muscle, Ad = adipose, Co = connective tissue; scale bar = 100µm). 
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4.4.4 MSCs cultured as 3D spheroids for 5 days maintain enhanced expression 
of reprogramming factors immediately after spheroid disaggregation 
The process of reprogramming human cells to pluripotency was established in 
HDFs, differentiated cells which are not reported to express the pluripotency factors 
Oct4, Nanog and Sox2. Recent work has demonstrated that the efficiency of 
reprogramming to pluripotency is improved if the starting cell population 
endogenously express some of the factors required for reprogramming (Kim et al., 
2009a; Kim et al., 2009b; Kim et al., 2008; Tsai et al., 2011; Tsai et al., 2010; Zhu et 
al., 2010). It was therefore possible that MSCs cultured in the optimised 3D model 
may reprogramme to pluripotency more efficiently than their donor-matched 2D 
samples. Comparative efficiencies for reprogramming to pluripotency rely on the 
accurate assessment of lentiviral transduction efficiencies, which then allow for the 
calculation of reprogramming efficiencies by counting reprogrammed colonies. 3D 
MSC spheroids were initiated from 60,000 cells, but it was not possible to accurately 
estimate the number of cells remaining after 5 days in 3D culture. Nor was it 
possible to assume that lentiviral particles would have access to all the cells within 
the spheroid equally. It was therefore necessary to adapt the system in order to make 
it comparable to 2D MSCs for reprogramming efficiency experiments.  
MSCs from 3 different primary donors were cultured as 2D monolayers and as 3D 
spheroids (initiated from 60,000 cells) for 5 days in culture. On day 5, 3D spheroids 
were disaggregated to a single cell suspension (d-3D MSCs) using enzymatic 
digestion. The resulting cell suspension was re-seeded onto plastic for 5 hours, 
allowing attachment. At 5 hours following return to 2D culture, RNA samples were 
isolated and analysed for expression of the ‘Yamanaka factors’ (Oct4, Sox2, Klf4 
and c-Myc, also known as OKSM). In order to assess the suitability of MSCs for 
reprogramming to pluripotency, the expression of OKSM was compared to 
expression levels in 2D HDFs. 
In 2D MSCs the expression of Oct4 was similar or slightly higher than in HDFs. 
Expression of Oct4 was enhanced in 3D MSCs, with around 5-16-fold up-regulation 
compared to HDFs, depending on MSC donor. At 5 hours following return to 2D 
culture, levels in disaggregated 3D (d-3D) MSCs had fallen, but still remained above 
those seen in HDFs and 2D MSCs (Figure 4.4.12). A similar pattern was seen when 
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Figure 4.4.12. qPCR analysis of Oct4 expression in MSCs  5 hours after 
spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for 5 
hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Oct4 for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in monolayer-
cultured HDFs. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors 
was pooled and subject to statistical analysis, mean fold changes are shown ± 
SEM, * p< 0.05. Statistical significance is relative to expression in HDFs (by 
Kruskal Wallis test, n = 3). 
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Sox2 expression was examined. Although levels of Sox2 in 2D MSCs were lower 
than those seen in HDFs, the levels of Sox2 in 3D MSCs and d-3D MSCs remained 
higher than those in HDFs. Up-regulation of Sox2 by approximately 5-35-fold in 3D 
MSCs (dependent on donor) and 4-7-fold in d-3D MSCs (dependent on donor) were 
observed compared to levels in HDFs (Figure 4.4.13). 
The expression of Klf4 was inconsistent across different MSC donors. In Donor 1, 
expression of Klf4 was at its lowest in 3D MSCs, although under these conditions 
expression remained comparable to HDFs. Expression of Klf4 in Donor 2 peaked in 
3D MSCs, whilst in d-3D MSCs, expression had fallen to levels similar to those in 
HDFs. Donor 3 showed that 3D culture had little effect on Klf4 expression, whilst 
Klf4 expression peaked in d-3D MSCs after return to 2D culture. Taken together 
these results suggest that 3D culture does not have a consistent effect on Klf4 
expression in primary MSC cultures, although they do demonstrate that across the 
primary donors tested and on average, Klf4 expression is higher in MSCs than 
HDFs, in all three culture conditions tested (Figure 4.4.14). c-Myc expression was 
observed to be higher in 2D and 3D MSCs than HDFs across all donors tested, 
although again, as with Klf4, the expression pattern of c-Myc across donors and 
conditions was less consistent than observed for Oct4 and Sox2. Following 
disaggregation, levels of c-Myc increased substantially in d-3D MSCs across all 
donors tested. Up-regulation of approximately 15-72-fold (dependent on donor) was 
observed compared to c-Myc expression in HDFs (Figure 4.4.15). Considered 
altogether, these results suggest that d-3D MSCs may represent a suitable cell type 
for reprogramming to pluripotency. Furthermore, increased endogenous expression 
of reprogramming factors may mean that they can be reprogrammed to pluripotency 
more efficiently, or with fewer factors, than their originating 2D cell populations 
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Figure 4.4.13. qPCR analysis of Sox2 expression in MSCs  5 hours after 
spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for 5 
hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Sox2 for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in monolayer-
cultured HDFs. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors 
was pooled and subject to statistical analysis, mean fold changes are shown ± 
SEM, * p< 0.05. Statistical significance is relative to expression in HDFs (by 
Kruskal Wallis test, n = 3).  
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Figure 4.4.14. qPCR analysis of Klf4 expression in MSCs  5 hours after 
spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for 5 
hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Klf4 for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in monolayer-
cultured HDFs. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors 
was pooled and subject to statistical analysis, mean fold changes are shown ± 
SEM, * p< 0.05. Statistical significance is relative to expression in HDFs (by 
Kruskal Wallis test, n = 3).  
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Figure 4.4.15. qPCR analysis of c-Myc expression in MSCs  5 hours after 
spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for 5 
hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of c-Myc for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in monolayer-
cultured HDFs. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 donors 
was pooled and subject to statistical analysis, mean fold changes are shown ± 
SEM, * p< 0.05. Statistical significance is relative to expression in HDFs (by 
Kruskal Wallis test, n = 3).  
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4.4.5 The efficiency of derivation of Oct4A+ ESC-like colonies is similar in 2D 
MSCs and d-3D MSCs 
In an attempt to derive iPSC colonies from MSCs, 3D MSCs were cultured under 
optimal conditions for 5 days, before disaggregation and re-seeding onto plastic (d-
3D MSCs) as described above. 2D MSCs were trypsinised and re-seeded at identical 
densities to d-3D MSCs. MSC duplicate wells were transduced with lentiviral 
vectors expressing OKSM for 22 hours, before culture in MSC media for 5 days. 
Identical wells were also infected with lentiviral vectors expressing GFP, in order to 
calculate transduction efficiencies. After 5 days, lenti-GFP wells were viewed using 
fluorescence microscopy, and multiple images per sample were taken (n=10). The 
number of GFP-positive cells was counted and then used to calculate the 
transduction efficiency for each sample. Example (inverted) images are shown in 
Figure 4.4.16, and transduction efficiencies are given in Table 4.4.1. The 
transduction efficiencies observed in d-3D MSCs from both donors tested were 
considerably higher than those observed in 2D MSCs. Increased transduction 
efficiency may be another benefit associated with the reprogramming of d-3D MSCs, 
as higher transduction efficiencies mean more cells will be exposed to the 
reprogramming cocktail, and so more cells have a chance of undergoing 
reprogramming to pluripotency. At day 5 following transduction, OKSM-transduced 
cells were trypsinised, counted and seeded onto irradiated MEF (iMEF) feeder cells 
in iPSC media and observed for colony formation. At day 18 (Donor 1) and day 27 
(Donor 2) following lentiviral transduction, individual wells were fixed and stained 
for the pluripotency markers Oct4A and Nanog. Wells were then imaged using 
confocal microscopy. A tile scanning method was applied, which was then used to 
generate a composite image of each whole well. The staining of Oct4A revealed 
intense immune-reactivity, so for each well, manual counting was applied to identify 
number of Oct4A+ colonies. This was then used with the transduction efficiencies 
generated from GFP-transduction, to determine the reprogramming efficiency for 
each sample (Table 4.4.2). The composite images are shown in Figure 4.4.17. In 
both donors examined, the generation of Oct4A+ colonies was slightly more 
efficient in 2D than d-3D MSCs, so enhanced expression of reprogramming factors 
at the time of transduction does not confer a reprogramming advantage on d-3D 
MSCs. Nor did it enhance the speed at which Oct4A+ colonies appeared in culture,  
123 
 
 
Figure 4.4.16 Analysis of lentiviral transduction efficiencies in 2D and d-3D 
MSCs  
d-3D MSCs and 2D MSCs were incubated with GFP-lentivirus for 24 hours. 
After 24 hours media was exchanged for MSC expansion media, and cells were 
cultured for 5 days. On day 5 2D and d-3D MSCs were examined by fluorescence 
microscopy, and counted for GFP+ cells. Multiple bright field and inverted 
fluorescence (GFP) images were used to calculate transduction efficiencies from 
mean GFP+ cells in each sample (n = 10, example images shown, GFP images 
are inverted). 
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Table 4.4.1. Transduction efficiencies of 2D and d-3D MSCs calculated from 
GFP+ cell numbers 
Sample ID Total cell no. GFP+ cell no. Transduction efficiency 
Donor 1 2D 101 38 37.6% 
Donor 1 d-3D 67 51 76.1% 
Donor 2 2D 72 37 51.4% 
Donor 2 d-3D 56 40 71.4% 
 
 
 
 
Table 4.4.2. Reprogramming efficiencies of 2D and d-3D MSCs calculated from 
Oct4A+ colony numbers 
 
Sample ID Transduction 
efficiency 
No. of cells 
plated 
No. of 
Oct4A+ 
colonies 
Reprogramming 
efficency 
Donor 1 2D 37.6% 20,000 65 0.86% 
Donor 1 d-3D 76.1% 20,000 93 0.61% 
Donor 2 2D 51.4% 20,000 18 0.18% 
Donor 2 d-3D 71.4% 20,000 16 0.11% 
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Figure 4.4.17 Analysis of the generation of Oct4a+ colonies from OKSM-
transduced 2D and d-3D MSCs  
d-3D MSCs and 2D MSCs were transduced with OKSM-expressing lentiviruses 
and cultured under standard protocols for the induction of pluripotency in 6-well 
plates. One well of a 6-well plate for each sample was stained with an antibody 
against Oct4a. Wells were examined by fluorescence microscopy, using a tile 
scanning method to allow quantification of absolute Oct4a+ colony numbers. 
Composite images of whole wells stained for Oct4a (red) for A) Donor 1 2D 
MSCs, B) Donor 1 d-3D MSCs, C) Donor 2 2D MSCs and D) Donor 2 d-3D 
MSCs. 
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this was donor-dependent, with samples from Donor 1 generating more colonies and 
much more quickly than Donor 2. Example higher magnification images of colonies 
generated from both 2D and d-3D MSCs, stained for Oct4A and Nanog, are shown 
in Figure 4.4.18.  
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Figure 4.4.18 Assessment of Oct4a and Nanog expression in colonies 
generated by OKSM transduction of 2D and d-3D MSCs 
Colonies generated from OKSM-transduced 2D and d-3D MSCs were stained for 
Oct4a and Nanog and imaged using fluorescence microscopy. Upper panels show 
staining of colonies generated from 2D MSCs for Oct4a (left) and Nanog (right). 
Lower panels show staining of colonies generated from d-3D MSCs for Oct4a 
(left) and Nanog (right, scale bar = 100µm). 
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4.4.6 Enhanced expression of pluripotency and reprogramming factors in 3D 
MSCs is lost within 24 - 48 hours of return to 2D culture 
In order to investigate the similarity of reprogramming efficiencies in 2D and d-3D 
MSCs, three different primary MSC donors were cultured as described in 4.4.5, and 
samples taken at 5, 24 and 48 hours following return to 2D culture, to track changes 
in pluripotency factor expression with time in 2D culture. In these experiments, 
expression in d-3D MSCs at 5, 24 and 48 hours was compared to that in 2D MSCs. 
The expression of all pluripotency factors returned to 2D MSCs levels in d-3D 
MSCs.  As previously observed when compared to HDF expression levels, the 
expression of Oct4 (Figure 4.4.19) and Sox2 (Figure 4.4.20) was highest in 3D 
MSCs and fell in d-3D MSCs 5 hours after return to 2D culture, whilst still 
remaining higher than levels in 2D MSCs. However within 24 hours of 
disaggregation expression levels of Oct4 reduced to 2D MSC levels (Figure 4.4.19), 
and a similar pattern was observed for Sox2, where between 24 and 48 hours after 
disaggregation, expression fell to 2D MSC levels (Figure 4.4.20). Although not one 
of the ‘Yamanaka factors’, Nanog plays a role in pluripotency maintenance, and was 
included in the four factor combination of reprogramming factors demonstrated to 
reprogramme HDFs to pluripotency by the Thompson laboratory (Yu et al., 2007). 
The expression pattern of Nanog was very similar to that of Oct4, with expression 
levels returning to those observed in 2D MSCs around 24 hours after spheroid 
disaggregation (Figure 4.4.21). Interestingly, the effect of returning 3D MSCs to 2D 
culture appeared to be detrimental to Klf4 expression in d-3D MSCs. 24 hours 
following disaggregation the expression of Klf4 in d-3D MSCs had actually fallen 
below levels observed in 2D MSCs, with only a small but donor-dependent recovery 
of expression 48 hours after disaggregation, and on average Klf4 levels were still 
significantly lower than those in 2D MSCs 48 hours after disaggregation (Figure 
4.4.22). Whilst a peak in c-Myc expression was observed 5 hours after return to 2D 
culture, this effect was transient, with expression in d-3D MSCs returning to 2D 
MSCs levels within 48 hours of return to 2D culture following spheroid 
disaggregation (Figure 4.4.23). 
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Figure 4.4.19. qPCR analysis of Oct4 expression in MSCs  up to 48 hours 
after spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for up to 
48 hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Oct4 for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in donor-
matched 2D samples. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 
donors was pooled and subject to statistical analysis, mean fold changes are 
shown ± SEM, * p< 0.05. Statistical significance is relative to expression in 2D 
MSCs (by Kruskal Wallis test, n = 3).  
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Figure 4.4.20. qPCR analysis of Sox2 expression in MSCs  up to 48 hours 
after spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for up to 
48 hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Sox2 for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in donor-
matched 2D samples. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 
donors was pooled and subject to statistical analysis, mean fold changes are 
shown ± SEM, * p< 0.05. Statistical significance is relative to expression in 2D 
MSCs (by Kruskal Wallis test, n = 3).  
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Figure 4.4.21. qPCR analysis of Nanog expression in MSCs  up to 48 hours 
after spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for up to 
48 hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Nanog for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in donor-
matched 2D samples. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 
donors was pooled and subject to statistical analysis, mean fold changes are 
shown ± SEM, * p< 0.05. Statistical significance is relative to expression in 2D 
MSCs (by Kruskal Wallis test, n = 3).  
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Figure 4.4.22. qPCR analysis of Klf4 expression in MSCs  up to 48 hours 
after spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for up to 
48 hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of Klf4 for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in donor-
matched 2D samples. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 
donors was pooled and subject to statistical analysis, mean fold changes are 
shown ± SEM, * p< 0.05. Statistical significance is relative to expression in 2D 
MSCs (by Kruskal Wallis test, n = 3).  
 
133 
 
  
Figure 4.4.23. qPCR analysis of c-Myc expression in MSCs  up to 48 hours 
after spheroid disaggregation. 
MSCs from 3 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to single cells and re-plated on tissue culture plastic for up to 
48 hours.  cDNA samples were generated and then analysed by qPCR. A) 
Expression of c-Myc for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in donor-
matched 2D samples. Fold changes were calculated as 2
-ddCt
. B) Data from all 3 
donors was pooled and subject to statistical analysis, mean fold changes are 
shown ± SEM, * p< 0.05. Statistical significance is relative to expression in 2D 
MSCs (by Kruskal Wallis test, n = 3).  
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4.4.7 Suspension culture of d-3D MSCs maintains enhanced expression of 
pluripotency factors following spheroid disaggregation  
Disaggregation studies demonstrated that enhanced expression of pluripotency 
factors in 3D MSCs was dependent on 3D culture, and that a return to adherent 
culture resulted in a return to 2D expression levels of these factors. In order to 
investigate if it was possible to expand 3D MSCs without the need to re-seed onto 
tissue culture plastic, MSCs were cultured as spheroids containing 60,000 cells for 5 
days, before disaggregation to small cell clumps, using a more gentle method of 
enzymatic digestion. Semi-solid media containing 1% methyl cellulose, is a gel-like 
culture media, where cells are held in a static position, but do not adhere to a 
substrate so preventing spreading and acquisition of typical 2D MSC shape and 
growth behaviour. The small cell clumps generated from spheroid disaggregation (d-
3D MSCs) were seeded into semi-solid media, containing either 5% FBS, or a 
serum-free media used for the culture of pluripotent cells. Over 7 days in culture, the 
d-3D MSC clusters were observed to increase in size, suggesting the cells were 
proliferating, and behaviour seemed similar in both media formulations (Figure 
4.4.24. A). To test the colony-forming capacity over time in semi-solid media, 
further experiments were performed, with disaggregation to single cells/cell clumps 
of very few cells. For these experiments media containing 5% FBS was selected, as 
in the previous experiments there was no obvious differences in cell behaviour in the 
different media. MSCs from 2 donors were tested under these conditions, and again 
over 7 days demonstrated an increase in cell clump size, indicative of proliferative 
capacity from single cells/small cell clumps within the cultures Figure 4.4.24. B). 
As discussed above, enhanced expression of pluripotency factors was lost when d-
3D MSCs were re-seeded on tissue culture plastic. RNA was isolated from d-3D 
MSCs cultured in semi-solid media for 7 days, and expression of pluripotency 
factors was analysed by qPCR. Expression was normalised to GAPDH and made 
relative to the donor-matched 2D (adherent) sample. In both semi-solid medias 
tested, d-3D MSCs maintained elevated expression of Oct4, Nanog, Sox2 and 
telomerase, compared to expression in 2D MSCs. Oct4 expression was up-regulated 
around 3-6 fold (dependent on donor) in d-3D MSCs cultured in semi-solid media 
with 5% serum, whilst up-regulation of around 3.5 fold was observed in serum-free  
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Figure 4.4.24. Analysis of MSC growth in non-adherent culture conditions 
following 3D spheroid disaggregation 
MSC spheroids were initiated (60,000 cells per spheroid) and cultured under 3D 
conditions for 5 days. On day 5 spheroids were disaggregated and re-seeded as 
cell clumps into semi-solid media (containing 1% methyl cellulose) with 5% 
serum or serum-free. A) Light microscopy images of MSCs disaggregated to 
small cell clumps and cultured for 7 days in semi-solid media with 5% serum 
(left panel) or serum-free (right panel). B) Light microscopy images of MSCs 
from 2 donors disaggregated to single cells/very small cell clumps and cultured 
for 7 days in semi-solid media with 5% serum (scale bars = 100µm). 
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semi-solid media (Donor 1 sample was lost during recovery from media) (Figure 
4.4.25. A). Similar results were observed for Nanog expression, although the up-
regulation of Nanog was much more variable between donors (4-24 fold in media 
with 5% serum). Enhancement of Nanog expression in serum-free media was highly 
similar to media with serum in Donor 2 (Figure 4.4.25. B). Expression of both Sox2 
and telomerase increased in both medias, although again, the expression changes 
between donors was highly variable. In media with 5% serum Sox2 expression was 
up-regulated 4-200 fold dependent on donor, whilst in Donor 2 culture in serum-free 
media resulted in a 250-fold increase in expression compared to 2D monolayer levels 
(Figure 4.4.26. A). Similarly expression of telomerase in serum free media increased 
around 66 fold in Donor 2, whilst up-regulation varied between 3-44 fold in media 
with 5% serum compared to 2D monolayer levels (Figure 4.4.26. B). This work 
supports the disaggregation studies with re-seeding on to plastic, and confirms that 
3D non-adherent culture is required for the maintenance of a de-differentiated 
phenotype. 
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Figure 4.4.25. qPCR analysis of Oct4 and Nanog expression in MSCs after 
spheroid disaggregation and culture in semi-solid media. 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to small cell clumps and re-seeded into semi-solid media 
(containing 1% methyl cellulose) with 5% serum or serum-free. cDNA samples 
were generated and then analysed by qPCR. A) Expression of Oct4 for each 
donor was normalised to expression of the housekeeping gene GAPDH and made 
relative to expression levels in donor-matched 2D samples. B) Expression of 
Nanog for each donor was normalised to expression of the housekeeping gene 
GAPDH and made relative to expression levels in donor-matched 2D samples, 
fold changes were calculated as 2
-ddCt
. Average dCt values ± SEM for technical 
replicates of both genes are shown in the table. 
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Figure 4.4.26. qPCR analysis of Sox2 and Telomerase expression in MSCs 
after spheroid disaggregation and culture in semi-solid media. 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for 5 days. After 5 days MSC spheroids 
were disaggregated to small cell clumps and re-seeded into semi-solid media 
(containing 1% methyl cellulose) with 5% serum or serum-free. cDNA samples 
were generated and then analysed by qPCR. A) Expression of Sox2 for each 
donor was normalised to expression of the housekeeping gene GAPDH and made 
relative to expression levels in donor-matched 2D samples. B) Expression of 
Telomerase for each donor was normalised to expression of the housekeeping 
gene GAPDH and made relative to expression levels in donor-matched 2D 
samples, fold changes were calculated as 2
-ddCt
. Average dCt values ± SEM for 
technical replicates of both genes are shown in the table. 
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4.4.8 3D MSCs show enhanced mesodermal potency in vivo and express 
markers of early mesendoderm in vitro 
As described above, although 3D MSCs did not form teratomas on in vivo 
implantation, they did give rise to small, organised tissue masses (Figure 4.4.11). 
This demonstrated an enhanced ability to form tissue in vivo, as 2D MSCs were 
without effect. Masson’s trichrome staining distinguishes collagen (blue) from 
smooth muscle (red) on histological sections. Tissue masses from 3D MSCs showed 
a substantial collagen component (connective tissue - blue) and also displayed some 
organised blocks of muscle (red) (Figure 4.4.27. A). In contrast, teratomas from 
ESCs showed a reduced connective tissue component, indicated by reduced blue 
staining, and lacked the organised muscle blocks observed in tissue masses form 3D 
MSCs (Figure 4.4.27. B). 
Considering the developmental origins of MSCs, and their propensity to form 
mesodermal-like tissues in vivo, expression of markers associated with early 
mesendoderm was examined. MSCs from two primary donors were cultured as 2D 
monolayers and 3D spheroids for up to 5 days in culture. The expression of all 
mesodermal markers examined was up-regulated in 3D versus 2D MSCs across all 
time points. However, maximal expression of markers did vary across time points, 
and there was some inter-donor variation observed. The expression of Brachyury 
was observed to increase in 3D culture, with maximal up-regulation of around 6-7 
fold compared to 2D cultures. Donor 1 showed a peak of Brachyury expression on 
day 5 of 3D culture, whilst in Donor 2 the peak was on day 3 with a slight reduction 
in expression by day 5 (Figure 4.4.28. A). Both donors showed an increase in 
Goosecoid expression with time in 3D, peaking at day 5, and with a 5.5-7.5 fold 
increase in expression compared to the donor matched 2D sample (Figure 4.4.28. B).  
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Figure 4.4.27. Histological analysis of the generation of mesoderm-derived 
tissue following implantation into nude mice  
3D MSC spheroids (initial cell number = 60’ 000 cells) were cultured in 3D 
conditions for 5 days before subcutaneous injection into nude mice. Mouse ESCs 
were also implanted as a positive control for teratoma formation. After 12 weeks 
tissue samples were recovered, fixed and stained with Massons Trichome. Light 
microscopy images of A) tissue masses generated by 3D MSCs and B) teratomas 
from mouse ESC positive controls. Labels indicate tissues of mesodermal origin 
– Mu = muscle, Ad = adipose, Co = connective tissue; scale bar = 100µm 
 
141 
 
  
Figure 4.4.28. qPCR analysis of expression of Brachyury and Goosecoid in 
MSCs over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. Expression of target gene for each 
donor was normalised to expression of the housekeeping gene GAPDH and made 
relative to expression levels in the donor matched 2D sample. Fold changes were 
calculated as 2
-ddCt
. A) Expression of Brachyury in 2 different MSC donors (left 
panel), and pooled donor data (right panel). B) Expression of Goosecoid in 2 
different MSC donors (left panel), and pooled donor data (right panel). Pooled 
donor data was subject to statistical analysis, mean fold changes are shown ± 
SEM, * p< 0.05. Statistical significance is relative to expression in 2D MSCs (by 
Kruskal Wallis test, n = 2).  
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KDR expression fell slightly on day 1 of 3D culture, but by day 3 expression of 
KDR had peaked in both donors, with levels 3-4.7 fold higher than in 2D MSCS. On 
day 5 expression of KDR had fallen in both donors, although this effect was more 
pronounced in Donor 2. In Donor 1 expression at days 3 and 5 was highly similar 
(Figure 4.4.29. A). Expression of Mixl1 increased with time in 3D culture, up to day 
3, with up-regulation of between 6-11 fold, depending on donor, and compared to 2D 
levels. By day 5 of 3D culture the expression of Mixl1 had fallen in both donors 
examined, although it remained higher than observed at day 1 of 3D culture (Figure 
4.4.29. B). Expression of CXCR4, a marker of haemangioblasts (blood/endothelial 
precursors) was highly up-regulated in 3D cultures. Although the expression pattern 
of CXCR4 was inconsistent across donors, both donors demonstrated prominent 
expression increases when cultured as 3D spheroids. Donor 1 showed increases of 
between 20-30 fold, whilst expression of CXCR4 increased 30-70 fold during 3D 
culture of Donor 2 (Figure 4.4.30). 
The expression of a number of these early mesendoderm markers were also 
examined by immunocytochemistry, to determine if detectable protein could be 
identified in 3D MSCs. MSCs were cultured as 3D spheroids for 5 days, snap-frozen 
and cryosectioned before incubation with specific antibodies. Positive staining for 
Brachyury (Figure 4.4.31. A) and CXCR4 (Figure 4.4.31. C) was observed, 
indicating that increased transcript levels did result in the production of sufficient 
protein for detection by immunocytochemistry. Weak positive staining for KDR was 
also observed (Figure 4.4.31. B). It is possible that KDR protein expression may 
have been higher at day 3, as was observed for KDR transcript.  
It was possible that sub-populations of cells within the 3D MSCs had undergone 
autophagy-driven reprogramming to different degrees due to their location within the 
spheroid. To investigate this, images of 3D MSC sections stained with anti-
Brachyury antibody were analysed using Volocity software to identify the highest 
and lowest Brachyury-expressing cells. Using this technique, it was clear that for 
both the lowest (top panel) and highest (bottom panel) Brachyury fluorescence 
intensity cells, there was a relatively even distribution of cells within the section and 
that no obvious sub-population could be identified by low/high Brachyury 
expression (Figure 4.4.32). 
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  Figure 4.4.29 qPCR analysis of expression of KDR and MIXL1 in MSCs 
over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. Expression of target gene for each 
donor was normalised to expression of the housekeeping gene GAPDH and made 
relative to expression levels in the donor matched 2D sample. Fold changes were 
calculated as 2
-ddCt
. A) Expression of KDR in 2 different MSC donors (left panel), 
and pooled donor data (right panel). B) Expression of MIXL1 in 2 different MSC 
donors (left panel), and pooled donor data (right panel). Pooled donor data was 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 2).  
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Figure 4.4.30. qPCR analysis of expression of CXCR4 in MSCs over time in 
3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. Expression of CXCR4 for each 
donor was normalised to expression of the housekeeping gene GAPDH and made 
relative to expression levels in the donor matched 2D sample. Fold changes were 
calculated as 2
-ddCt
. Expression of CXCR4 in 2 different MSC donors (left panel), 
and pooled donor data (right panel). Pooled donor data was subject to statistical 
analysis, mean fold changes are shown ± SEM, * p< 0.05. Statistical significance 
is relative to expression in 2D MSCs (by Kruskal Wallis test, n = 2).  
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Figure 4.4.31. Staining of 3D MSC spheroid sections for early mesodermal 
markers 
3D spheroids (60,000 MSCs) were cultured for 5 days. Spheroids were then snap-
frozen, sectioned and stained for markers of early mesoderm. Samples were 
imaged using confocal microscopy. Red staining for Brachyury (A), KDR (B) 
and CXCR4 (C), with DAPI counterstain (cyan) of 3D MSC sections (upper two 
panels). Lower two panels show matched secondary antibody only controls (red) 
with DAPI (cyan). Scale bar = 100µm. 
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Figure 4.4.32. Analysis of the distribution of Brachyury
+
 MSCs within the 
3D spheroid structure 
MSCs were cultured as 3D spheroids with an initiating cell number of 60,000 
cells for 5 days in culture. Spheroids were then snap-frozen, sectioned and stained 
for Brachyury (red) with DAPI (cyan). Samples were imaged using confocal 
microscopy. The image was subject to analysis with the Velocity Software 
program, to identify cells expressing the lowest (top panel) and highest (bottom 
panel) levels of Brachyury, which were highlighted in yellow (n = 48). 
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CXCR4 is a marker of mesoderm and haemangioblasts (Oldershaw et al., 2010), and 
is expressed by early haematopoietic progenitors, acting as a marker of definitive 
haematopoiesis during embryogenesis (Moepps et al., 2000). CXCR4 expression 
was highly up-regulated in 3D MSCs. To test if enhanced expression of early 
mesendoderm/haemangioblast markers indicated enhanced in vitro haematopoietic 
potential in 3D MSCs, 2D and 3D MSCs were cultured for 5 days. 3D MSCs were 
disaggregated to a single cell suspension (d-3D MSCs), and 2D MSCs were detached 
from plastic and prepared as a single cell suspension. The cell suspensions were then 
mixed with Methocult (a semi-solid methyl cellulose-based haematopoietic induction 
media). After 16 days in this media, cells were examined by light microscopy to 
monitor the appearance of haematopoietic-like colonies. 2D monolayer MSCs 
remained as single cells and very few tiny cell clusters were observed. There also 
appeared to be increased cell debris in 2D samples, indicative of cell death (Figure 
4.4.33, top panels). In contrast, colonies were observed in d-3D MSC samples, 
which were larger, irregular in shape, and appeared to be producing a ‘halo’ of 
smaller cells around them (Figure 4.4.33, bottom panels, arrows indicate ‘budding’ 
cells). These colonies were similar, but not typical, of the blast-like colonies of early 
haematopoietic progenitors seen in a standard CFU assay using CD34+ cells. Further 
investigation, such as isolation and analysis for CD45-positivity would confirm the 
haematopoietic status of the colonies derived from d-3D MSCs. 
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Figure 4.4.33 Assessment of MSC haematopoietic CFU ability in semi-solid 
induction media 
3D spheroids were initiated from 60,000 MSCs and cultured for 5 days, before 
disaggregation to a single cell suspension. 2D and d-3D MSCs were seeded in 
haematopoietic induction media, and cultured for 16 days, before being analysed 
with brightfield microscopy for the presence of haematopoietic-like colonies. 
Example images from 2 different MSC donors for 2D (A, C) and d-3D (B, D) 
samples are shown. (Scale bar = 100µm, arrows indicate cells ‘budding’ from d-
3D MSC colonies)  
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4.4.9 3D culture reverses morphological changes and growth arrest associated 
with replicative senescence 
As described in section 3.4.3, when 3D MSCs were disaggregated and re-seeded 
onto tissue culture plastic, they re-adopted a typical 2D MSC morphology over 24-
48 hours. However, in relation to the originating 2D MSC population, the size and 
morphology of d-3D MSCs was different. d-3D MSCs were smaller, and noticeably 
less spread out than the 2D MSCs they originated from. When 2D MSCs are 
maintained in culture for long periods of time, they gradually acquire morphological 
features of senescent cells, becoming larger, flatter and more spread out. There is 
also a reduction in proliferative capacity over a number of passages, although the 
time taken to reach cellular senescence is donor-dependent. Given that 3D MSCs 
express markers of a more primitive state, and d-3D MSCs appeared 
morphologically distinct from in vitro cultured MSCs, the effects of 3D culture on in 
vitro-aged MSCs was determined. 2D MSCs were cultured in vitro until they ceased 
to proliferate (Figure 4.4.34.A). At this stage, 2D MSCs had a flat, well spread 
morphology, typical of non-proliferative/senescent cells (Figure 4.4.34.B, left panel). 
These cells were then cultured under optimised 3D conditions for 5 days. Following 
disaggregation and re-seeding onto plastic, d-3D MSCs appeared morphologically 
distinct from the originating 2D MSC population, they were small, and non-spread 
(Figure 4.4.34.B, right panel) and had regained proliferative capacity (Figure 
4.4.34.A). This suggests that optimised 3D culture conditions are sufficient to restore 
proliferative capacity to non-proliferative, in vitro-aged MSC cultures, and reverse 
senescence-associated cellular hypertrophy to a more primitive morphology. 
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  Figure 4.4.34 Analysis of morphology and proliferative capacity of senescent 
MSCs before and after 3D culture 
2D MSCs were repeatedly passaged until a non-proliferative population was 
reached. Culture-aged MSCs were then used to initiate 3D spheroids (60,000 
MSCs per spheroid) and cultured for 5 days, before disaggregation and re-seeding 
onto plastic. A) Cumulative population doublings are shown for culture-aged 
MSCs before and after 3D culture. B) Sample MSCs before and 48 hours after 
disaggregation were stained with crystal violet and imaged using brightfield 
microscopy (Example grayscale images are shown, scale bar = 100µm).   
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4.5 Discussion 
The transcription factor Oct4 is expressed in the epiblast in vivo, and undifferentiated 
ESCs and ECs in vitro (Okamoto et al., 1990; Rosner et al., 1990). Nanog expression 
is also restricted to pluripotent cells (Chambers et al., 2003; Mitsui et al., 2003), 
whilst Sox2 is expressed throughout the epiblast and in pluripotent cells in vitro 
(Avilion et al., 2003). The expression of these factors is also up-regulated in human 
somatic cells, when they are reprogrammed to pluripotency by forced expression of 
defined factors (Takahashi et al., 2007; Yu et al., 2007). Increased expression of 
pluripotency factors was selected as a marker of de-differentiation/reprogramming in 
3D MSCs, and used to identify optimal 3D conditions. 
As demonstrated in section 3.4.1, 3D spheroid size was dependent on initial MSC 
seeding density and time in culture, and a wide repertoire of spheroid sizes could be 
generated using the conditions tested. Optimal/high expression of Oct4, Nanog and 
Sox2 was consistently observed across the donors examined when 60,000 MSCs 
were cultured in 3D for 5 days. The combined up-regulation of all 3 pluripotency 
factors could indicate that the level of stress imposed on 60,000 MSCs after 5 days 
in 3D culture, is optimal for driving an autophagy-reponse which initiates 
reprogramming towards pluripotency. Telomere shortening occurs during ageing in 
the absence of telomerase expression. This limits the proliferative capacity of normal 
adult cells, as when telomeres become critically short, they enter replicative 
senescence. Pluripotent cells, when cultured under the correct conditions have 
unlimited self-renewal capacity, express telomerase, and maintain telomere length 
through repeated passage in culture. In optimal 3D culture conditions (60,000 MSCs 
per spheroid), expression of telomerase was up-regulated compared to donor-
matched 2D samples. This indicates that MSCs re-acquire telomerase expression, 
another marker of pluripotency, through culture under optimal 3D conditions. It has 
recently been demonstrated that during iPSC generation, activity of telomerase is 
restored (Takahashi et al., 2007), but also that after a few passages, iPSCs have 
telomeres of equivalent length to ESCs (Marion et al., 2009b). This shows that not 
only is expression of telomerase reactivated in iPSCs, but that it acts to lengthen and 
maintain telomeres in the same manner as observed in pluripotent ESCs. Increased 
mRNA expression of telomerase in 3D MSCs could indicate an increase in activity 
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during 3D culture, but this would require further validation of both telomerase 
activity, and telomere lengthening, to be comparable to the changes observed in 
factor-based reprogramming to pluripotency.  
During traditional factor-based methods, partial reprogramming to pluripotency has 
been reported by a number of groups. In fact, the breakthrough experiments by 
Takahashi and Yamanaka produced cells with similar but not identical characteristics 
to pluripotent mouse ESCs. The Fbx15-selected iPSCs showed variable expression 
of endogenous pluripotency factors, at levels lower than observed in ESCs. The 
iPSCs generated were also unable to form viable adult chimeras, so were not 
equivalent of ESCs in terms of in vivo potency (Takahashi and Yamanaka, 2006). 
Similar to this, it was observed that, under optimal culture conditions (60,000 MSCs, 
day 5), whilst 3D MSCs up-regulated expression of all 3 pluripotency factors 
compared to 2D MSCs, the expression of these factors was lower than in H9 ESCs, 
in all MSC donors examined. Furthermore, there was no detectable Oct4A, Nanog or 
Sox2 protein expression in 3D MSCs, and they did not form teratomas when 
implanted into immunocompromised mice. Taken together these results suggest that 
3D MSCs cultured under optimal conditions increase mRNA expression for factors 
associated with pluripotency, but that this is not associated with increased protein 
expression. Expression levels remain below levels observed in ESCs, and 3D MSCs 
are not pluripotent in vivo, as they are unable to form teratomas. Notably low 
endogenous expression of pluripotency factors (Lin et al., 2009) and absence of 
teratoma formation (Mikkelsen et al., 2008) have both been observed in cells 
partially reprogrammed with factor-based methods, and further treatment was 
required to induce full reprogramming to pluripotency. It was previously 
demonstrated in the lab that 3D MSCs are quiescent, and do not express the 
proliferation marker Ki67 (Elen Bray, unpublished observations). Ruiz and 
colleagues demonstrated that proliferation was required during reprogramming to 
pluripotency, and that cell cycle inhibition resulted in an absence of reprogrammed 
cells. Furthermore, it was demonstrated that increased proliferation increased the 
number of reprogrammed cells generated, rather than affecting reprogramming 
kinetics, which suggested that proliferation at the individual cell level is a 
requirement for reprogramming to pluripotency (Ruiz et al., 2011). Given that 3D 
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MSCs are quiescent, lack of the necessary cell proliferation could explain why they 
do not appear to undergo full reprogramming to pluripotency under 3D conditions.  
As 3D MSCs are not pluripotent, but up-regulate expression of pluripotency factors, 
they were considered a potentially good source of cells for efficient factor-based 
reprogramming techniques. To allow for comparable experiments, 3D MSCs were 
disaggregated and re-seeded onto plastic (d-3D MSCs). After 5 hours, expression 
levels of OKSM were examined, and compared to both 2D MSCs and HDFs, which 
are commonly used for reprogramming. Expression levels of Oct4, Sox2 and c-Myc 
were higher in d-3D MSCs than HDFs and 2D MSCs, whilst on average this was 
also the case for Klf4, although Klf4 expression was not consistently regulated by 
3D culture of MSCs. NSCs (Kim et al., 2009a; Kim et al., 2009b; Kim et al., 2008), 
dermal papilla cells (Tsai et al., 2011; Tsai et al., 2010) and keratinocytes (Zhu et al., 
2010) all express some of the reprogramming factors at levels higher than in HDFs, 
and have been reprogrammed to pluripotency with increased efficiency and fewer 
factors. This suggested that when transduced at 5 hours post-disaggregation, 3D 
MSCs may be reprogrammed more efficiently than their donor matched 2D samples. 
In fact, reprogramming efficiencies were higher in 2D MSCs in both donors 
examined, although the differences between culture conditions were relatively 
minor. Whilst iPSC-like colonies generated from 2D and d-3D MSCs stained for 
both Oct4A and Nanog, they were difficult to maintain in culture with serial 
passaging. Further experiments revealed that whilst at 5 hours post-disaggregation d-
3D MSCs expressed OKSM at higher levels that 2D MSCs, by 24-48 hours, these 
levels had dropped, and were equivalent of 2D MSC expression. The optimal 
recommended treatment time with lentiviral vectors used was 20-24 hours, so even 
during this time 3D MSCs had lost the increased expression of pluripotency factors, 
which was hypothesised to enhance factor based reprogramming. Given the similar 
efficiencies achieved in both 2D and 3D MSC reprogramming, it is likely that the 
cells were highly similar at the time when lentiviral integration occurred. It is also 
probable that considering the difficulties associated with colony expansion, which is 
common in partially reprogrammed cells (Shi et al., 2008; Silva et al., 2008), that the 
colonies generated in these experiments represented partially reprogrammed, rather 
than true pluripotent iPSCs. 
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Potential technical difficulties associated with lentiviral reprogramming of 3D MSCs 
in suspension culture lead to the use of d-3D MSCs in the reprogramming 
experiments described above, but clearly any reprogramming advantage that 3D 
culture may confer onto 3D MSCs is lost on re-plating to tissue culture plastic. Loss 
of enhanced expression of Oct4, Nanog and Sox2 in d-3D MSCs clearly 
demonstrates that this up-regulation is dependent on 3D non-adherent culture 
conditions. The hypothesis suggests that cell stress, imposed on cells through varied 
nutrient and oxygen availability in 3D culture, is sufficient to drive reprogramming 
towards pluripotency. On return to tissue culture plastic 3D MSCs re-adopt typical 
adherent MSC morphology and behaviour in the presence of plentiful nutrients and 
oxygen. It would therefore seem sensible that in the absence of conditions which 
confer a de-differentiated state onto MSCs, the hallmarks of reprogramming would 
be lost, as is indeed the case for d-3D MSCs. It was demonstrated that 
disaggregation of 3D MSCs to both small cell clumps, and single cells, before 
seeding in a suspension culture in supportive semi-solid media, yielded cell colonies 
which increased in size with time in culture. d-3D MSCs proliferated to a similar 
extent in both media tested. One media consisted of DMEM supplemented with 5% 
FBS, to confer a level of nutrient deprivation onto cells, whilst the other media was 
serum-free iPSC maintenance media, which should help in the maintenance of 
undifferentiated cells, as it is devoid of factors in serum which can induce 
differentiation. QPCR revealed that in 2 different MSC donors, the expression of 
Oct4, Nanog, Sox2 and telomerase was higher in d-3D MSCs, cultured in semi-solid 
conditions for 7 days, than in 2D MSCs. This indicates that enhanced expression of 
pluripotency factors is maintained in d-3D MSCs well beyond the 5 hour window of 
enhanced expression observed when d-3D MSCs are re-seeded onto plastic. Clearly, 
return to 2D culture conditions is responsible for loss of pluripotency markers, and 
maintenance of MSCs in a 3D environment drives continued expression of 
pluripotency factors. As mentioned above, proliferation is required for 
reprogramming to pluripotency (Ruiz et al., 2011). It may be that releasing 3D 
MSCs from their quiescent state, whilst culturing them in an environment which 
supports the maintenance of a de-differentiated state is sufficient to sustain enhanced 
expression of pluripotency factors. 
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The teratoma assays also demonstrated that 3D MSCs, when freed from the 
constraints of plastic-adherent culture, had increased mesodermal potency compared 
to 2D MSCs. 2D MSCs were unable to form any tissues in vivo, whilst 3D MSCs 
formed small, highly organised masses composed of tissues of mesodermal origin. 
The absence of teratomas, but formation of mesodermal tissues from 3D MSCs 
suggests that these cells are more potent than 2D MSCs, but not pluripotent. 
Formation of mesoderm in vivo suggests that 3D MSCs may have de-differentiated 
to early primitive mesodermal stem cells, with the capacity to form mesodermally-
derived tissue, which 2D MSCs were unable to form. The presence of tissue masses 
also demonstrates the proliferative potential of 3D MSCs when exposed to 
exogenous cues, and this proliferative capacity was also demonstrated in vitro, when 
d-3D MSCs proliferated whilst maintaining pluripotency factor expression after 
dissagregation appeared to release them from their quiescent state. This lineage-
restricted de-differentiation rather than full reprogramming to pluripotency may 
actually improve the potential of 3D MSCs for therapeutic applications. Recently an 
increasing focus has been placed on ‘direct reprogramming,’ which is the 
reprogramming of one cell type to another, without passage through pluripotency. 
This method would be considered preferable in the generation of cells for therapeutic 
application, as it effectively circumvents pluripotency and associated teratoma risk. 
Functional neurons (Vierbuchen et al., 2010), hepatocytes (Huang et al., 2011) and 
cardiomyocytes (Ieda et al., 2010) have all been generated from mouse fibroblasts by 
direct reprogramming, and human fibroblasts have been directly reprogrammed to 
haematopoietic progenitors and mature cell types (Szabo et al., 2010). Furthermore 
factor-based direct reprogramming has been demonstrated in vivo, when β-cells were 
reprogrammed to mature exocrine cells of the pancreas, a cell type which, like β-
cells, arise from pancreatic endoderm (Zhou et al., 2008). These studies clearly 
demonstrate that forced expression of factors associated with a particular cell fate 
can directly reprogramme fibroblast and other cell types to that fate, without the need 
for passage through pluripotency. In the proposed model, it would appear that 3D 
conditions initiate a de-differentiation programme, that is associated with increased 
expression of pluripotency factors, but which halts before reaching pluripotency, 
resulting in MSCs which have adopted a lineage-restricted post-pluripotent state. 
Oldershaw and colleagues demonstrated directed differentiation of human ESCs to 
chondrocytes, through a series of stepwise differentiation events which mimicked in 
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vivo development (Oldershaw et al., 2010). In fact, the mesendoderm/mesoderm 
markers expressed by MSCs during 3D culture bore a striking resemblance to the 
stage-specific markers proposed in this paper.  Stage 1 was defined as primitive 
streak/mesendoderm and was characterised by expression of factors including 
Brachyury, Goosecoid and MIXL1, whilst Stage 2, defined as mesoderm was 
characterised by expression of Brachyury, KDR and CXCR4. However qPCR 
actually showed that at Stage 1, high expression of Oct4, Nanog, Sox2, Brachyury 
and Goosecoid was observed, whilst maximal expression of KDR and MIXL1 was 
observed at Stage 2 (Oldershaw et al., 2010). 3D MSCs expressed high/maximal 
levels of Oct4, Nanog and Sox2, along with Brachyury and Goosecoid at day 5 of 
3D culture, suggesting a similarity to the primitive streak/mesendoderm cells 
described by Oldershaw and colleagues. Most strikingly, expression of KDR and 
MIXL1 was highest at day 3 in 3D MSCs, and at Stage 2 (mesoderm cells) in this 
publication. This suggests that 3D MSCs undergo de-differentiation in a manner that 
passes through stages similar to those observed when ESCs are differentiated in a 
stage-specific manner, thought to represent the normal developmental process. 
Taken together these results indicate that the de-differentiation initiated by 3D 
culture could represent a stage-specific reversal of normal developmental 
progression, and that 3D MSCs at day 5 share similarities with cells of the primitive 
streak/mesendoderm. Expression of markers of mesendoderm was not restricted to 
mRNA, as Brachyury protein was detectable by immunofluorescence at day 5 of 3D 
culture. KDR protein was weakly detected at this time point, though it could be 
speculated that expression would have been stronger if day 3 samples had been 
examined. This would also have provided further evidence for the theory of step-
wise de-differentiation, from the starting population of MSCs, though mesoderm to 
primitive streak/mesendoderm at day 5 of 3D culture. Interestingly it appeared that 
the distribution of Brachyury+ cells was uniform throughout the 3D structure, so a 
small highly expressing population was not responsible for the observed up-
regulation of Brachyury mRNA. In fact, based on Brachyury expression, 
approximately 70% of cells were positive for Brachyury staining (using Volocity 
software, calculated as a percentage of DAPI+ nuclei). This indicates that 3D culture 
is highly efficient at inducing Brachyury expression in 3D MSCs at day 5. Strong 
expression of the mesoderm/haemangioblast marker CXCR4 was also observed in 
3D MSCs, along with an enhanced ability to form blast-like colonies when 
157 
disaggregated and re-seeded in haematopoietic induction media, suggestive of a 
functional enhancement of potency in 3D compared to 2D MSCs. Along with this 
ability to drive de-differentiation in cycling cells, 3D culture also appeared to reverse 
the effects of culture-induced cell senescence in MSCs. Cellular ageing is associated 
with the accumulation of damaging protein aggregates and mutated mitochondria, 
which are thought to contribute to the phenotype of aged cells. Indeed, age-
associated neurodegeneration is caused by these damaging protein aggregates, and 
recently compounds which drive cytoplasmic clearance (including autophagy 
stimulators) have been found to reverse some of the effects of protein accumulation 
(Ravikumar et al., 2004; Rubinsztein, 2006; Rubinsztein et al., 2011). Autophagy 
stimulators are also associated with increased longevity (Eisenberg et al., 2009; 
Harrison et al., 2009; Morselli et al., 2009), and autophagy inhibition results in 
cellular degeneration which mimics that observed in physiological ageing (Harris 
and Rubinsztein, 2012; Rubinsztein et al., 2011). This suggests that reversal of 
replicative senescence in MSCs could indeed be induced by an enhanced autophagy 
response, stimulated by 3D culture conditions. 
The results presented in this chapter suggest that 3D culture drives de-differentiation 
of 3D MSCs, characterised by enhanced/maximal expression of markers of 
pluripotency/primitive streak/mesendoderm. 3D MSCs do not reach full 
pluripotency, which could indicate a reduced teratoma risk when compared to 
pluripotent, teratoma-initiating cells. Instead 3D culture appears to drive a highly 
efficient lineage-restricted de-differentiation to a population of mesendoderm-like 
cells with enhanced potency in vitro and in vivo, although the mechanism driving 
this de-differentiation is unknown. 3D culture is key, as return to tissue culture 
plastic results in loss of de-differentiated characteristics, which supports the initial 
hypothesis that de-differentiation would be induced by autophagy, driven by nutrient 
deprivation in 3D conditions. Cytoplasmic clearance has been demonstrated to 
reverse age-associated defects in studies of neurodegeneration, and 3D culture 
reversed replicative senescence in culture aged MSCs. Although stimulation of 
autophagy and metabolic remodelling are mainly considered in the context of full 
reprogramming to pluripotency, it is possible that in lineage-restricted 
reprogramming, these processes could also play a role. If one considers 
reprogramming to pluripotency as a progressive reversal of the developmental 
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process, rather than a simple ‘switch’ from one cell type to another, with no 
intermediates in between, then it makes sense that cells would passage through de-
differentiation and a number of increasingly primitive cell fates before reaching 
pluripotency. In this scenario, the principles of cytoplasmic clearance and metabolic 
restructuring would also play a role in lineage restricted de-differentiation, as well as 
in reprogramming to full pluripotency. Chapter 5 will attempt to confirm the 
mechanism driving de-differentiation in 3D MSCs by investigating autophagy 
markers, to determine an active autophagic response in MSCs under 3D culture 
conditions. It will also examine the metabolic profile of 3D MSCs to investigate if, 
in 3D MSCs, autophagy is driving cytoplasmic clearance and metabolic remodelling 
to a more primitive state. 
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Chapter 5: Mechanisms driving enhanced potency in 3D 
MSCs 
5.1  Introduction 
As previously described, the metabotype of pluripotent stem cells is distinct from 
that of differentiated cells, and during reprogramming to pluripotency, there is a 
requirement for metabolic remodelling. A number of hallmarks of metabolic 
reprogramming have been observed during factor-based reprogramming. These 
include a decrease in oxygen consumption and an increase in lactate production 
compared to the originating cell population. iPSC colonies derived from MEFs with 
4 factors (OKSM) had highly similar oxygen consumption, cellular lactate levels and 
lactate efflux to ESCs, and these levels were significantly different to those of the 
parent MEFs (Folmes et al., 2011). Differential expression of components of the 
oxidative phosphorylation complexes I and II were also observed under these 
reprogramming conditions, with down-regulation of these components in iPSCs 
compared to expression in parental MEFs. Under TEM examination, tubular cristae 
rich mitochondrial networks were observed in MEFs, whilst in iPSCs, mitochondria 
were small, primitive and cristae-poor, occupying a perinuclear location, highly 
similar to mitochondria in ESCs. iPSCs also showed an increased nuclear to 
cytoplasmic ratio, another hallmark of pluripotent cells (Folmes et al., 2011).  
Autophagy is a physiological mechanism, which recycles organelles and cytoplasmic 
contents, to aid cell survival in response to nutrient starvation. Breakdown and 
recycling of the components of an autophagosome relies on fusion with a lysosome, 
which contains degradative enzymes. Genes encoding lysosome proteins are 
expressed in a co-ordinated fashion, and this expression is regulated by the master 
regulator of lysosomal biogenesis transcription factor EB (TFEB) (Sardiello et al., 
2009). TFEB is a member of the microphthalmia–transcription factor E (MiT/TFE) 
subfamily of basic helix-loop-helix (bHLH) transcription factors. In analyses of 
mechanisms that drive lysosome biogenesis it was observed that many lysosomal 
genes contained a common motif, situated close to the transcriptional start site. This 
motif was a palindromic 10bp GTCACGTGAC motif, which is similar to sequences 
known to be bound by MiT/TFE family members. When all human genes with at 
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least two of these motifs within 200bp of the transcriptional start site were identified, 
this group was found to be strongly enriched for genes associated with lysosome 
biogenesis and function. This suggested that this element regulated the expression of 
many lysosomal genes, and lead to the naming of the motif as a Coordinated 
Lysosome Expression and Regulation (CLEAR) element. Chromatin 
immunoprecipitation showed that TFEB was able to bind to CLEAR elements in 
lysosomal genes, and mRNA levels of such genes increased upon TFEB over-
expression. TFEB over-expression also resulted in increased lysosome numbers. The 
lysosomal-associated membrane protein LAMP1 is a major component of lysosomal 
membranes, and LAMP1 expression is regulated by TFEB (Sardiello et al., 2009). 
Increased expression of LAMP1 can act as a marker of increased lysosome numbers, 
whilst another marker can be used to indicate an increase in autophagosome 
formation. The microtubule-associated protein I light chain 3 (LC3) is a homologue 
of the yeast protein Atg8, which is essential for autophagy, and is thought to play a 
role in autophagosome formation. LC3 exists in two forms, LC3 I is cytoplasmic, 
whilst LC3 II is incorporated into autophagosome membranes. Short term serum and 
amino acid depletion is sufficient to drive an increase in LC3 II levels, so this can act 
as a marker of a starvation-driven enhanced autophagic response (Kabeya et al., 
2003). It was recently demonstrated that TFEB regulates not only lysosomal but also 
autophagy genes, coordinating the regulation of these closely linked cellular 
clearance mechanisms. Overexpression of TFEB resulted in an increase in 
autophagosomes, and enhanced autophagic flux (the rate at which autophagosomes 
are delivered to lysosomes). There was also an increase in expression of autophagy 
related genes. In contrast, autophagy genes were down-regulated after TFEB 
silencing, even under starvation. Furthermore the autophagy marker LC3 II also 
decreased under starvation conditions when TFEB was depleted, indicating a 
requirement for TFEB for a functional autophagy response after nutrient depletion 
(Settembre et al., 2011). The work in this chapter will utilise these well-defined 
markers of autophagy and metabolic remodelling to investigate the hypothesis that 
3D culture regulates autophagy to drive cytoplasmic and metabolic remodelling in 
MSCs. Autophagy is a physiological response to cell stress, and if 3D culture does 
stimulate autophagy to drive cytoplasmic clearance as a survival mechanism, then 
this should be observed in cell types other than MSCs. However, the tolerance of 
nutrient deprivation in 3D culture is likely to be cell-type specific, so it may be 
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necessary to optimise conditions for any cell type cultured in 3D. To investigate this 
theory, I will also attempt to establish optimal 3D culture conditions for human 
dermal fibroblasts. HDFs have been reprogrammed to pluripotency using traditional 
factor based methods (Yu et al., 2007), so are amenable to the induction of de-
differentiation through forced expression of pluripotency factors. Here I will 
investigate if optimal 3D culture conditions alone are sufficient to drive enhanced 
expression of pluripotency factors in HDFs, in the absence of exogenous factors. 
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5.2 Aims 
The general aim of the work presented in this chapter is to analyse the metabolic 
status and autophagy response in 3D MSCs. 
More specifically, the objectives are to: 
 Examine the expression of markers of autophagy in 3D MSCs 
 Assess the metabolic status and identify evidence of metabolic 
remodelling in 3D MSCs  
 Investigate if optimised 3D culture conditions are sufficient to drive 
enhanced pluripotency factor expression in other cell types 
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5.3 Methods 
5.3.1 Transmission electron microscopy  
3D spheroids were seeded with initiating cell numbers of 60,000 MSCs and cultured 
for up to 5 days as described in 2.2.1.5. For general analysis of autophagy-induced 
ultrastructural changes, samples were isolated on days 1 and 5; for more detailed 
analysis of mitochondria, samples were isolated on day 5. All samples were fixed as 
described in 2.2.4.1. Samples were stained as described in 2.2.4.2 or for high contrast 
mitochondrial imaging, staining was as described in 2.2.4.3. All samples were then 
prepared and imaged as described in 2.2.4.4. 
5.3.2 Quantitative real time polymerase chain reaction 
2D MSCs were cultured as described in 2.2.1.3. 3D spheroids were seeded with 
initiating cell numbers of 60,000 MSCs and cultured for up to 5 days as described in 
2.2.1.5. Samples were isolated every day of 3D culture for analysis of TFEB 
expression. For qPCR of rapamycin-treated cells, 3D spheroids were initiated from 
60,000 MSCs, and maintained in culture for 5 days as described in 2.2.1.5. Medium 
was refreshed daily. For treated samples, 3D MSC medium was supplemented with 
0.3nM rapamycin; 3D MSC medium alone was used for control samples. 2D HDF 
monolayers were cultured as described in 2.2.1.4, and 3D HDFs were cultured as 
described in 2.2.1.6 for 5 days, with samples isolated daily. RNA was isolated from 
all 2D and 3D samples before cDNA was generated and analysed by qPCR as 
described in 2.2.5. Primer sequences for TFEB were as follows (5’-3’):  
forward primer: CCAGAAGCGAGAGCTCACAGA;  
reverse primer: TGTGATTGTCTTTCTTCTGCCG 
5.3.3 Promoter analysis for TFEB binding sites 
A promoter search was performed using the Gene Name Input option of 
MatInspector software. Searches were performed for human Oct4, Nanog and Sox2. 
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5.3.4 Protein isolation and quantification 
Monolayer MSCs were trypsinised, centrifuged and re-suspended in RIPA buffer 
(Thermo Scientific) containing 0.5% protease inhibitor cocktail set III (Calbiochem) 
and 100μM Na3VO4 (Sigma). 3D MSC spheroids were homogenized in RIPA buffer 
as above. Protein quantification was performed using the BCA Protein Assay Kit 
(Thermo Scientific). Absorbance was measured at 570nm, then protein 
concentrations were calculated from a standard curve generated from standard 
samples of known concentrations. 
5.3.5 Western blot analysis 
For LAMP1 immunoblotting, 20µg of total protein was loaded onto a 10% SDS 
polyacrylamide gel, electrophoresed at 180V, and then wet transferred to a 
nitrocellulose membrane and probed with an anti-LAMP1 antibody. For LC3 
immunoblotting, 20g of total protein was loaded onto a 15% SDS polyacrylamide 
gel, which following electrophoresis at 180V, was wet transferred to a PVDF 
membrane and probed with an anti-LC3 antibody. Detection was performed by 
enhanced chemiluminescence (ECL) following manufacturer’s instructions 
(Promega) and intensities quantified using Image J analysis software. Antibody 
details are given in Table 5.3.1. 
Table 5.3.1 Antibodies used in Western Blot 
Antibody Host Dilution Supplier Cat. no. 
Anti-LAMP1 Mouse 1:1000 Developmental Studies 
Hybridoma Bank 
H4A3 
Anti-LC3 Mouse 1:200 Nanotools 0231-100 
Anti-GAPDH Mouse 1:2000 GeneTex GTX28245 
Anti-Mouse IgG 
(HRP conjugate) 
Goat 1:2000 Santa Cruz 
Biotechnology 
sc-2005 
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5.3.6 Transcriptomics analyses 
2D MSC were cultured as described in 2.2.1.3. 3D spheroids were initiated from 
60,000 MSCs and maintained in culture for 5 days as described in 2.2.1.5. For global 
gene expression analyses, duplicate RNA samples from two primary MSC donors 
were generated as described in 2.2.5.1 and 2.2.5.2.  RNA quality was assessed using 
the Agilent 2100 Bioanalyzer, both samples had RNA integrity numbers of 9.8 or 
greater. 150ng RNA per sample was then spiked with control RNA, and labelled 
with Cy-3. 600ng Cy3-labelled RNA per sample was then hybridized onto an 
Agilent SurePrint G3 Human Gene Expression 8x60K v2 Microarray. Arrays were 
scanned using an Agilent DNA Microarray Scanner (G2565CA) with SureScan 
High-Resolution Technology. Data was analysed using Genespring version 12.1 
software (Agilent technologies). Pathway analysis was performed on lists of genes 
differentially expressed in response to 3D culture conditions, using the pathway 
analysis tool within Genespring v12.1 software.  
5.3.7 Metabolic measurements 
3D spheroids were seeded with initiating cell numbers of 60,000 MSCs and cultured 
for up to 5 days as described in 2.2.1.5. Oxygen consumption by 3D MSCs was 
measured using the BD Biosciences Oxygen Biosensor System (OBS). Briefly, 
every day for 5 days, two MSC spheroids were cultured in triplicate wells of the 
OBS plates in 50µl of culture medium, alongside blank wells containing medium 
alone.  Cells were maintained at 37
o
C on 5% CO2 in air for the duration of the 
assays.  Kinetic measurements were taken every 20 seconds for 30 minutes. Raw 
fluorescence data was corrected against a pre-blank reading and converted to oxygen 
concentration in accordance with manufacturer’s guidelines. The OBS 96-well plates 
contain a proprietary fluorescent compound immobilized to the bottom of each well 
which is quenched in the presence of oxygen. Aerobically respiring cells reduce the 
concentration of oxygen dissolved in the media, which means there is a reduction in 
fluorescence quenching and an increase in fluorescence intensity. The oxygen 
consumption rate (OCR) was calculated as the gradient of change in oxygen 
concentration over time in nmol/spheroid/hr.  At the end of oxygen assays, the 
medium was collected and lactate release into the medium was determined by using 
enzyme linked fluorescent assays. Briefly, sample media were added to an assay 
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mixture and incubated at 25ºC for 30 minutes. The assay mixture contained lactate 
dehydrogenase (40 IU ml
-1
) in a glycine hydrazine buffer, pH 9.4. Changes in 
fluorescence due to NAD
+
 reduction were proportional to lactate concentration in the 
culture medium, which was calculated using a standard curve. Results were analysed 
for statistical significance using a T-test (n=3). 
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5.4  Results 
5.4.1 Enhanced autophagy in 3D MSCs 
I hypothesised that cell stress triggered by 3D culture would be sufficient to induce 
autophagy in 3D MSCs, and that the cytoplasmic clearance and restructuring which 
cells undergo during an autophagic response, could drive de-differentiation to a more 
primitive state.  
As TFEB is the master regulator of lysosomal biogenesis, and also regulates the 
expression of many autophagy genes the effects of 3D culture on TFEB expression 
were determined. MSCs from two different primary donors were cultured as 2D 
monolayers and 3D spheroids for up to 5 days. RNA samples were isolated and 
samples analysed for TFEB expression by qPCR. In both donors examined, 
expression of TFEB increased during 3D culture. By day 1 of 3D culture, up-
regulation of almost 3-fold was observed, relative to the donor-matched 2D sample. 
This up-regulation continued to day 2, where expression in 3D MSCs was just over 
5-fold higher than in 2D MSCs. In both donors there was a small decrease in 
expression of TFEB on day 3, before expression increased again on day 4 and was 
maintained to day 5 around 4.5-5.5 fold higher than 2D MSCs depending on donor 
(Figure 5.4.1. A). Pooling donor data showed significantly enhanced expression on 
days 2-5 of 3D culture, relative to 2D MSCs (Figure 5.4.1. B). TFEB regulates 
expression of lysosomal/autophagy genes through binding the Coordinated 
Lysosomal Expression and Regulation (CLEAR) consensus sequence. Multiple 
CLEAR elements can be found close to the transcriptional start sites of genes 
regulated by TFEB. A promoter search using MatInspector identified a CLEAR 
element immediately upstream of the human Sox2 transcriptional start site (Figure 
5.4.2). However, no functional validation of this binding site was performed in this 
study. CLEAR elements were not identified in Oct4 or Nanog promoters. 
Lysosomal-associated membrane protein 1 (LAMP1) is a lysosome membrane 
protein, and an increase in LAMP1 is associated with an increase in lysosome 
numbers, which can indicate enhanced autophagy. To assess the effects of 3D culture 
on LAMP1 levels, MSCs were cultured as 2D monolayers and 3D spheroids for up 
to 5 days. Protein samples were isolated and analysed for LAMP1 expression by  
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Figure 5.4.1. qPCR analysis of expression of the lysosome and autophagy 
regulator TFEB in MSCs over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. A) Expression of TFEB for each 
donor was normalised to expression of the housekeeping gene GAPDH and 
made relative to expression levels in the donor matched 2D sample. Fold 
changes were calculated as 2
-ddCt
. B) Data from both donors was pooled and 
subject to statistical analysis, mean fold changes are shown ± SEM, * p< 0.05. 
Statistical significance is relative to expression in 2D MSCs (by Kruskal Wallis 
test, n = 2).  
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Figure 5.4.2. Identification of a TFEB binding site in the promoter region of 
the Sox2 gene 
A promoter search using MatInspector identified a sequence, which matches that 
of known TFEB binding sites, at the transcriptional start site of the human Sox2 
gene. 
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Western blot. In the two primary MSC donors examined, expression of LAMP1 
increased in 3D culture. A small increase was observed by day 1, and expression had 
increased further by day 5 of 3D culture (Figure 5.4.3). To examine if 3D culture-
induced autophagy was reversed when 3D MSCs were returned to 2D culture, 
further studies were performed. MSCs were cultured as 2D monolayers and 3D 
spheroids for 5 days in culture. On day 5 of 3D culture, 3D MSC spheroids were 
disaggregated to single cells (d-3D MSCs) and re-seeded onto tissue culture plastic. 
d-3D MSCs were maintained in 2D culture for up to 7 days. When these samples 
were analysed for LAMP1 expression, it was again observed that LAMP1 expression 
increased during 3D culture. Maximal expression was observed on 3D day 5. 
Following return to 2D culture, the levels of LAMP1 reduced in both primary donors 
examined. Four days after return to 2D culture, levels of LAMP1 in d-3D MSCs 
were lower than observed in the donor matched 2D sample. There was a small 
recovery towards 2D levels in d-3D MSCs 7 days after return to 2D culture (Figure 
5.4.4). These results suggest that enhanced expression of LAMP1 in MSCs is 
induced by 3D culture, and that return to 2D culture is sufficient to reverse the 
observed increase in LAMP1 expression. 
Microtubule-associated protein 1 light chain 3 (LC3) exists in two forms; LC3 I is 
cytoplasmic, whilst the lipidated form, LC3 II is associated exclusively with 
autophagosome membranes. Reduction of LC3 I and increase in LC3 II indicate an 
increase of autophagosome numbers. To assess the effects of 3D culture on LC3 
levels, MSCs were cultured as 2D monolayers and 3D spheroids for up to 5 days. 
Protein samples were isolated and analysed for LC3 expression by Western blot. By 
day 5 of 3D culture, there was near total loss of LC3 I, in both primary MSC donors 
examined, indicating that at this point LC3 existed almost exclusively in its 
autophagosome-incorporated form (Figure 5.4.5).  
Examination of 3D MSCs over time in culture using TEM revealed the presence of 
few cytoplasmic vesicular structures at day 1 of 3D culture (Figure 5.4.6, A-B). In 
contrast, by day 5, many typical autophagic structures were observed in the 
cytoplasm of 3D MSCs. These included double-membrane bound vesicles, and 
contained presumptive degraded cytoplasmic contents (Figure 5.4.6, C-F) 
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Figure 5.4.3. Analysis of the expression of the lysosomal membrane protein 
LAMP1 in MSCs over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. Total protein 
was isolated from each sample and analysed by Western blot. The membrane 
was probed against anti-LAMP1 and anti-GAPDH, which was used as a loading 
control. Densitometry was performed using ImageJ, normalised to GAPDH and 
made relative to levels in 2D MSCs, displayed on the bar chart as relative 
normalised intensity. 
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Figure 5.4.4. Analysis of the expression of the lysosomal membrane protein 
LAMP1 in MSCs following disaggregation of 3D spheroids and return to 2D 
culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. On day 5 
spheroids were disaggregated to a single cell suspension and re-seeded onto 
tissue culture plastic for up to 7 days. Total protein was isolated from each 
sample and analysed by Western blot. The membrane was probed against anti-
LAMP1 and anti-GAPDH, which was used as a loading control. Densitometry 
was performed using ImageJ, normalised to GAPDH and made relative to levels 
in 2D MSCs, displayed on the bar chart as relative normalised intensity. 
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Figure 5.4.5. Analysis of the expression of the autophagy marker LC3 in 
MSCs over time in 3D culture 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. Total protein 
was isolated from each sample and analysed by Western blot. The membrane 
was probed against anti-LC3 and anti-GAPDH, which was used as a loading 
control. Densitometry to evaluate loss of cytoplasmic LC3 I was performed 
using ImageJ, normalised to GAPDH and made relative to levels in 2D MSCs, 
displayed on the bar chart as relative normalised intensity. 
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Figure 5.4.6. TEM analysis of 3D MSCs for the presence of cytoplasmic 
markers of enhanced autophagy 
3D spheroids were initiated from 60,000 MSCs and maintained in culture for up 
to 5 days. On days 1 and 5, spheroids were fixed, stained and sectioned for TEM 
analysis. Sections were then examined for the presence of markers of enhanced 
autophagy. Example images are shown of 3D MSCs at day 1 (A-B) and day 5 
(C-F). Scale bars = 1µm, arrows indicate typical autophagasomes, arrow heads 
indicate autophagic vesicles which appear to be bound by double membranes. 
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5.4.2 Donor-dependent enhancement of pluripotency factor expression in 3D 
MSCs treated with rapamycin 
Rapamycin is a known autophagy stimulator, acting through inhibition of the mTOR 
complex (itself an autophagy inhibitor). To investigate if pharmacological 
enhancement of autophagy was sufficient to drive further increased expression of 
pluripotency factors in 3D MSCs, MSCs were cultured as 2D monolayers and 3D 
spheroids for up to 5 days in culture. 3D spheroids were grown in the presence and 
absence of 0.3nm rapamycin. Cultures were fed daily and samples harvested each 
day for 5 days. Samples were analysed by qPCR for expression of Oct4, Nanog and 
Sox2. Notably the 2 primary MSC donors examined responded differently to 
treatment.  In Donor 1, by day 5 of 3D culture, expression of all 3 pluripotency 
factors examined was over two times higher in rapamycin-treated versus control 
samples. Clearly in this donor, rapamycin stimulated an increase in pluripotency 
factor expression. In contrast, donor 2 showed little or no change in pluripotency 
factor expression with rapamycin treatment (Figures 5.4.7. - 5.4.9). These results 
highlight the donor-dependent nature of increased pluripotency factor expression in 
response to pharmacological inhibition of autophagy. Given the contradicting 
responses to rapamycin treatment in these two primary donors, there is little to be 
gained from pooling data at this stage. Further analysis of more donors would 
indicate if there is a common response to rapamycin treatment in 3D MSCs, or if this 
response is donor-dependent and highly variable across a greater range of samples.  
5.4.3 Metabolic differences are observed in MSCs cultured as 3D spheroids 
Enhanced autophagy in 3D MSCs may be driving cytoplasmic and organelle 
remodelling. Mitophagy is a form of autophagy, which recycles mitochondria and 
remodels the mitochondrial network. Transcriptomics analyses were performed on 2 
primary MSC donors, cultured under 2D and optimised 3D conditions. Gene 
ontology analysis was used to identify the pathways in which many related genes 
were differentially expressed. Figure 5.4.10 shows the top 25 differentially expressed 
pathways in 3D versus 2D MSCs, included in this list were a number of pathways 
related to autophagy and oxidative metabolism. The electron transport chain and 
oxidative phosphorylation pathways were ranked first and third in this list. 67 of the 
genes assigned to the electron transport chain by gene ontology analysis were  
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Figure 5.4.7. qPCR analysis of expression of Oct4 in 3D MSCs treated with 
the autophagy stimulator rapamycin 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. Media was 
refreshed daily with 3D MSC media (control samples) or 3D MSC media 
supplemented with 0.3nM rapamycin. 3D MSCs were isolated every day for 5 
days, before cDNA samples were generated and then analysed by qPCR. 
Expression of target gene for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in the donor 
matched 2D sample. Fold changes were calculated as 2
-ddCt
. Expression of Oct4 
in 2 different MSC donors in both control and treated samples is shown. Average 
dCt values ± SEM for technical replicates are shown in the table. 
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Figure 5.4.8. qPCR analysis of expression of Nanog in 3D MSCs treated 
with the autophagy stimulator rapamycin 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. Media was 
refreshed daily with 3D MSC media (control samples) or 3D MSC media 
supplemented with 0.3nM rapamycin. 3D MSCs were isolated every day for 5 
days, before cDNA samples were generated and then analysed by qPCR. 
Expression of target gene for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in the donor 
matched 2D sample. Fold changes were calculated as 2
-ddCt
. Expression of 
Nanog in 2 different MSC donors in both control and treated samples is shown. 
Average dCt values ± SEM for technical replicates are shown in the table. 
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Figure 5.4.9. qPCR analysis of expression of Sox2 in 3D MSCs treated with 
the autophagy stimulator rapamycin 
MSCs from 2 donors were cultured as 2D monolayers and 3D spheroids with an 
initiating cell number of 60,000 cells for up to 5 days in culture. Media was 
refreshed daily with 3D MSC media (control samples) or 3D MSC media 
supplemented with 0.3nM rapamycin. 3D MSCs were isolated every day for 5 
days, before cDNA samples were generated and then analysed by qPCR. 
Expression of target gene for each donor was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression levels in the donor 
matched 2D sample. Fold changes were calculated as 2
-ddCt
. Expression of Sox2 
in 2 different MSC donors in both control and treated samples is shown. Average 
dCt values ± SEM for technical replicates are shown in the table. 
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Figure 5.4.10 Agilent array analysis of the top 25 differentially expressed 
pathways in 3D vs 2D MSCs 
MSCs from 4 different donors were cultured as 2D monolayers and 3D 
spheroids (60,000 MSCs for 5 days). Samples were then subject to 
transcriptomics analyses, which identified differentially expressed pathways 
between 2D and 3D samples. The top 25 differentially expressed pathways are 
shown (arrows highlight pathways related to metabolism and autophagy). 
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significantly differentially expressed in 3D versus 2D MSCs, and out of these, 66 
were down-regulated in 3D (Figure 5.4.11 and Table 5.4.1). Similarly, 42 genes 
assigned to oxidative phosphorylation by pathway analysis were differentially 
expressed, and of these 41 were down-regulated in 3D MSCs (Figure 5.4.11 and 
Table 5.4.2). Supportive of a reduction in oxidative phosphorylation, analysis of 
oxygen consumption rates (OCR) demonstrated that oxygen consumption reduced 
with time in optimised 3D conditions. By day 5 of 3D culture OCR had reduced 
17.5-fold compared to consumption on day 1. This difference was statistically 
significant (Figure 5.4.12.A). Under identical culture conditions, 3D MSCs also 
maintained efflux of lactate into the culture medium, indicating sustained lactate 
production throughout 3D culture (Figure 5.4.12.B). Another feature of pluripotent 
ESCs is a distinct cytotype, characterised by few, immature, rounded mitochondria. 
TEM examination of 3D MSCs revealed the presence of small, rounded 
mitochondria, typical of those seen in ESCs, after 5 days cultured under optimal 3D 
conditions (Figure 5.4.13).  
5.4.4 Expression of pluripotency factors identifies optimal 3D conditions for 
HDFs 
If autophagy induction by cell stress in 3D culture is responsible for the changes 
observed in MSCs, it should be possible to induce similar changes in other cell 
types, and this phenomenon should not be specific to MSCs. To investigate if the 
optimised 3D model could enhance expression of pluripotency factors in other cell 
types, HDF monolayer cultures were grown to confluence on tissue culture plastic, 
before seeding as 3D spheroids, initiated from 60,000 cells and maintained in 3D 
culture for 5 days. RNA samples were isolated and examined for expression of 
pluripotency factors by qPCR. In 3D HDFs expression of Oct4 remained unchanged, 
whilst there was a significant reduction in expression of Nanog relative to expression 
in 2D HDFs. There was however a significant increase of around 100-fold of Sox2 
expression compared to 2D levels (Figure 5.4.14). Although expression of Sox2 was 
enhanced by the optimised 3D model, it appeared that 3D culture had no/negative 
effects on the expression of other pluripotent transcription factors, so the conditions 
optimised for MSCs were not sufficient to induce enhanced expression of all three 
pluripotency factors in HDFs. If this mechanism relies on a precise scaling of cell  
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Figure 5.4.11. Agilent array analysis of expression of genes assigned to the 
electron transport chain and oxidative phosphorylation pathways in 3D vs 
2D MSCs 
Transcritomics analyses identified the electron transport chain (A) and oxidative 
phosphorylation (B) amongst the most differentially expressed pathways in 3D 
MSCs. Relative expression of genes assigned to these pathways is shown in 3D 
versus 2D MSCs. Gene lists and fold changes are shown in Tables 5.4.1 and 
5.4.2. 
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Table 5.4.1 Fold change expression of genes assigned to the electron transport 
chain pathway (using Genespring v12.1) in 3D MSCs vs 2D MSCs. 
Gene name Fold change Gene name Fold change 
ND4L -5.05674 NDUFA8 -1.5948 
SLC25A4 -3.34134 ATP5B -1.58734 
ATP5G1 -2.84382 NDUFB10 -1.57776 
COX7A1 -2.61804 NDUFA9 -1.575 
ATPIF1 -2.48431 NDUFAB1 -1.57454 
NDUFS8 -2.20634 ATP5S -1.57138 
SLC25A5 -2.09295 NDUFS4 -1.56911 
COX8A -2.07 ATP5G3 -1.5637 
NDUFB7 -2.03715 ATP5L -1.54443 
NDUFB2 -2.01686 COX6B1 -1.53532 
ATP5J2 -1.98975 ATP5G2 -1.53316 
NDUFA4 -1.93893 ATP5O -1.53188 
NDUFA7 -1.93 COX7B -1.52843 
COX5A -1.89533 NDUFA6 -1.52465 
ATP5F1 -1.89167 COX7C -1.51127 
UCRC -1.84434 NDUFB5 -1.50213 
DAP13 -1.84087 NDUFA2 -1.49991 
ATP5D -1.8098 COX5B -1.4669 
UQCRFS1 -1.80153 ATP5J -1.438 
NDUFS6 -1.79843 SURF1 -1.41699 
ATP5H -1.77936 NDUFA1 -1.40509 
NDUFB3 -1.77505 NDUFS5 -1.39763 
NDUFC1 -1.76233 SCO1 -1.3874 
ATP5A1 -1.75855 ATP5E -1.37441 
COX6A1 -1.75063 NDUFS1 -1.34605 
QP-C -1.70969 NDUFB9 -1.33539 
ATP5C1 -1.69572 UQCRB -1.3215 
SDHB -1.68605 NDUFC2 -1.2961 
NDUFA3 -1.66852 NDUFS3 -1.26757 
NDUFB6 -1.63827 NDUFS7 -1.2454 
NDUFB1 -1.62896 UQCRC1 -1.23871 
SDHC -1.6136 NDUFA10 -1.1436 
UQCRH -1.61309 COX11 1.054393 
NDUFB8 -1.60262   
 
  
183 
Table 5.4.2 Fold change expression of genes assigned to the mitochondrial 
oxidative phosphorylation pathway (using Genespring v12.1) in 3D vs 2D 
MSCs. 
Gene name Fold change Gene name Fold change 
ATP5G1 -2.84382 FASN2A -1.57454 
NDUFS8 -2.20634 ATP5S -1.57138 
B18 -2.03715 AQDQ -1.56911 
NDUFB2 -2.01686 ATP5G3 -1.5637 
ATP5J2 -1.98975 ATP5L -1.54443 
NDUFA4 -1.93893 ATP5G2 -1.53316 
B14.5a -1.93 ATP5O -1.53188 
ATP5F1 -1.89167 B14 -1.52465 
ATP5D -1.8098 CI-SGDH -1.50213 
NDUFS6 -1.79843 NDUFA2 -1.49991 
ATP5H -1.77936 ATP5J -1.438 
KFYI -1.76233 NDUFS5 -1.39763 
ATP5A1 -1.75855 ATP5E -1.37441 
B9 -1.66852 ATP6AP1 -1.37354 
B17 -1.63827 CI-75Kd -1.34605 
CI-SGDH -1.62896 B22 -1.33539 
ASHI -1.60262 B14.5b -1.2961 
NDUFA8 -1.5948 NDUFS3 -1.26757 
ATP5B -1.58734 NDUFS7 -1.2454 
NDUFB10 -1.57776 CI-42KD -1.1436 
NDUFA9 -1.575 NUOMS 3.654102 
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Figure 5.4.12. Analysis of oxygen consumption rates and lactate production 
in 3D MSCs over time in 3D culture 
3D spheroids were initiated from 60,000 MSCs and maintained in culture for up 
to 5 days. Every day a measure of oxygen consumption rate (A) and lactate 
production (B) was taken. Mean values are shown, ± SEM, * p< 0.05. Statistical 
significance is relative to expression in 3D MSCs at day 1 (by T-test, n = 3). 
185 
 
  
Figure 5.4.13. TEM analysis of 3D MSCs for evidence of mitochondrial 
remodelling  
3D spheroids were initiated from 60,000 MSCs and maintained in culture for 5 
days. On day 5, spheroids were fixed, stained and sectioned for TEM analysis. 
Sections were then examined for the presence of pluripotent stem cell-like 
mitochondria. Arrows indicate small, rounded mitochondria, typical of those 
seen in primitive cell types (scale bar  = 1µm). 
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  Figure 5.4.14. qPCR analysis of expression of pluripotency factors in HDFs 
cultured under optimised 3D conditions 
HDFs were cultured as 2D monolayers and 3D spheroids (initiating cell number 
– 60,000 cells per spheroid) for 5 days in culture. RNA samples from three 
biological replicates were isolated and analysed for expression of Oct4, Nanog 
and Sox2. In all samples expression was normalised to expression of the 
housekeeping gene GAPDH and made relative to expression in 2D monolayers. 
Expression of A) Oct4, B) Nanog and C) Sox2 in 60,000 HDF 3D spheroids 
after 5 days in 3D culture compared to expression in HDF 2D monolayers. Data 
was pooled and subject to statistical analysis, mean fold changes are shown ± 
SEM, * p< 0.05, ** p<0.01. Statistical significance is relative to expression in 
2D HDFs (by T-test, n = 3). 
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stress to stimulate autophagy and drive pluripotency factor expression, different cells 
may require slightly modified conditions to achieve optimal autophagy induction. To 
investigate whether this was the case, 3D HDF spheroids initiated from 30-, 60-, or 
120,000 cells were cultured for up to 5 days. RNA samples were isolated and 
analysed for expression of Oct4, Nanog and Sox2. Strikingly it again appeared that 
an optimal time point could be identified by maximal expression of Oct4, Nanog and 
Sox2. When spheroids initiated from 30,000 HDFs were cultured for 4 days, there 
was a peak in the expression of Oct4, around 3 fold higher than expression observed 
in 2D HDFs (Figure 5.4.15). This pattern was also observed for Nanog expression. 
At day 4 of 3D culture, spheroids initiated from 30’000 HDFs showed around a 3.8 
fold increase compared to 2D HDFs (Figure 5.4.16). Notably day 4 of 3D culture 
also showed a peak of Sox2 expression, with around a 37 fold up-regulation 
compared to 2D levels, in spheroids initiated from 30,000 HDFs (Figure 5.4.17). 
These results provide evidence that increased expression of pluripotency factors 
during 3D culture is not an MSC-specific phenomena, and that optimal culture 
conditions to stimulate this up-regulation can be identified in other cell types. 
Further investigation would be necessary to confirm if similar changes in 
metabolism and autophagy markers also occur in the HDF optimised model. 
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Figure 5.4.15. qPCR analysis of expression of the pluripotency factor Oct4 
in HDFs over time in 3D culture 
HDFs were cultured as 2D monolayers and 3D spheroids with initiating cell 
numbers of 30-, 60-, or 120,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. Expression of Oct4 was normalised 
to expression of the housekeeping gene GAPDH and made relative to expression 
levels in the 2D sample. Fold changes were calculated as 2
-ddCt
. Average dCt 
values ± SEM for technical replicates are shown in the table. 
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Figure 5.4.16. qPCR analysis of expression of the pluripotency factor Nanog 
in HDFs over time in 3D culture 
HDFs were cultured as 2D monolayers and 3D spheroids with initiating cell 
numbers of 30-, 60-, or 120,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. Expression of Nanog was 
normalised to expression of the housekeeping gene GAPDH and made relative 
to expression levels in the 2D sample. Fold changes were calculated as 2
-ddCt
. 
Average dCt values ± SEM for technical replicates are shown in the table. 
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Figure 5.4.17. qPCR analysis of expression of the pluripotency factor Sox2 
in HDFs over time in 3D culture 
HDFs were cultured as 2D monolayers and 3D spheroids with initiating cell 
numbers of 30-, 60-, or 120,000 cells for up to 5 days in culture. cDNA samples 
were generated and then analysed by qPCR. Expression of Sox2 was normalised 
to expression of the housekeeping gene GAPDH and made relative to expression 
levels in the 2D sample. Fold changes were calculated as 2
-ddCt
. Average dCt 
values ± SEM for technical replicates are shown in the table. 
 
191 
5.5 Discussion 
The results presented in this chapter confirm enhanced autophagy in MSCs cultured 
as 3D spheroids. There is also evidence that 3D culture drives metabolic remodelling 
in 3D MSCs. Transcriptomics analyses highlighted the senescence and autophagy 
pathway as one of the top 25 differentially expressed pathways in 3D versus 2D 
MSCs. Autophagy and lysosomal biogenesis are regulated by the master 
transcriptional regulator TFEB (Sardiello et al., 2009; Settembre et al., 2011). TFEB 
expression was up-regulated early (day 1) in 3D culture, and reached maximal up-
regulation by day 2. High expression of TFEB was then maintained throughout 3D 
culture. It has recently been demonstrated that TFEB is itself regulated by the 
nutrient sensor and autophagy inhibitor mTORC1, so showing a direct link between 
nutrient availability and TFEB activity. Under nutrient-rich conditions, mTORC1 
acts to phosphorylate and inactivate proteins required for the initiation of autophagy, 
so inhibiting an autophagic response. In contrast, nutrient deprivation leads to the 
inactivation of mTORC1, and induction of autophagy (Martina et al., 2012). 
mTORC1 also regulates TFEB localisation through phosphorylation of both serine 
142 (Settembre et al., 2012) and serine 211 (Martina et al., 2012; Settembre et al., 
2012). When nutrients are plentiful, TFEB is phosphorylated by mTORC1, and 
through interactions with a member of the 14-3-3 family of proteins, is maintained in 
the cytosol (Martina et al., 2012). However during nutrient deprivation, mTORC1 is 
inactivated, TFEB is not phosphorylated, and translocates to the nucleus, where it 
regulates the expression of lysosome and autophagy genes (Martina et al., 2012; 
Settembre et al., 2012). Although the localisation of TFEB was not tracked during 
3D culture, strong, sustained up-regulation of TFEB expression was observed in 3D 
MSCs. Nuclear translocation in fact occurs before TFEB up-regulation in response to 
nutrient starvation. Nuclear translocation of TFEB was observed very quickly after 
elimination of nutrients from the media, whilst increase in TFEB expression 
occurred several hours later (Settembre et al., 2013). Exogenous over-expression of 
TFEB could also positively regulate endogenous TFEB expression, suggesting the 
presence of a positive auto-regulatory loop, in which nuclear translocation of TFEB-
induced TFEB up-regulation in response to starvation (Settembre et al., 2013). The 
presence of an auto-regulatory loop is supportive of the results seen in 3D MSCs, 
where there was progressive up-regulation of TFEB expression from day 1 of 3D 
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culture. It is likely that TFEB nuclear translocation would have been observed prior 
to the up-regulation of TFEB mRNA. Using TEM, many typical autophagic 
structures were observed in the cytoplasm of day 5 3D MSCs, including vesicles 
with presumptive degraded cytoplasmic contents and double-membrane bound 
structures. This coincided with an increase in the lysosome marker LAMP1 during 
3D culture, indicating an increase in lysosome numbers. This increase was 
dependent on 3D culture, as expression returned to 2D levels after 3D MSCs were 
disaggregated and re-plated onto plastic. The recovery of ‘normal’ LAMP1 levels 
after return to 2D conditions provides strong evidence that the observed increase in 
lysosomes is driven by 3D culture conditions, supporting the hypothesis that 3D 
culture induces an autophagic response. Conversion of LC3 I to LC3 II is a marker 
of an increase in autophagosome abundance (Kabeya et al., 2003). In 3D MSCs, by 
day 5 of 3D culture, there is almost complete loss of cytoplasmic LC3 I, indicating 
that by this stage virtually all LC3 exists in its autophagosome-incorporated form. 
This indicates a highly active autophagy response in MSCs by day 5 of 3D culture. 
This also supports the sustained expression of TFEB through to day 5. TFEB is 
required to activate the expression of many autophagy genes, so would be expressed 
throughout an autophagic response. A number of compounds which act to enhance 
autophagy have been demonstrated to increase reprogramming efficiency, including 
rapamycin, PP242 and spermidine (Chen et al., 2011). Using Oct4, Nanog and Sox2 
expression as a readout of de-differentiation, the effect of rapamycin treatment on 
3D MSCs was examined. The response to rapamycin was donor-dependent in the 
MSC donors examined. One donor up-regulated pluripotency factor expression 
during 3D culture in response to rapamycin, whilst the other donor did not. It may be 
that Donor 2 was unresponsive to rapamycin at this concentration. It is also possible 
that whilst in this donor, pluripotency factors were not up-regulated, other markers of 
de-differentiation, such as early mesendoderm markers may have been enhanced by 
rapamycin treatment. Furthermore, it has been demonstrated that rapamycin is a 
partial mTORC1 inhibitor, as some phosphorylation of mTORC1 substrates has been 
observed during rapamycin treatment (Settembre et al., 2012). It is possible that in 
Donor 2, the level of rapamycin treatment was insufficient to entirely inactivate 
mTORC1, so some level of autophagy inhibitory activity may have remained even 
during treatment. Alternatively, in this donor, 3D conditions alone may have 
achieved mTORC1 inhibition through nutrient starvation, so no further enhancement 
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of the autophagy response (and pluripotency factor expression) was stimulated 
through pharmacological intervention. The results presented here confirm an active 
autophagy response, which is stimulated early in 3D culture, is 3D culture-
dependent, and is reversed when 3D MSCs are re-plated onto tissue culture plastic.  
Transcriptomics analyses also highlighted the electron transport chain and oxidative 
phosphorylation as the first and third most differentially expressed pathways in 3D 
versus 2D MSCs. 66/67 and 41/42 significantly differentially expressed genes were 
down-regulated in 3D compared to 2D MSCs respectively. This is similar to the 
down-regulation of electron transport chain genes when cells undergo 
reprogramming to pluripotency (Folmes et al., 2011). Indeed, the observed down-
regulation of these pathways suggests that by day 5 of 3D culture, MSCs have a 
markedly reduced reliance on oxidative metabolism. This was further supported by 
the observation that oxygen consumption reduced progressively over time in 3D 
culture, and 3D MSCs maintained lactate production throughout 3D culture, both 
hallmarks of a shift to an anerobic metabolism, which was again observed when 
MEFs underwent reprogramming to pluripotency (Folmes et al., 2011). It was 
previously demonstrated that there is no detectable HIF1α staining in 3D MSCs, 
suggesting that 3D culture does not generate a hypoxic environment (Elen Bray, 
unpublished observations). Strikingly, this would indicate that the shift to an 
anerobic metabolism is not driven by hypoxia in 3D MSCs, and anaerobic 
metabolism in the presence of plentiful oxygen is a hallmark of pluripotent cells 
(Zhang et al., 2012). Another feature of ESCs is a distinct mitochondrial profile, 
consisting of few small, simple, perinuclear mitochondria, whilst differentiated cells 
have a cytoplasmic network of tubular cristae-rich mitochondria, which can support 
the oxidative metabolism in these cells (Varum et al., 2011). The mitochondria in 3D 
MSCs were highly similar to mitochondria observed in ESCs, with a small, rounded 
morphology. The presence of a reduced mitochondrial network could explain the 
metabolic shift observed in 3D MSCs, as it would result in a decrease in overall 
oxidative capacity, and an increased reliance on anaerobic metabolism. Altogether, 
these results confirm that during 3D culture, MSCs undergo metabolic remodelling, 
and that by day 5 of 3D culture, resemble pluripotent cells in both metabolism and 
mitochondrial phenotype.  
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Finally, the robustness of the hypothesis was tested using HDFs. If de-differentiation 
is driven by  the induction of autophagy alone, then this mechanism should be 
applicable to other cell types, not just MSCs, which may be more amenable to 
reprogramming and de-differentiation due to their multipotent developmental state. 
Whilst MSC-optimised 3D conditions only stimulated the enhanced expression of 
Sox2 in HDFs, it was observed that when 30,000 HDFs were cultured in 3D for 4 
days, there was maximal up-regulation of Oct4, Nanog and Sox2. Further study 
would be required to investigate the metabolic status of these cells, and also to 
provide evidence of a functional autophagy response. However, this does suggest 
that with optimisation, 3D culture can be used to drive expression of pluripotency 
factors in cells other than MSCs. 
Much of the research in reprogramming to pluripotency has focused on the need for 
somatic cells to re-adopt an ESC-like gene expression and epigenetic profile, as 
these factors are thought to underlie the mechanisms of pluripotency maintenance, 
and often the need for metabolic remodelling had been overlooked. However, more 
recently, the importance of metabolic reprogramming has been acknowledged. 
Indeed, it has been demonstrated that factors which enhance glycolysis can increase 
reprogramming efficiency (Panopoulos et al., 2012), whilst blocking glycolysis 
inhibited reprogramming to pluripotency (Folmes et al., 2011; Panopoulos et al., 
2012). Furthermore, inhibition of mitochondrial fission, through the use of a 
compound which drives the production of mitochondrial net-like structures, 
significantly reduced the formation of iPSC colonies in MEFs. Early treatment was 
sufficient to inhibit iPSC formation, suggesting that the remodelling of the 
mitochondrial network was a necessary early event in the reprogramming process 
(Vazquez-Martin et al., 2012).  
Although in this case, I observe lineage-restricted de-differentiation rather than 
reprogramming to pluripotency, the underlying principles of metabolic remodelling 
would still apply. The evidence presented here indicates that metabolic remodelling 
occurs, not only during factor-based reprogramming to pluripotency, but also in 
culture-driven de-differentiation. This would suggest that cytoplasmic clearance and 
resetting of the metabolism is a fundamental requirement when cells undergo de-
differentiation. It makes sense that if differentiation involves the development of an 
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increasingly complex metabolism and cytotype, then forced de-differentiation would 
require the reversal of this process, to a simplistic, primitive metabolism and 
cytotype. Although the precise mechanism which facilitates metabolic remodelling 
remains unknown, in separate studies, it has been demonstrated that a functional 
autophagy response is required early during factor-based reprogramming to 
pluripotency (Wang et al., 2013). Autophagy is an effective cytoplasmic clearance 
mechanism, which clears cytoplasmic contents including mitochondria, during cell 
stress (Klionsky and Emr, 2000). The hypothesis of this work stated that a scaled 
autophagic response would be sufficient to drive de-differentiation in MSCs cultured 
under optimised 3D conditions. An autophagy response was observed early in 3D 
culture, whilst the metabolic remodelling appeared progressive over the culture 
period, which would support the idea that autophagy is the mechanism by which 
cytoplasmic clearance occurs. A diminished oxidative capacity due to the reduced 
mitochondrial network would then necessitate a shift to an anaerobic metabolism. 
Strikingly, a promoter search revealed the presence of a TFEB binding site directly 
upstream of the Sox2 promoter. Although this would require functional validation, it 
does provide a potential direct link between mechanisms driving enhanced 
autophagy and pluripotency factor expression. Although no such site was observed 
in the Oct4 or Nanog promoters, Sox2 is known to bind both Oct4 and Nanog and 
positively regulate their expression (Boyer et al., 2005). Taken together, these results 
suggest that nutrient deprivation could stimulate autophagy, and that autophagy, 
through cytoplasmic clearance, could drive metabolic remodelling, whilst autophagy 
related expression of TFEB could initiate expression of pluripotency factors via a 
Sox2-mediated positive auto-regulatory feedback loop, in MSCs cultured in our 
optimised 3D model. 
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Chapter 6: Discussion 
Heterogeneity is common in un-sorted MSCs isolated from bone-marrow. Although 
enhanced expression of pluripotency/mesendoderm-associated genes is highly 
similar across different MSC donors, the response to rapamycin was notably 
different in the 2 donors examined, demonstrating that it is always necessary to 
perform experiments in as many primary donors as possible. It is therefore most 
important to consider the results presented here in that context. One must be careful 
to ensure that they do not overestimate the extent to which the behaviours observed 
in a small number of donors are representative of MSC behaviours across a large 
population. That said, results such as those presented here, which show similar cell 
behaviour across MSCs isolated from a number of donors can be used as an indicator 
of MSC behaviour, and form the basis for more extensive study in further donors. 
The use of primary cells in this way also ensures that one is forced to consider 
variations in cell behaviour, which may be overlooked when using biological 
replicates of a single cell line, where you could expect behaviour to be much more 
homogeneous.   
Since the first derivation of iPSCs from mouse somatic cells in 2006 (Takahashi and 
Yamanaka, 2006), our knowledge of reprogramming has grown. The generation of 
human iPSCs using distinct factor combinations (Takahashi et al., 2007; Yu et al., 
2007) has been followed by a range of technical refinements, including removal of 
the oncogene c-Myc to reduce tumour incidence in offspring (Nakagawa et al., 2008; 
Wernig et al., 2008), along with the use of epigenetic compounds (Huangfu et al., 
2008a; Huangfu et al., 2008b; Mikkelsen et al., 2008; Shi et al., 2008) and diverse 
cell types aimed at improving the efficiency of reprogramming to pluripotency (Kim 
et al., 2009b; Kim et al., 2008; Tsai et al., 2011; Tsai et al., 2010). The process of 
direct reprogramming has also been developed, based on the principles of factor 
based reprogramming, whereby exogenous expression of factors associated with a 
particular lineage can drive reprogramming towards that cell fate in other somatic 
cell types. Of particular note, the process of direct reprogramming switches one cell 
type from another, without passage through a pluripotent state. This effectively 
circumvents the associated teratoma risk of induced pluripotency, so is of particular 
relevance to therapeutic applications, as a safer way to generate patient-specific cells 
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(Huang et al., 2011; Ieda et al., 2010; Szabo et al., 2010; Vierbuchen et al., 2010). 
Recent work has highlighted the need for metabolic transition during the 
reprogramming process. As well as a resetting of the transcriptome and epigenome, 
the metabotype of differentiated cells also requires resetting to the pluripotent state. 
Pluripotent ESCs have a simple cytotype, characterised by the presence of very few, 
immature mitochondria, with a rounded, cristae-poor morphology, which are 
observed in a perinuclear location. The limited oxidative capacity of ESCs means 
they rely on glycolysis (anaerobic metabolism) to meet their energy needs, even 
under normoxic conditions. In contrast, differentiated cells generally respire 
aerobically, unless they are exposed to a hypoxic environment, and contain a 
cytoplasmic network of tubular, cristae rich mitochondria (Varum et al., 2011). It has 
been demonstrated that a glycolytic shift is required for successful reprogramming to 
pluripotency (Folmes et al., 2011; Panopoulos et al., 2012), although the exact 
mechanism of this shift, and the mechanism which facilitates mitochondrial 
remodelling has not been identified. However, if we consider differentiation as the 
acquisition of increased cellular and cytoplasmic complexity, then clearly the 
process of reprogramming or de-differentiation, which is essentially the reversal of 
differentiation, would require mechanisms to reduce cytoplasmic/metabolic 
complexity and to reinstate the less complex cytotype of pluripotent cells. 
Autophagy is known to recycle cytoplasmic contents, including mitochondria, during 
a cell stress response (Klionsky and Emr, 2000). Separately it has been demonstrated 
that a functional autophagy response is also required for reprogramming to 
pluripotency, and that exogenous Sox2 expression can actually trigger a transient 
autophagy response (Wang et al., 2013). Longevity-promoting drugs such as 
rapamycin and spermidine have been shown to enhance the efficiency of 
reprogramming to pluripotency (Chen et al., 2011), although both these drugs are 
known autophagy inducers, so it may be that they act through their ability to induce 
autophagy to enhance the reprogramming process. As of yet though, there seems to 
be little connection between autophagy and metabolic remodelling in 
reprogramming/de-differentiation. The work presented in this thesis investigated the 
hypothesis that the requirement for a functional autophagy response and metabolic 
remodelling during de-differentiation are in fact closely linked, and that autophagy 
could be the mechanism by which cytoplasmic clearance is facilitated. Previous 
work in the laboratory showed that when 3D MSCs are cultured as spheroids, they 
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up-regulate expression of Oct4, Nanog and Sox2. It was assumed that oxygen and 
nutrient gradient across the spheroid structure must be providing optimal conditions 
for MSC potency, although the precise mechanisms driving enhanced pluripotency 
factor expression remained unknown (Elen Bray, unpublished observations). In this 
study I hypothesised that controlled induction of autophagy by nutrient deprivation, 
was the mechanism driving de-differentiation in 3D MSCs. The variation of initial 
cell seeding number and culture time enabled the generation of a wide range of 
spheroid sizes, and associated variation in nutrient deprivation. It was hypothesised 
that under optimal conditions, cell stress alone, in the absence of exogenous factors, 
would be sufficient to induce an optimal autophagic response, resulting in 
widespread cytoplasmic clearance and metabolic remodelling to drive de-
differentiation.   
Under optimal 3D conditions, enhanced pluripotency factor expression was 
observed, along with evidence of active autophagy, including high expression of 
TFEB, the master regulator of autophagy and lysosomal biogenesis. TFEB can 
positively regulate its own expression, and the activity of TFEB is positively 
regulated by the nutrient sensor (and autophagy inhibitor) mTORC1 during nutrient 
deprivation (Settembre et al., 2012). Coinciding with maximal expression of 
pluripotency markers, there was maximal reduction in OCR, reduced mitochondrial 
complexity, and decreased expression of genes linked to oxidative metabolism under 
optimal 3D culture conditions. Although a direct link between autophagy and 
metabolic remodelling in 3D MSCs was not demonstrated, autophagy was activated 
early in 3D culture, whilst reduced oxygen consumption was a gradual process, so it 
is possible that mitochondrial clearance through sustained autophagy was 
responsible for the observed shift to an anaerobic metabolism. Though it was not 
functionally validated during this study, the presence of a TFEB binding site was 
identified in the promoter of Sox2. This binding site was optimally positioned 
directly upstream of the transcriptional start site, and if functional, provides a direct 
link between nutrient deprivation, autophagy and increased pluripotency factor 
expression. TFEB, activated by the nutrient sensor mTORC1 during nutrient 
deprivation in 3D culture conditions, could translocate to the nucleus, and establish a 
positive feedback loop to maintain autophagy in the presence of nutrient deprivation. 
As well as regulating its own expression and that of lysosome and autophagy genes, 
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TFEB could also up-regulate expression of Sox2, by binding to the CLEAR element 
in the Sox2 promoter. Expression of Sox2 could then positively regulate the 
expression of itself, along with Oct4 and Nanog. Indeed stimulation of autophagy 
through rapamycin treatment could increase expression of pluripotency factors in 
some primary MSCs cultured in 3D, although this was donor-dependent. At the same 
time, cytoplasmic clearance by autophagy, driven by sustained nutrient deprivation 
during 3D culture, could result in mitochondrial remodelling and a reduced 
mitochondrial network. This would in turn result in a reduced oxidative capacity, and 
an increased reliance on anaerobic metabolism. 
The processes occurring during reprogramming to pluripotency in vitro are not 
dissimilar to those which are required for tissue regeneration in vivo. During tissue 
regeneration, there is widespread reorganisation of the cytoplasmic compartment. 
Studies of zebrafish caudal fin regeneration have demonstrated a requirement for 
functional autophagy following fin amputation (Varga et al., 2013). Autophagy is 
also known to play a key role in early embryogenesis, during pre-implantation 
mammalian development. Embryos showed reduced protein synthesis and failed to 
develop beyond the 4-8 cell stage in the absence of functional autophagy. It is 
suggested that this is likely due to the failure to degrade maternally-derived proteins, 
which would provide metabolites and amino acids for zygotic protein production and 
normal development, as pre-implantation mammalian embryos develop in the 
absence of an extracellular nutrient store (Tsukamoto et al., 2008). 3D MSCs had 
enhanced capacity to generate tissue in vivo, possibly fuelled by increased autophagy 
and the provision of sufficient metabolites and amino acids for tissue generation. The 
regeneration of the caudal fin also requires de-differentiation of differentiated cells 
in the area of the amputation. It was observed that when autophagy was impaired, 
these cells showed reduced proliferative capacity, increased cell death, and 
differentiation defects, leading to failure of fin regeneration. Autophagy clearly plays 
a fundamental role in driving tissue de-differentiation through cytoplasmic clearance, 
and promotes cell survival and proliferation following cell stress (Varga et al., 2013). 
3D culture restored proliferation in culture-aged MSCs, and reversed senescence-
associated hypertrophy. After non-proliferative MSCs were cultured as 3D 
spheroids, they re-entered active cell cycling following disaggregation onto tissue 
culture plastic. The resultant cells were also notably smaller and less spread than the 
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originating 2D cell population, suggestive of re-organisation and reduction of the 
cytoplasmic compartment during 3D culture. Aging in cells is associated with 
increased mTOR activity (Chen et al., 2009) and presumably impaired autophagy. 
Reduced self-renewal capacity and poor haematopoietic reconstitution are both 
features of aged HSCs.  Restoration of self-renewal and in vivo haematopoietic 
regenerative capacity were observed in HSCs following treatment with rapamycin 
(Chen et al., 2009). Autophagy stimulation through cellular rejuvenation is the likely 
mechanism for these observations, and this supports our observation that culture-
aged MSCs are rejuvenated by 3D culture-driven autophagy.  
3D MSCs did not form teratomas in vivo, instead they gave rise to highly organised 
tissue of mesodermal origin, showing enhanced in vivo potency compared to their 
originating 2D cell population, which could not form any tissue on implantation into 
nude mice. d-3D MSCs were also responsive to in vitro haematopoietic induction, 
forming non-typical blast-like colonies in a haematopoietic colony assay. This 
clearly demonstrated enhanced in vitro potency, as 2D MSCs were unresponsive to 
such induction. Haematopoietic lineages arise from early mesoderm, branching off 
before the specification of MSCs (Oldershaw et al., 2010), which suggests that 3D 
MSCs have de-differentiated sufficiently far to regain their haematopoietic potential. 
The absence of teratoma formation by 3D MSCs suggests they are in a post-
pluripotent state. Supportive of this, although mRNA levels of Oct4, Nanog and 
Sox2 are up-regulated under optimal 3D conditions, these levels remain lower than 
expression levels in human ESCs, and pluripotency factor protein expression is 
variable or undetectable in 3D MSCs.  
It is interesting to observe expression of pluripotency factors, albeit at the transcript 
level, in the absence of pluripotency. However, the recent establishment of mouse 
EpiSCs from post-implantation blastocysts should perhaps change the way we 
traditionally view pluripotency. It has long been known that mouse and human ESCs 
are distinct in their requirements for cell signalling to maintain their pluripotent state, 
with mouse ESCs requiring LIF (Nichols et al., 1990; Smith et al., 1988), whilst 
human ESCs rely on FGF/Activin/Nodal signalling to maintain pluripotency (James 
et al., 2005; Vallier et al., 2005). Mouse EpiSCs in fact closely resemble human 
ESCs in their signalling requirements, and are also less potent than mouse ESCs, as 
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they are not capable of germline contribution (Brons et al., 2007; Tesar et al., 2007). 
Some groups have shown that mouse EpiSCs can revert to ESCs, through the use of 
stringent cell culture conditions (Bao et al., 2009), suggesting that EpiSCs represent 
a slightly later developmental state than ESCs. It has even been observed that some 
EpiSC lines, although capable of teratoma formation, so technically pluripotent, 
express the mesendoderm markers Brachyury and Goosecoid, alongside the 
pluripotency markers Oct4, Nanog and Sox2. It was noted that expression of these 
mesendodermal markers made EpiSCs refractory to culture-based reprogramming to 
ESCs, whilst the most easily reprogrammed EpiSCs were those which only 
expressed pluripotency markers (Bernemann et al., 2011). This again suggests 
another element of complexity to the definition of pluripotency, as this study alone 
highlighted 3 distinct developmental states, all pluripotent by teratoma assay, but 
subtly distinct in their gene expression profile and differentiation potential in vitro. 
Strikingly, co-expression of pluripotency factors with markers of mesendoderm was 
observed in 3D MSCs, and given the similarity to their gene expression profile, one 
could speculate that 3D MSCs represent a developmental state  ‘downstream’ of the 
EpiSCs which co-express pluripotency and mesendoderm markers. 3D MSCs remain 
distinctly post-pluripotent, but have undergone de-differentiation to a primitive 
mesendoderm state, capable of enhanced lineage-restricted differentiation, and 
marked by characteristics of a primitive developmental state, including gene 
expression, metabotype and mitochondrial profile.  
The concept of cell stress as a driving mechanism for de- differentiation/ 
reprogramming has been highlighted by 2 recent high profile publications (Obokata 
et al., 2014a; Obokata et al., 2014b). Obokata and colleagues claimed that simple 
exposure to sub-lethal cell stress (acidic pH) was sufficient to drive reprogramming 
to pluripotency in neonatal mouse cells (Obokata et al., 2014b). A 30 minute 
incubation at pH 5.4-5.8 induced Oct4-GFP expression in CD45+ haematopoietic 
cells, which by day 7 after acid exposure showed extensive demethylation of the 
Oct4 and Nanog promoters and were capable of teratoma formation and chimera 
contribution. This process was named stimulus-triggered acquisition of pluripotency 
(STAP), and the resultant cells were referred to as STAP cells. Although there were 
notable differences between STAP cells and ESCs, such as the lack of proliferative 
capacity of STAP cells in LIF-supplemented media, this work suggested that simple, 
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non-physiological sub-lethal cell stress was sufficient to drive de-differentiation to a 
fully reprogrammed state. The authors raised the question of in vivo induction of 
pluripotency by cell stress, and how this might be regulated to prevent teratoma 
formation in tissues frequently exposed to acidic pH, such as the oesophageal 
mucosa (Obokata et al., 2014b). However, no mechanism was identified in this 
study, and since publication, questions have been raised about the reproducibility of 
the method. Whilst I am unable to comment on the reproducibility or the validity of 
the results presented in the publications by Obokata and colleagues, I believe that the 
work presented in this thesis may offer support to the theory of sub-lethal stress 
induced de-differentiation. It would appear that in MSCs, sub-lethal cell stress (in 
this case nutrient deprivation) is sufficient to drive de-differentiation. Strikingly, 
some of the observations made by Obokata and colleagues are not dissimilar to those 
seen in 3D MSCs. It was noted that STAP cells were observed to decrease in size 
prior to Oct4-GFP expression (Obokata et al., 2014b), possibly reflective of active 
autophagy and cytoplasmic recycling in response to cell stress. It was also observed 
that by day 3, between one third and one half of cells had been lost through apoptotic 
cell death (Obokata et al., 2014b), perhaps representative of autophagy scaled in 
favour of apoptosis in these cells. Cells strongly expressed Oct4-GFP and other 
pluripotency markers at day 7, but at day 3 expressed mesodermal markers such as 
KDR, indicating a progressive passage to pluripotency (Obokata et al., 2014b), 
similar to the progressive de-differentiation process proposed for 3D MSCs. Many 
questions remain regarding the research into STAP cells, but the theory behind their 
generation is in part supported here by evidence that sub-lethal cell stress (although 
distinct from that applied to generate STAP cells) can drive de-differentiation in 
MSCs cultured under optimal 3D conditions. 
In this study ‘optimal conditions’ are defined as the point when maximal expression 
of pluripotency and mesendoderm markers and maximal evidence of metabolic shift 
is observed. This most likely represents the point where autophagy is finely balanced 
between its pro-survival/anti-apoptotic and its pro-apoptotic effects, the threshold 
point between sub-lethal and lethal cell stress. It is proposed that autophagy may 
play a role in hormesis, the phenomenon by which pre-conditioning of cells by 
exposure to sub-lethal stress confers resistance when cells are later exposed to the 
same stress at a level which would normally prove lethal (Rubinsztein et al., 2011). 
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As previously discussed, autophagy has also been demonstrated to have fundamental 
roles in reprogramming to pluripotency (Wang et al., 2013) and tissue regeneration 
(Varga et al., 2013). The work presented in this thesis provides a mechanism to help 
interpret the recent body of work linking cell-stress and autophagy to de-
differentiation and reprogramming. It demonstrates that an intrinsic mechanism, 
driven by controlled sub-lethal cell stress precisely scales the autophagy response in 
favour of optimal cytoplasmic clearance and cell survival in MSCs cultured as 3D 
spheroids. In these conditions cells undergo lineage-restricted reprogramming, 
avoiding pluripotency and teratoma formation, and giving rise to a primitive cell 
population with enhanced tissue forming capacity in vivo (Figure 6.1). It could be 
considered that the process of STAP, through uncontrolled cell stress, drives 
inappropriate reprogramming to a pluripotent, teratoma initiating state, whilst in 
contrast, the model presented here could reflect a physiologically-relevant capacity 
for lineage-restricted de-differentiation and tissue formation in response to controlled 
cell stress. 
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Figure 6.1. Schematic summarising the data presented in this thesis and 
showing the proposed mechanism of de-differentiation and cellular 
rejuvenation in 3D MSCs 
2D MSCs are characterised by increased mitochondrial network complexity, 
aerobic metabolism and decreased cell cycling with time in culture. Optimal 3D 
culture conditions precisely scale sub-lethal cell stress, driving enhanced 
autophagy, cytoplasmic remodelling, a metabolic shift to anerobic metabolism 
and expression of markers of mesendodermal and pluripotent cells. This results 
in increased cell cycling and reversal of cellular hypertrophy in vitro, and 
enhanced mesodermal tissue regeneration in vivo. 
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List of abbreviations 
2i 2 compounds which maintain ESCs in an undifferentiated state 
when used in combination 
3i 3 compounds which maintain ESCs in an undifferentiated state 
when used in combination 
5' AZA 5' azacytidine 
BMP Bone morphogenetic protein 
CLEAR Coordinated Lysosome Expression and Regulation 
DIA differentiation inhibitory activity 
d-3D MSCs Disaggregated 3D MSCs 
Dox doxycycline 
DMEM Dulbecco's Modified Eagle Medium 
EC embryonal carcinoma 
ESCs embryonic stem cells 
EpiSCs Epiblast stem cells 
ERK Extracellular signal-regulated kinase 
FGF Fibroblast growth factor  
FGF4 Fibroblast growth factor 4 
GSK3β Glycogen synthase kinase 3 beta 
GFP Grren fluorescent protein 
H3K79me3 Histone 3 dimethylated at lysine 36 
H3K27me3 Histone 3 trimethylated at lysine 27 
H3K36me3 Histone 3 trimethylated at lysine 36 
H3K4me3 Histone 3 trimethylated at lysine 4 
H3K36me2 Histone 3 trimethylated at lysine 80 
H3K9me3 Histone 3 trimethylated at lysine 9 
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H4K20me3 Histone 4 trimethylated at lysine 20 
HDAC Histone deacetylase 
HDFs Human dermal fibroblasts 
HUVECs Human umbilical vein endothelial cells 
IVF In vitro fertilisation 
iPSCs  induced pluripotent stem cells 
ICM inner cell mass 
iMEF Irradiated mouse embryonic fibroblasts 
lenti-GFP Lentiviral particles constitutively expressing green fluorescent 
protein 
LIF Leukaemia inhibitory factor 
mTOR mammalian target of rapamycin 
MTORC1 mammalian target of rapamycin complex 1 
MSCs Mesenchymal stem cell/multipotent stromal cells 
MAPK Mitogen-activated protein kinase 
MEK Mitogen-activated protein kinase kinase (often referred to as 
MAPKK) 
MEFs mouse embryonic fibroblasts 
3D MSCs MSCs cultured as 3D spheroids 
2D MSCs MSCs cultured as adherent monolayers 
NSCs Neural stem cells 
NuRD Nucleosome remodelling and histone deacetylation 
O Oct4 (in the context of single factor reprogramming) 
OM  Oct4 and c-Myc 
OK Oct4 and Klf4 
OS Oct4 and Sox2 
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OKS Oct4, Klf4 and Sox2  
OKSM Oct4, Klf4, Sox2 and c-Myc 
OSNL Oct4, Sox2, Nanog and Lin28 
OCR Oxygen consumption rate 
PcG Polycomb group 
PRC Polycomb repressive complex  
RNAi RNA interference 
SCID Severe combined immunodeficient 
shRNA Short hairpin RNA 
siRNA Short interfering RNA 
SSEA Stage specific embryonic antigen 
STAP Stimulus triggered acquisition of pluripotency 
TGFβ Transforming growth factor beta 
TEM Transmission electron microscopy 
VPA Valproic acid 
208 
References 
Andrews, P.W. (2002). From teratocarcinomas to embryonic stem cells. 
Philosophical transactions of the Royal Society of London Series B, Biological 
sciences 357, 405-417. 
Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and Lovell-Badge, 
R. (2003). Multipotent cell lineages in early mouse development depend on SOX2 
function. Genes & development 17, 126-140. 
Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jorgensen, H.F., John, R.M., Gouti, 
M., Casanova, M., Warnes, G., Merkenschlager, M., et al. (2006). Chromatin 
signatures of pluripotent cell lines. Nat Cell Biol 8, 532-U189. 
Bao, S., Tang, F., Li, X., Hayashi, K., Gillich, A., Lao, K., and Surani, M.A. (2009). 
Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem 
cells. Nature 461, 1292-1295. 
Beddington, R.S.P., and Robertson, E.J. (1999). Axis development and early 
asymmetry in mammals. Cell 96, 195-209. 
Bernemann, C., Greber, B., Ko, K., Sterneckert, J., Han, D.W., Arauzo-Bravo, M.J., 
and Scholer, H.R. (2011). Distinct developmental ground states of epiblast stem cell 
lines determine different pluripotency features. Stem cells 29, 1496-1503. 
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., 
Meissner, A., Wernig, M., Plath, K., et al. (2006). A bivalent chromatin structure 
marks key developmental genes in embryonic stem cells. Cell 125, 315-326. 
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., 
Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., et al. (2005). Core 
transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-
956. 
209 
Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., 
Levine, S.S., Wernig, M., Tajonar, A., Ray, M.K., et al. (2006). Polycomb 
complexes repress developmental regulators in murine embryonic stem cells. Nature 
441, 349-353. 
Brons, I.G., Smithers, L.E., Trotter, M.W., Rugg-Gunn, P., Sun, B., Chuva de Sousa 
Lopes, S.M., Howlett, S.K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R.A., et al. 
(2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. 
Nature 448, 191-195. 
Chambers, I., Colby, D., and Robertson, M. (2003). Functional Expression Cloning 
of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells. Cell 113, 643-
655. 
Chen, C., Liu, Y., Liu, Y., and Zheng, P. (2009). mTOR regulation and therapeutic 
rejuvenation of aging hematopoietic stem cells. Science signaling 2, ra75. 
Chen, T.T., Shen, L., Yu, J., Wan, H.J., Guo, A., Chen, J.K., Long, Y., Zhao, J., and 
Pei, G. (2011). Rapamycin and other longevity-promoting compounds enhance the 
generation of mouse induced pluripotent stem cells. Aging Cell 10, 908-911. 
Constantinescu, D., Gray, H.L., Sammak, P.J., Schatten, G.P., and Csoka, A.B. 
(2006). Lamin A/C expression is a marker of mouse and human embryonic stem cell 
differentiation. Stem cells 24, 177-185. 
Cowan, C.A., Atienza, J., Melton, D.A., and Eggan, K. (2005). Nuclear 
reprogramming of somatic cells after fusion with human embryonic stem cells. 
Science 309, 1369-1373. 
Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D.K., Solimando, L., 
and Goldman, R.D. (2008). Nuclear lamins: major factors in the structural 
organization and function of the nucleus and chromatin. Genes & development 22, 
832-853. 
210 
Dreesen, O., Chojnowski, A., Ong, P.F., Zhao, T.Y., Common, J.E., Lunny, D., 
Lane, E.B., Lee, S.J., Vardy, L.A., Stewart, C.L., et al. (2013). Lamin B1 
fluctuations have differential effects on cellular proliferation and senescence. The 
Journal of cell biology 200, 605-617. 
Efroni, S., Duttagupta, R., Cheng, J., Dehghani, H., Hoeppner, D.J., Dash, C., 
Bazett-Jones, D.P., Le Grice, S., McKay, R.D., Buetow, K.H., et al. (2008). Global 
transcription in pluripotent embryonic stem cells. Cell stem cell 2, 437-447. 
Eisenberg, T., Knauer, H., Schauer, A., Buttner, S., Ruckenstuhl, C., Carmona-
Gutierrez, D., Ring, J., Schroeder, S., Magnes, C., Antonacci, L., et al. (2009). 
Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 11, 1305-
1314. 
Evans, M.J., and Kaufman, M.H. (1981). ESTABLISHMENT IN CULTURE OF 
PLURIPOTENTIAL CELLS FROM MOUSE EMBRYOS. Nature 292, 154-156. 
Folmes, C.D., Nelson, T.J., Martinez-Fernandez, A., Arrell, D.K., Lindor, J.Z., 
Dzeja, P.P., Ikeda, Y., Perez-Terzic, C., and Terzic, A. (2011). Somatic oxidative 
bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear 
reprogramming. Cell metabolism 14, 264-271. 
Freund, A., Laberge, R.M., Demaria, M., and Campisi, J. (2012). Lamin B1 loss is a 
senescence-associated biomarker. Molecular biology of the cell 23, 2066-2075. 
Frith, J.E., Thomson, B., and Genever, P.G. (2010). Dynamic Three-Dimensional 
Culture Methods Enhance Mesenchymal Stem Cell Properties and Increase 
Therapeutic Potential. Tissue Eng Part C-Methods 16, 735-749. 
Gurdon, J.B. (1962). DEVELOPMENTAL CAPACITY OF NUCLEI TAKEN 
FROM INTESTINAL EPITHELIUM CELLS OF FEEDING TADPOLES. Journal 
of Embryology and Experimental Morphology 10, 622-&. 
Harris, H., and Rubinsztein, D.C. (2012). Control of autophagy as a therapy for 
neurodegenerative disease. Nature reviews Neurology 8, 108-117. 
211 
Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K., 
Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., et al. (2009). Rapamycin fed 
late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395. 
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, 
K., and Yamanaka, S. (2009). Suppression of induced pluripotent stem cell 
generation by the p53-p21 pathway. Nature 460, 1132-1135. 
Huang, P.Y., He, Z.Y., Ji, S.Y., Sun, H.W., Xiang, D., Liu, C.C., Hu, Y.P., Wang, 
X., and Hui, L.J. (2011). Induction of functional hepatocyte-like cells from mouse 
fibroblasts by defined factors. Nature 475, 386-U142. 
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E., and 
Melton, D.A. (2008a). Induction of pluripotent stem cells by defined factors is 
greatly improved by small-molecule compounds. Nature biotechnology 26, 795-797. 
Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., 
Muhlestein, W., and Melton, D.A. (2008b). Induction of pluripotent stem cells from 
primary human fibroblasts with only Oct4 and Sox2. Nature biotechnology 26, 1269-
1275. 
Ichida, J.K., Blanchard, J., Lam, K., Son, E.Y., Chung, J.E., Egli, D., Loh, K.M., 
Carter, A.C., Di Giorgio, F.P., Koszka, K., et al. (2009). A small-molecule inhibitor 
of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell stem 
cell 5, 491-503. 
Ieda, M., Fu, J.D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B.G., 
and Srivastava, D. (2010). Direct Reprogramming of Fibroblasts into Functional 
Cardiomyocytes by Defined Factors. Cell 142, 375-386. 
James, D., Levine, A.J., Besser, D., and Hemmati-Brivanlou, A. (2005). 
TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in 
human embryonic stem cells. Development 132, 1273-1282. 
212 
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., 
Kominami, E., Ohsumi, Y., and Yoshimori, T. (2003). LC3, a mammalian homolog 
of yeast Apg8p, is localized in autophagosome membranes after processing (vol 19, 
pg 5720, 2000). Embo J 22, 4577-4577. 
Kawamura, T., Suzuki, J., Wang, Y.V., Menendez, S., Morera, L.B., Raya, A., Wahl, 
G.M., and Izpisua Belmonte, J.C. (2009). Linking the p53 tumour suppressor 
pathway to somatic cell reprogramming. Nature 460, 1140-1144. 
Kidder, B.L., Palmer, S., and Knott, J.G. (2009). SWI/SNF-Brg1 regulates self-
renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem 
cells 27, 317-328. 
Kim, J.B., Greber, B., Arauzo-Bravo, M.J., Meyer, J., Park, K.I., Zaehres, H., and 
Scholer, H.R. (2009a). Direct reprogramming of human neural stem cells by OCT4. 
Nature 461, 649-643. 
Kim, J.B., Sebastiano, V., Wu, G., Arauzo-Bravo, M.J., Sasse, P., Gentile, L., Ko, 
K., Ruau, D., Ehrich, M., van den Boom, D., et al. (2009b). Oct4-induced 
pluripotency in adult neural stem cells. Cell 136, 411-419. 
Kim, J.B., Zaehres, H., Wu, G., Gentile, L., Ko, K., Sebastiano, V., Arauzo-Bravo, 
M.J., Ruau, D., Han, D.W., Zenke, M., et al. (2008). Pluripotent stem cells induced 
from adult neural stem cells by reprogramming with two factors. Nature 454, 646-
650. 
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji, H., 
Ehrlich, L.I., et al. (2010). Epigenetic memory in induced pluripotent stem cells. 
Nature 467, 285-290. 
Kim, Y., Sharov, A.A., McDole, K., Cheng, M., Hao, H., Fan, C.M., Gaiano, N., Ko, 
M.S., and Zheng, Y. (2011). Mouse B-type lamins are required for proper 
organogenesis but not by embryonic stem cells. Science 334, 1706-1710. 
213 
Klionsky, D.J., and Emr, S.D. (2000). Cell biology - Autophagy as a regulated 
pathway of cellular degradation. Science 290, 1717-1721. 
Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-
705. 
Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther, M.G., Levine, S.S., Kumar, R.M., 
Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K., et al. (2006). Control of 
developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 
301-313. 
Lin, T.X., Ambasudhan, R., Yuan, X., Li, W.L., Hilcove, S., Abujarour, R., Lin, 
X.Y., Hahm, H.S., Hao, E., Hayek, A., et al. (2009). A chemical platform for 
improved induction of human iPSCs. Nat Methods 6, 805-U824. 
Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., 
Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S., et al. (2011). 
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem 
cells. Nature 471, 68-73. 
Loh, Y.H., Zhang, W., Chen, X., George, J., and Ng, H.H. (2007). Jmjd1a and 
Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem 
cells. Genes & development 21, 2545-2557. 
Maherali, N., and Hochedlinger, K. (2009). Tgfbeta signal inhibition cooperates in 
the induction of iPSCs and replaces Sox2 and cMyc. Current biology : CB 19, 1718-
1723. 
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., 
Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007). Directly reprogrammed 
fibroblasts show global epigenetic remodeling and widespread tissue contribution. 
Cell stem cell 1, 55-70. 
Marion, R.M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-
Capetillo, O., Serrano, M., and Blasco, M.A. (2009a). A p53-mediated DNA damage 
214 
response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 
1149-1153. 
Marion, R.M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M., 
and Blasco, M.A. (2009b). Telomeres acquire embryonic stem cell characteristics in 
induced pluripotent stem cells. Cell stem cell 4, 141-154. 
Martin, G.R. (1981). ISOLATION OF A PLURIPOTENT CELL-LINE FROM 
EARLY MOUSE EMBRYOS CULTURED IN MEDIUM CONDITIONED BY 
TERATOCARCINOMA STEM-CELLS. Proceedings of the National Academy of 
Sciences of the United States of America-Biological Sciences 78, 7634-7638. 
Martin, G.R., and Evans, M.J. (1975). DIFFERENTIATION OF CLONAL LINES 
OF TERATOCARCINOMA CELLS - FORMATION OF EMBRYOID BODIES 
INVITRO. Proc Natl Acad Sci U S A 72, 1441-1445. 
Martina, J.A., Chen, Y., Gucek, M., and Puertollano, R. (2012). MTORC1 functions 
as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. 
Autophagy 8, 903-914. 
Meshorer, E., Yellajoshula, D., George, E., Scambler, P.J., Brown, D.T., and Misteli, 
T. (2006). Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic 
stem cells. Developmental cell 10, 105-116. 
Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., 
Bernstein, B.E., Jaenisch, R., Lander, E.S., and Meissner, A. (2008). Dissecting 
direct reprogramming through integrative genomic analysis. Nature 454, 49-55. 
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., 
Maruyama, M., Maeda, M., and Yamanaka, S. (2003). The homeoprotein Nanog is 
required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 
631-642. 
Moepps, B., Braun, M., Knopfle, K., Dillinger, K., Knochel, W., and Gierschik, P. 
(2000). Characterization of a Xenopus laevis CXC chemokine receptor 4: 
215 
implications for hematopoietic cell development in the vertebrate embryo. Eur J 
Immunol 30, 2924-2934. 
Morselli, E., Galluzzi, L., Kepp, O., Criollo, A., Maiuri, M.C., Tavernarakis, N., 
Madeo, F., and Kroemer, G. (2009). Autophagy mediates pharmacological lifespan 
extension by spermidine and resveratrol. Aging-US 1, 961-970. 
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., 
Okita, K., Mochiduki, Y., Takizawa, N., and Yamanaka, S. (2008). Generation of 
induced pluripotent stem cells without Myc from mouse and human fibroblasts. 
Nature biotechnology 26, 101-106. 
Nichols, J., Evans, E.P., and Smith, A.G. (1990). ESTABLISHMENT OF GERM-
LINE-COMPETENT EMBRYONIC STEM (ES) CELLS USING 
DIFFERENTIATION INHIBITING ACTIVITY. Development 110, 1341-1348. 
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, 
I., Scholer, H., and Smith, A. (1998). Formation of pluripotent stem cells in the 
mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391. 
Niwa, H., Miyazaki, J., and Smith, A.G. (2000). Quantitative expression of Oct-3/4 
defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genet 
24, 372-376. 
Obokata, H., Sasai, Y., Niwa, H., Kadota, M., Andrabi, M., Takata, N., Tokoro, M., 
Terashita, Y., Yonemura, S., Vacanti, C.A., et al. (2014a). Bidirectional 
developmental potential in reprogrammed cells with acquired pluripotency. Nature 
505, 676-680. 
Obokata, H., Wakayama, T., Sasai, Y., Kojima, K., Vacanti, M.P., Niwa, H., 
Yamato, M., and Vacanti, C.A. (2014b). Stimulus-triggered fate conversion of 
somatic cells into pluripotency. Nature 505, 641-647. 
Okamoto, K., Okazawa, H., Okuda, A., Sakai, M., Muramatsu, M., and Hamada, H. 
(1990). A NOVEL OCTAMER BINDING TRANSCRIPTION FACTOR IS 
216 
DIFFERENTIALLY EXPRESSED IN MOUSE EMBRYONIC-CELLS. Cell 60, 
461-472. 
Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-competent 
induced pluripotent stem cells. Nature 448, 313-317. 
Oldershaw, R.A., Baxter, M.A., Lowe, E.T., Bates, N., Grady, L.M., Soncin, F., 
Brison, D.R., Hardingham, T.E., and Kimber, S.J. (2010). Directed differentiation of 
human embryonic stem cells toward chondrocytes. Nature biotechnology 28, 1187-
1194. 
Pajerowski, J.D., Dahl, K.N., Zhong, F.L., Sammak, P.J., and Discher, D.E. (2007). 
Physical plasticity of the nucleus in stem cell differentiation. Proc Natl Acad Sci U S 
A 104, 15619-15624. 
Panopoulos, A.D., Yanes, O., Ruiz, S., Kida, Y.S., Diep, D., Tautenhahn, R., 
Herrerias, A., Batchelder, E.M., Plongthongkum, N., Lutz, M., et al. (2012). The 
metabolome of induced pluripotent stem cells reveals metabolic changes occurring in 
somatic cell reprogramming. Cell research 22, 168-177. 
Pittenger, M.F. (1999). Multilineage Potential of Adult Human Mesenchymal Stem 
Cells. Science 284, 143-147. 
Rais, Y., Zviran, A., Geula, S., Gafni, O., Chomsky, E., Viukov, S., Mansour, A.A., 
Caspi, I., Krupalnik, V., Zerbib, M., et al. (2013). Deterministic direct 
reprogramming of somatic cells to pluripotency. Nature 502, 65-70. 
Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, 
F., Easton, D.F., Duden, R., O'Kane, C.J., et al. (2004). Inhibition of mTOR induces 
autophagy and reduces toxicity of polyglutamine expansions in fly and mouse 
models of Huntington disease. Nat Genet 36, 585-595. 
Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A., and Bongso, A. (2000). 
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. 
Nature biotechnology 18, 399-404. 
217 
Rosner, M.H., Vigano, M.A., Ozato, K., Timmons, P.M., Poirier, F., Rigby, P.W.J., 
and Staudt, L.M. (1990). A POU-DOMAIN TRANSCRIPTION FACTOR IN 
EARLY STEM-CELLS AND GERM-CELLS OF THE MAMMALIAN EMBRYO. 
Nature 345, 686-692. 
Rubinsztein, D.C. (2006). The roles of intracellular protein-degradation pathways in 
neurodegeneration. Nature 443, 780-786. 
Rubinsztein, D.C., Marino, G., and Kroemer, G. (2011). Autophagy and aging. Cell 
146, 682-695. 
Ruiz, S., Panopoulos, A.D., Herrerias, A., Bissig, K.D., Lutz, M., Berggren, W.T., 
Verma, I.M., and Izpisua Belmonte, J.C. (2011). A high proliferation rate is required 
for cell reprogramming and maintenance of human embryonic stem cell identity. 
Current biology : CB 21, 45-52. 
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D.L., Valenza, M., Gennarino, 
V.A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R.S., et al. (2009). A 
gene network regulating lysosomal biogenesis and function. Science 325, 473-477. 
Sehgal, P., Chaturvedi, P., Kumaran, R.I., Kumar, S., and Parnaik, V.K. (2013). 
Lamin A/C haploinsufficiency modulates the differentiation potential of mouse 
embryonic stem cells. PloS one 8, e57891. 
Settembre, C., De Cegli, R., Mansueto, G., Saha, P.K., Vetrini, F., Visvikis, O., 
Huynh, T., Carissimo, A., Palmer, D., Klisch, T.J., et al. (2013). TFEB controls 
cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell 
Biol 15, 647-658. 
Settembre, C., Di Malta, C., Polito, V.A., Garcia Arencibia, M., Vetrini, F., Erdin, 
S., Erdin, S.U., Huynh, T., Medina, D., Colella, P., et al. (2011). TFEB links 
autophagy to lysosomal biogenesis. Science 332, 1429-1433. 
Settembre, C., Zoncu, R., Medina, D.L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., 
Ferron, M., Karsenty, G., Vellard, M.C., et al. (2012). A lysosome-to-nucleus 
218 
signalling mechanism senses and regulates the lysosome via mTOR and TFEB. The 
EMBO journal 31, 1095-1108. 
Shi, Y., Do, J.T., Desponts, C., Hahm, H.S., Scholer, H.R., and Ding, S. (2008). A 
combined chemical and genetic approach for the generation of induced pluripotent 
stem cells. Cell stem cell 2, 525-528. 
Shimi, T., Butin-Israeli, V., Adam, S.A., Hamanaka, R.B., Goldman, A.E., Lucas, 
C.A., Shumaker, D.K., Kosak, S.T., Chandel, N.S., and Goldman, R.D. (2011). The 
role of nuclear lamin B1 in cell proliferation and senescence. Genes & development 
25, 2579-2593. 
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T.W., and Smith, A. 
(2008). Promotion of reprogramming to ground state pluripotency by signal 
inhibition. PLoS biology 6, e253. 
Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M., and 
Rogers, D. (1988). INHIBITION OF PLURIPOTENTIAL EMBRYONIC STEM-
CELL DIFFERENTIATION BY PURIFIED POLYPEPTIDES. Nature 336, 688-
690. 
Szabo, E., Rampalli, S., Risueno, R.M., Schnerch, A., Mitchell, R., Fiebig-Comyn, 
A., Levadoux-Martin, M., and Bhatia, M. (2010). Direct conversion of human 
fibroblasts to multilineage blood progenitors. Nature 468, 521-526. 
Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., and Tada, T. (2001). Nuclear 
reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11, 
1553-1558. 
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and 
Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human 
fibroblasts by defined factors. Cell 131, 861-872. 
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from 
mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. 
219 
Tesar, P.J., Chenoweth, J.G., Brook, F.A., Davies, T.J., Evans, E.P., Mack, D.L., 
Gardner, R.L., and McKay, R.D. (2007). New cell lines from mouse epiblast share 
defining features with human embryonic stem cells. Nature 448, 196-199. 
Thomson, J.A. (1998). Embryonic stem cell lines derived from human blastocysts 
(vol 282, pg 1147, 1998). Science 282, 1827-1827. 
Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., Becker, R.A., 
and Hearn, J.P. (1995). ISOLATION OF A PRIMATE EMBRYONIC STEM-CELL 
LINE. Proc Natl Acad Sci U S A 92, 7844-7848. 
Tsai, S.Y., Bouwman, B.A., Ang, Y.S., Kim, S.J., Lee, D.F., Lemischka, I.R., and 
Rendl, M. (2011). Single Transcription Factor Reprogramming of Hair Follicle 
Dermal Papilla Cells to Induced Pluripotent Stem Cells. Stem cells 29, 964-971. 
Tsai, S.Y., Clavel, C., Kim, S., Ang, Y.S., Grisanti, L., Lee, D.F., Kelley, K., and 
Rendl, M. (2010). Oct4 and klf4 reprogram dermal papilla cells into induced 
pluripotent stem cells. Stem cells 28, 221-228. 
Tsukamoto, S., Kuma, A., Murakami, M., Kishi, C., Yamamoto, A., and Mizushima, 
N. (2008). Autophagy is essential for preimplantation development of mouse 
embryos. Science 321, 117-120. 
Vallier, L., Alexander, M., and Pedersen, R.A. (2005). Activin/Nodal and FGF 
pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell 
Sci 118, 4495-4509. 
Varga, M., Sass, M., Papp, D., Takacs-Vellai, K., Kobolak, J., Dinnyes, A., 
Klionsky, D.J., and Vellai, T. (2013). Autophagy is required for zebrafish caudal fin 
regeneration. Cell death and differentiation. 
Varum, S., Rodrigues, A.S., Moura, M.B., Momcilovic, O., Easley, C.A.t., Ramalho-
Santos, J., Van Houten, B., and Schatten, G. (2011). Energy metabolism in human 
pluripotent stem cells and their differentiated counterparts. PloS one 6, e20914. 
220 
Vazquez-Martin, A., Cufi, S., Corominas-Faja, B., Oliveras-Ferraros, C., Vellon, L., 
and Menendez, J.A. (2012). Mitochondrial fusion by pharmacological manipulation 
impedes somatic cell reprogramming to pluripotency: New insight into the role of 
mitophagy in cell stemness. Aging-US 4, 393-401. 
Vierbuchen, T., Ostermeier, A., Pang, Z.P., Kokubu, Y., Sudhof, T.C., and Wernig, 
M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. 
Nature 463, 1035-U1050. 
Wagers, A.J., and Weissman, I.L. (2004). Plasticity of adult stem cells. Cell 116, 
639-648. 
Wang, S., Xia, P., Ye, B., Huang, G., Liu, J., and Fan, Z. (2013). Transient 
Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important 
Early Step in Reprogramming to Pluripotency. Cell stem cell 13, 617-625. 
Wernig, M., Meissner, A., Cassady, J.P., and Jaenisch, R. (2008). c-Myc is 
dispensable for direct reprogramming of mouse fibroblasts. Cell stem cell 2, 10-12. 
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., 
Bernstein, B.E., and Jaenisch, R. (2007). In vitro reprogramming of fibroblasts into a 
pluripotent ES-cell-like state. Nature 448, 318-324. 
Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., and Campbell, K.H.S. (1997). 
Viable offspring derived from fetal and adult mammalian cells (vol 385, pg 810, 
1997). Nature 386, 200-200. 
Yamanaka, S. (2012). Induced pluripotent stem cells: past, present, and future. Cell 
stem cell 10, 678-684. 
Yang, S.H., Chang, S.Y., Yin, L., Tu, Y., Hu, Y., Yoshinaga, Y., de Jong, P.J., Fong, 
L.G., and Young, S.G. (2011). An absence of both lamin B1 and lamin B2 in 
keratinocytes has no effect on cell proliferation or the development of skin and hair. 
Human molecular genetics 20, 3537-3544. 
221 
Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, 
P., and Smith, A. (2008). The ground state of embryonic stem cell self-renewal. 
Nature 453, 519-523. 
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, 
S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced pluripotent 
stem cell lines derived from human somatic cells. Science 318, 1917-1920. 
Zhang, J., Nuebel, E., Daley, G.Q., Koehler, C.M., and Teitell, M.A. (2012). 
Metabolic regulation in pluripotent stem cells during reprogramming and self-
renewal. Cell stem cell 11, 589-595. 
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., and Melton, D.A. (2008). In vivo 
reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632. 
Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., 
and Ding, S. (2010). Reprogramming of human primary somatic cells by OCT4 and 
chemical compounds. Cell stem cell 7, 651-655. 
 
 
